World Health Assembly Condemns Iranian Strikes on Gulf States, Health Fallout of Hormuz Closure 21/05/2026 Stefan Anderson The 79th World Health Assembly in session. GENEVA – The World Health Assembly (WHA) voted 91-2 to adopt a resolution condemning Iranian attacks on civilian infrastructure across Gulf countries amid its war with the United States and Israel. The resolution condemns “in the strongest terms” the Iranian attacks on civilians and civilian objects in Gulf states and Jordan, citing damage to “medical and healthcare facilities, water desalination plants, energy facilities, airports and ports.” It further calls on member states to safeguard health system continuity and address disruptions to maritime routes, “including through the Strait of Hormuz, in order to safeguard global health supply chains.” Support for the resolution, spearheaded by the states of the Gulf Cooperation Council (GCC) and Jordan, included every country in the Middle East excluding Iran, all European Union Members, and Ukraine, which has rallied alongside Gulf states due to Iran’s role in supplying drones used by Russia to invade its skies. “These public health consequences addressed in this resolution clearly fall within the mandate of the WHO, and it focuses exclusively on the public health consequences and humanitarian locations resulting from their terrorist Iranian attacks,” the United Arab Emirates said following the vote. Iran was joined only by Nicaragua in opposition. WHA79 voting on the resolution on Iran’s attacks on the Gulf states. “These attacks also have health implications at the global level,” the UAE added. “As we’ve seen from Iran’s disruption of the Strait of Hormuz, and to the essential lifelines for the delivery of medicines, vaccines, medical products, essential health commodities, food, and fuel, all of which are necessary for the functioning of health systems.” The Iranian delegation described the resolution as applying “a selective use of international law”, which it called “inconsistent with the technical, evidence-based and impartial character of this organisation” and setting “a dangerous precedent that risks eroding the main objective and functions” of the WHO. “The proposed text deliberately ignores severe damages inflicted on Iran’s own health infrastructure as a result of military actions in the region,” its delegate said. “It fails to acknowledge the root causes of the current situation, including provocations and aggressions that compel defensive responses while presenting a distorted and incomplete picture of events.” The resolution asks WHO Director-General Dr Tedros Adhanom Ghebreyesus to deliver two reports to next year’s WHA: a global assessment of how Hormuz disruptions and rising energy and transport costs are affecting access to medicines, vaccines and essential health commodities in low- and middle-income countries, and a separate report on the mental health toll of the Iranian attacks and on supply-chain delays for humanitarian medical deliveries. “We are deeply concerned by the suffering of civilians and the destruction of health systems, civilian infrastructure, and supply chains,” Indonesia’s delegation said. “The destruction is profound, but it has not fallen equally across the region. A credible public health response is possible only when all parties cease hostilities and return to the path of diplomacy.” Notable abstentions Thirty-one countries abstained, including Switzerland, Mexico, Russia, South Africa, Brazil, China, Indonesia and Malaysia. China described the Iranian crisis as “one of the most urgent challenges” faced by the international community – and became the only country in the assembly to address the US-sized elephant in the room. “The root cause of this crisis is that an individual country, without the Security Council’s authorisation, has flagrantly launched a military attack on Iran, which seriously violates the basic norms governing international relations based on the principles of the UN charter,” China said. “WHO’s response should follow the principles of objectivity, neutrality, and professionalism, which will help de-escalate the situation rather than aggravating tensions.” South Africa, acknowledging the severe threat of rising energy, fertilizer and seed costs on the livelihoods of people on the African continent in particular, struck a similar middle-ground, noting that while there can be “no military solution” to the war, its “root causes cannot be ignored.” “We have spoken out against attacks on all sides of the conflict. The ravages of the conflict across the region must be acknowledged, as we cannot afford to create a hierarchy of victims,” said South Africa. Strait of Hormuz supply shocks The resolution takes particular aim at the continued de facto closure of the Strait of Hormuz, which has seriously disrupted supply chains for life-saving medicines, food, fertiliser, fuel and commodities on which health systems and the livelihoods of civilian populations depend. “The continued closure of the Strait of Hormuz remains a critical pressure point, disrupting global supply chains and increasing the cost of essential medical commodities,” said WHO Assistant Director-General Dr Chikwe Ihekweazu. “Humanitarian settings are already experiencing funding shortages, now further compounded by fuel, food, and medicine costs.” Several countries in the midst of intense conflicts worsened by the closure of the Strait, including Sudan, Somalia and Yemen, joined the resolution as co-authors. None of the three currently holds voting powers at the WHO due to unpaid membership dues. “The de facto closure of the Strait of Hormuz has only compounded the impacts on already devastated healthcare systems in some of the most vulnerable humanitarian contexts in the world, from Sudan to Gaza,” the UK delegation said. “The delayed supply of medicines and vaccines, and the increasing fuel costs, are reducing the reliability of essential services.” Both the US and Iran blame the closure on one another. Iran has turned the Strait into a minefield and begun enforcing a tiered system of checkpoints and fees, and the US military continues to enforce a blockade on vessels bound for Iran. Countries on both sides of the resolution vote reaffirmed the importance of opening the Strait. Healthcare is a war target now The resolution’s focus on the security of medical personnel and facilities reflects growing concern about the dark tide of violence against health workers and facilities that has come to define modern conflicts. “It cannot be emphasised enough that civilian healthcare personnel, hospitals, and medical facilities must be respected and protected at all times in accordance with international humanitarian law,” Malaysia’s delegate said. Attacks on hospitals, once cause for severe international reckoning and condemnation, are now routine in wars around the globe. Healthcare – in current wars – is now a target. Russian strikes on Ukrainian healthcare since the start of its full-scale invasion surpassed the 3,000 mark earlier this month. In Gaza, WHO has confirmed 2,148 attacks on healthcare since the war began, resulting in 1,048 deaths – destruction so complete UN Special Rapporteurs call it a “medicide”. Amid Sudan’s brutal civil war, the violence inflicted on medical facilities and personnel – particularly in the throws the ongoing genocide in Darfur – is equally extreme, with WHO confirming at least 2,052 deaths. No healthcare strikes While Iran has launched hundreds of missile and drone strikes throughout the region – hitting residential buildings, desalination plants, energy infrastructure, hotels, airports, embassies and other civilian targets, resulting in 41 deaths – no direct attacks on healthcare against Gulf States or Jordan have been documented in the WHO’s Surveillance System for Attacks on Healthcare (SSA) database. Independent global verification authorities, including conflict monitor ACLED and Human Rights Watch, equally list no attacks on healthcare in Gulf countries by Iran’s strikes, out of 660 listed. Israeli health facilities have been hit nine times by Iranian attacks. No deaths or injuries occurred as a result of those strikes, according to WHO data. However, Iranian strikes have repeatedly hit desalination plants, the foundation of clean water systems in the Gulf. Another attack set a fire outside the UAE’s largest nuclear power plant, raising fears it could be targeted again. “Several Gulf countries rely on desalination for 70 to 90% of safe water supplies, making these systems both essential and highly vulnerable,” said Dr Hanan Balky, WHO’s Eastern Mediterranean regional director. “Damage to energy and desalination infrastructure carry major public health risks, including worsening air pollution, disruption to safe water supply and sanitation, and reduced continuity of essential health services.” Resolution from Iran defeated On Tuesday, Lebanon received overwhelming support from the majority of member states in the wake of Israeli attacks on its health infrastructure. Ninety-five member states voted in favour of a resolution that noted “a health emergency in Lebanon resulting from ongoing and recently intensified hostilities” and called for “the full protection of healthcare in Lebanon, including patients, health personnel, facilities and transport”. Only Israel and Honduras opposed the resolution, which did not name Israel as the aggressor. SSA documents 170 attacks on health infrastructure in Lebanon, resulting in 116 deaths of medical personnel and patients. Israeli strikes so far have killed around 2,700 people. “Millions of people have been displaced, approximately 3.2 million internally displaced people in the Islamic Republic, and one million in Lebanon,” Ihekweazu said, citing IOM figures. Meanwhile, the SSA has confirmed 32 attacks on Iranian health facilities since the onset of the violence, resulting in 12 deaths. The US and Israel have launched thousands of bombs across the country, killing a total of at least 3,375 people. However, during the same debate on Tuesday, Iran’s resolution, condemning recent attacks on its patients and health infrastructure, including on the Pasteur Institute, was defeated. Only 19 countries supported Iran, 30 voted against, and a whopping 58 countries abstained. Several countries cited Iran’s attacks against its own citizens and Gulf states, and the blockade of the Strait of Hormuz, preventing the flow of medical supplies, as reasons for not supporting the resolution. Image Credits: X/WHO. EXCLUSIVE: World Health Assembly to Suspend USA’s Voting Rights, Retains Iran’s 21/05/2026 Felix Sassmannshausen & Elaine Ruth Fletcher Delegates attend the WHA Committee B meeting in the Assembly Hall at the Palais des Nations on Thursday after the decision to restore Iranian voting rights. WHO member states on Thursday agreed to suspend the voting rights of the United States in the World Health Assembly as of May 2027 if some $280 million in outstanding 2024–25 dues remain unpaid – despite the US announcement of withdrawal last year. In the same resolution, the suspension of Iran’s voting rights was averted after it caught up on outstanding debts. The decision by WHA’s Committee B, which was approved by consensus and without any debate, signals that member states won’t recognize the US announced withdrawal from WHO in 2025 until the back dues are paid, in accordance with a Congressional decision made at the time when the US joined WHO in 1948. Former WHO Legal Counsel, Gian Luca Burci, described the little-noticed technical decision as politically and legally “consequential,” in a comment to Health Policy Watch. “Even with all the unavoidable ambiguities in such an unusual situation, WHO has not accepted its withdrawal because the US has not fulfilled the terms that they [the US] themselves imposed back in 1948. So, at least on the basis of the advice of the WHO Secretariat to the Executive Board in February, for WHO the US is still a member until it pays its assessed contribution.” The self-declared American exit in January 2025 forced the global health body to reduce its upcoming base budget by 21%, to $4.2 billion, leading to layoffs of nearly 25% of WHO staff in a convulsive year of internal programme cuts and reorganization. According to the WHO Constitution, there is no real provision for member states to withdraw. The sole exception was the US, which made the right to withdraw a condition of joining the global health body in 1948, a stipulation that WHO accepted at the time. However, according to the US’s own rules set by Congress, that right would only be effective if outstanding dues were paid, stating: “The United States reserves its right to withdraw from the organization on a one-year notice, provided, however, that the financial obligations of the United States to the organization shall be met in full for the organization’s current fiscal year.” And, if the following limbo continues, more years of unpaid US dues would technically pile up in 2026 – until the issue is otherwise resolved. WHA to decide on voting rights and Argentina’s exit Tomorrow, the Assembly is also set to address the self-declared departure of Argentina last year in what is likely to lead to a more prolonged debate. Draft decisions currently circulating propose two contradictory paths forward. A proposal put forward by Paraguay would formally “recognize” Argentina’s withdrawal – despite the absence of a legal exit ramp in the WHO constitution. However, a competing draft decision proposed by a separate group of countries, including Germany, takes a decidedly more passive approach. This alternate draft merely “takes note of the request from the UN legal counsel for a WHO clarification on the status of Argentina’s request to withdraw,” Burci explained. This manoeuvre intentionally leaves “the situation ambiguous because the membership is divided on whether Argentina has the right to withdraw, and so effectively the WHA doesn’t take any concrete decision.” If delegates were to adopt Paraguay’s proposal, it would set a significant legal precedent. The WHO Constitution currently contains no provision for a member state to withdraw, and the organization has never formally accepted such a departure in its history. When seven Soviet-bloc nations attempted to withdraw in 1949 and 1950, the organization refused to accept their exit. The WHO instead treated these states as “inactive members”. When the countries sought to resume active participation a few years later, the World Health Assembly allowed them to return by submitting a fraction of their unpaid dues, completely bypassing the need for a formal re-accession process. Looking ahead, the silent committee approval of the American suspension could, nonetheless, provoke more debate – and diplomatic fallout on the issue at Saturday’s final, plenary session. Typically, the decisions of the WHA’s two Committees (A and B) are merely gavelled to approval in rapid succession in the final plenary, with no further debate. But nothing about the US withdrawal from WHO has been typical. See related story: Stars and Stripes No Longer Flying at WHO – But US Can’t Really Leave Until Dues are Paid, Agency Says US suspension set for next year along with nine developing nations Along with the United States, the draft resolution also noted the suspension by 2027 of nine developing nations due to unpaid dues, including: Burundi, Côte d’Ivoire, Djibouti, Equatorial Guinea, Nigeria, Panama, São Tomé and Príncipe, Timor-Leste, and Turkmenistan. Strikingly, while African delegates urged members to pay their debts, the committee approved the penalty measure without any direct debate or remark regarding Iran or the ongoing US withdrawal. In the morning proceedings, the WHO Secretariat formally proposed amendments, striking Iran from the penalty list, alongside Grenada. “Grenada and Iran, Islamic Republic of, have made sufficient payment to clear their arrears, therefore are no longer at risk of losing voting privileges,” said the WHO Controller during the session. Before the assembly, Iran owed $3.29 million in arrears that triggered an automatic suspension warning under Article Seven of the WHO Constitution. Furthermore, Tehran carried a $7.15 million remaining balance under a special long-term settlement arrangement. However, it remains unclear exactly how much Tehran actually paid, as officials only confirmed the sum was “sufficient” to avert the penalty. According to the draft resolution A79-17, the voting rights of nine other countries, including Afghanistan, Dominica, Myanmar, Saint Lucia, Somalia, South Sudan, Sudan, Venezuela and Yemen were already suspended at the time of the opening of this year’s World Health Assembly, and will remain so until their outstanding dues are paid. Image Credits: Felix Sassmannshausen/HPW. Stopping Outbreaks at Source: Pandemic Preparedness Stumbles at Local Level 21/05/2026 Kerry Cullinan Health workers in the DRC put together protective gear during an Ebola outbreak in 2019. The world is not ready for the next pandemic – and it won’t be unless local capacity is strengthened, global health experts agreed at an event in Geneva on Tuesday. Does anyone brief cruise ship captains, cruise operators and passengers from Argentina that hantavirus is an endemic virus? asked Helen Clark, co-chair of the Independent Panel for Pandemic Preparedness and Response. “We can have perfect rules, but if we’re not risk-informed, if we’re not alert to the possibility of endemic viruses emerging, none of it is going to count for much,” said Clark, at an event co-hosted by the Independent Panel and the Global Health Centre‘s International Geneva Global Health Platform on Tuesday, alongside the World Health Assembly. Clark stressed that pandemic preparedness involves countries and people knowing their risk: “What are you looking out for? What are you preparing for?” But Dr Mariângela Simão, Brazil’s Secretary of Health and Environmental Surveillance, said that local health facilities “need to have access to diagnostics to help timely intervention”. She noted that hantavirus can be similar to dengue to start with, while dengue, chikungunya, and Zika all have similar characteristics in early infection. The current Ebola outbreak in the Democratic Republic of Congo (DRC) took over a month to detect, with a long journey from “village communities to specialised labs”, said Dr Edem Adzogenu, Global Emissary for the Accra Reset, Africa’s plan to move from aid dependency to health sovereignty. “The inability to detect was simply because of the unavailability of a broad-spectrum diagnostic,” he added. ”What that tells us is, no matter how much preparation you put in place, if it’s not comprehensive, you miss that process. “We’re talking about a country that, since 1976, has had cyclical outbreaks of Ebola, and still does not have the diagnostics to deal with detection at source.” Richard Horton (moderator) and panellists Els Torreele, Dr Mariângela Simão, Maria Guevara and Helen Clark. Mpox response ‘failed miserably’ Els Torreele, an advisor to The Independent Panel, recently completed research into the mpox outbreak – and describes the mpox response as having “failed miserably”. “We need to stop outbreaks when and where they occur, and this is the repeated lesson that we don’t seem to be able to learn,” said Torreele. The world realised that the global stockpiles of smallpox vaccines are effective against mpox – but during the international mpox outbreak in 2022, these were “made available mostly in the Americas and in Europe”, she said, adding that “none of these vaccines actually arrived at the endemic area”. “When the second mpox public health emergency of international concern (PHEIC) was declared [in 2024], we knew there was an effective vaccine, and again it wasn’t made available [immediately],” she pointed out. “WHO pre-qualification was requested, even though the vaccine was registered by the FDA, EMA, and had been shown in the global outbreak to be effective, so delay upon delay.” When vaccines eventually arrived in the DRC and other hot spots, “it was too little, too late because, in an epidemic response, vaccinating the right people at the right moment is critical to curb the pandemic”. Officials in one of the countries affected by the outbreak told Torreele that their vaccines arrived had arrived “when we didn’t have cases anymore”. In addition, only around 23% of all mpox cases were ultimately confirmed in the DRC because it took too long to get samples to Kinshasa and regional capitals for testing. Maria Guevara, international medical secretary for Médecins Sans Frontières (MSF), described the DRC’s health system as “broken”. “If you look at the 2024 national immunisation numbers data, their measles coverage is 55% Why? Because the vaccines aren’t coming there, even if there are existing supplies,” she said, adding that conflict made several areas “inaccessible”, and that there are also “administrative barriers” Two MSF Ebola treatment centres were burnt down in 2019 because community members didn’t trust them, Guevara pointed out. No trust, no PABS agreement Panellists Qatar’s Dr Hanan Al Kuwari, Edem Adzogenu, Global Emissary for the Accra Reset. and WHO’s Olla Shideed. Trust is a key ingredient in pandemic preparedness, said Hanan Al Kuwari, advisor to Qatar’s Prime Minister for Public Health Affairs. The lack of it is hampering agreement on the pathogen access and benefit-sharing (PABS) annex to the Pandemic Agreement. “Trust was weakened and jeopardised by specific facts during COVID-19. When South Africa rapidly sequenced and shared the Omicron variant, exactly what the global health agreements asked countries to do, more than 50 countries responded with immediate travel bans,” said Al Kuwari. “The TRIPS waiver, which could have enabled local vaccine production in the countries that needed it most [during COVID-19], did not receive the support required, reflecting the difficult tensions between global equity commitments and industrial needs. “Vaccines were not distributed equally, and health workers in poor nations went unprotected for months. These are not system failures in the abstract sense. These were decisions whose history sits at the PABS negotiating table with every delegation. That is why regaining trust is not a diplomatic formality. It is the operational precondition for PABS to work.” She described PABS as “the core equity commitment of the entire architecture, which determines whether the country that rapidly shares a pathogen sample will actually benefit from the vaccines and treatments that follow”. Al Kuwari stressed: “Until that is resolved, the agreement cannot be signed or ratified.” The hanavirus outbreak depended on “countries sharing data rapidly and openly, as well as on a WHO that is fully funded and retaining competent staff able to interpret the evidence and inform the decision makers and the public”, she added. Olla Shideed, WHO’s unit head for health emergencies governance, said that 64 countries had spoken in favour of a PABS agreement during a WHA debate on Monday. She, along with Clark, urged countries not to wait for agreement on PABS but to start implementing the Pandemic Agreement. “Speed is of the essence. Speed in detecting speed in surveillance, speed in reporting, and speed in coordinating the action at the national, regional level, and international levels is really what helps us to move forward.” No finances Adzogenu also pointed out that the countries worst affected by the current Ebola outbreak – the DRC and Uganda – have “really serious fiscal constraints” as they are servicing debt. “There’s the manufacturing gap as well,” he said, adding that the Accra Reset aims to ensure that countries have what they need on the ground. Clark said that the United Nations High-Level Meeting on Pandemic Prevention, Preparedness and Response (PPPR), scheduled for September, could push for the conclusion of the PABS negotiations. “But I think it needs to bang a drum on finance, because we’re talking global public goods here. If a disease gets away, it knows no sovereignty, gender, or whatever. “We need new ways of funding global public goods like preparedness. Some of the bold ideas out there, like global public investment, need member-state champions. “The global public investment model talks about everybody putting into the fund with applications according to need. If everyone’s putting up the money, low-income countries will get more say [in governance].” Image Credits: John Wessels/ MSF. Pharma Industry Demands Repositioning of Medical Innovation as Strategic Investment, Not Cost 21/05/2026 Felix Sassmannshausen Global health leaders discuss strategic medical innovation. From the left: Isabelle Kumar (moderator), Monique Vledder (World Bank), Penny Heaton (Johnson & Johnson), Florika Fink-Hooijer (EU HERA), and Michael Lobritz (Roche). Amid surging geopolitical tensions, increased global health threats, and strained public budgets, global health leaders and pharmaceutical executives converged in Geneva with a unified message: medical innovation must be treated as a critical investment not a healthcare drain. Showcasing this shift, Canada unveiled strategic investments and new regulations. GENEVA – Inside the packed ballroom of the luxurious Intercontinental Hotel, during a flagship event hosted by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) on Tuesday, large screens broadcast a simple promise of continuous innovation so that “the next generation of medicines and vaccines can deliver a healthier, stronger future”. “Pharmaceutical innovation has accounted for more than 70% of the increase in life expectancy across G20 and developing countries,” said moderator Isabelle Kumar in her opening remarks. But at the same time, G20 economies are losing an estimated one trillion dollars every year to preventable health conditions, she added. Exploring solutions at scale, the panel keynotes and discussions bridged public, private, and geopolitical sectors. The high-level speakers included Canadian Minister of Health Marjorie Michel and AstraZeneca chair Michel Demaré. They were followed by a panel discussion with Monique Vledder, World Bank Group global director, Florika Fink-Hooijer, Director-General of the EU’s Health Emergency Preparedness and Response Authority (HERA), Penny Heaton of Johnson & Johnson, and Michael Lobritz of Roche. The experts acknowledged that global health architecture currently faces immense strain from escalating vulnerabilities, including ageing populations, antimicrobial resistance, and rising rates of non-communicable diseases. Consequently, leaders urged a major mindset shift, positioning sustained investments in medical innovation as vital catalysts for economic growth. Health investments’ economic potential Despite their differing mandates, the panellists reached a firm consensus: governments must abandon short-term budgeting and invest in medical innovation to secure long-term national resilience and productivity. This demands a profound departure from reactive spending toward proactive strategic investments. IFPMA Director General David Reddy. Echoing this shared conviction during his concluding remarks, IFPMA Director General David Reddy emphasised the overarching economic value of the sector. “Investing in health innovation is not a tradeoff, it’s a multiplier,” said Reddy. To explain the broader economic stakes, the World Bank’s Vledder noted that an unhealthy workforce fundamentally stalls local economies, while funds flowing into the health sector offer tremendous potential for job creation. Industry pushes for tripling of prevention budgets AstraZeneca Chair Demaré reinforced this point, stating that a healthy population experiences fewer sick days and drives higher productivity. He highlighted that establishing a healthy global population could boost the GDP by 7% by 2050 – an economic gain equivalent to the combined economies of Germany and Japan. “So we need a mindset change here to look at medicine and especially innovative medicines as an investment for the future,” said Demaré. Early diagnosis and preventative treatments could drastically reduce long-term hospital costs and boost this overall economic productivity. Currently, OECD countries allocate an average of only 3% of their healthcare budgets to prevention, a figure Demaré argued should double or triple to have a real impact. He emphasised that this shift should rely heavily on functional public-private partnerships, pointing to specific collaborative efforts, such as the Partnership for Health System Sustainability and Resilience, which assesses health systems across more than 30 countries to identify localised governance gaps and propose targeted technological solutions. Canada announces strategic investment Canadian Health Minister Marjorie Michel announced a $131 million public investment into the Pan-Canadian Pharmaceutical Alliance. In the spirit of the industries’ demands, Canada positioned itself as a pragmatic, reliable partner in the global supply chain, navigating amidst geopolitical instability and contrasting its approach with nations relying heavily on threats and tariffs – an indirect reference to the United States under President Trump. “Tariffs are not the Canadian way. Our values are anchored in respect yet viability, predictability and collaboration and the fundamental belief in talent and research,” said Michel. Breaking news on the IFPMA stage, she announced a fresh $131 million injection into the Pan-Canadian Pharmaceutical Alliance. The public investment aims to unify Canada’s fragmented healthcare system into a single market, thereby accelerating drug price negotiations and reducing administrative burdens. The government had also previously announced $1.7 billion to attract world-leading researchers, transforming the nation into a clinical trial powerhouse. By modernising clinical trial frameworks and aligning with international regulators, Canada aims to reduce the time between drug submission and approval by up to 50%. “We need a regulatory system that is timely, predictable, and grounded in science. One that fiercely protects Canadians while giving companies a clear reason to invest in Canada,” said Michel. AstraZeneca Chair Michel Demaré calls for tripling prevention budgets during an IFPMA panel discussion. Europe pivots to security amidst new threats Across the Atlantic, the EU is also heavily investing in its pharmaceutical sector to secure long-term strategic autonomy. Recent legislative moves, such as the Critical Medicines Act, aim to prevent medicine shortages, boost domestic manufacturing, and position the bloc as a global leader by fostering a competitive innovation ecosystem. However, these proactive health initiatives face a formidable obstacle: severe budget constraints compounded by escalating geopolitical conflicts. As financial resources shrink across Europe, medical innovation is increasingly losing critical funding to traditional military priorities against the backdrop of Russia’s ongoing war in Ukraine and increased geopolitical tension. “We had quite a stable budget, and then the political levels decided… we have security as a major risk. So we lost €1 billion… because indeed health got the lower priority,” said Fink-Hooijer. HERA Director-General Florika Fink-Hooijer. To maintain regional production capacity and true preparedness, Fink-Hooijer argued that European officials can no longer view medical innovation merely as an ad hoc healthcare cost. Instead, they must treat it as a foundational pillar of geopolitical defence through structured investments. Reflecting this shift in mindset, HERA actively bridges the gap between health and traditional security by establishing a dedicated unit to monitor advanced biowarfare risks. “We do have now also a civil-military unit in order to really look at that type of threat scenario… because we know that it could also be with AI abuse due to other types of artificial or intentionally produced pathogens,” Fink-Hooijer announced. Meanwhile, restricted public budgets inevitably force regulatory bodies into making high-stakes gambles on future threats. HERA recently directed its scarce resources toward developing a vaccine for the Ebola Sudan strain – a calculated strategic bet that became a bad choice in hindsight, Fink-Hooijer admitted, as it completely missed the current outbreak. Fragility, fragmentation and folly Roche’s Michael Lobritz outlined the industry’s structural vulnerabilities through what he termed the “three Fs”: fragility, fragmentation, and folly. While scientific capabilities accelerate at unprecedented rates and countries compete over production capacities, the global health architecture remains vulnerable to fragmented supply chains. Roche’s Lobritz outlined the industry’s structural weak points through what he termed the “three Fs”: fragility, fragmentation, and folly. He warned that innovation pipelines remain extremely fragile, lacking the investor capital necessary to mature early-stage compounds. Out of 14 viral families with pandemic potential, there are currently only 18 clinical compounds in development, mirroring similar capital shortages in the antimicrobial resistance market. Furthermore, fragmented ecosystems prevent diverse health sectors from coordinating effectively, leading to the dangerous folly of relying on reactive scaling during a sudden crisis without prior preparation. True resilience demands sustained, peacetime collaboration to ensure every therapeutic agent is ready before the crisis hits. Likening the pharmaceutical supply chain to a bustling restaurant kitchen handling a massive dinner rush, he emphasised the vast, unseen preparation required behind the scenes to successfully deliver the final product. “The creation of a novel medicine that changes the course of the life of an individual is not an eventuality or a certainty and needs to be supported,” concluded Lobritz. Addressing the global healthcare gap For this, governments must invest, also to ensure life-saving medical innovation actually reaches the populations that need it most, the participants argued. Outside the IFPMA ballroom, however, health equity advocates caution that framing high-cost pharmaceutical innovation and public-private partnerships as primary drivers of economic resilience can overshadow the need for fundamental strengthening of public health infrastructure, particularly in low- and middle-income countries where access to basic therapeutics remains a major obstacle. The challenge extends far beyond laboratory breakthroughs to the ultimate end-user. Outlining the World Bank’s current attempt to reach 1.5 billion people with essential health services, Vledder acknowledged that scientific innovation means little if delivery systems in fragile states remain broken. Global Health Needs More than Money – Philanthropy Can Amplify Impacts Image Credits: Felix Sassmannshausen/HPW. Russia Tries to Block Debate on Attacks on Health Facilities in Ukraine 20/05/2026 Disha Shetty Interior of a hospital room in Kherson heavily damaged during conflict, showing extensive structural destruction and debris. Neither Russia’s delegate banging her desk to interrupt Ukraine’s representative speaking at the World Health Assembly (WHA), nor her request to dismiss debate, stopped member states from condemning Russia’s attacks on Ukraine’s health system. A report by the World Health Organization’s (WHO) Director-General before delegates estimated that Russia’s aggression on Ukraine has caused 55,600 civilian casualties, including 14,999 deaths. Violence intensified in 2025 with civilian casualties going up by 31% compared to the previous year, and by 70% when compared to 2023. The WHO also documented 579 attacks on healthcare facilities that caused 19 deaths and 204 injuries among healthcare workers and patients in 2025. This was an 18% increase compared to 2024. “Since this report was published, WHO has recorded 190 new attacks on health care, with 86 injuries and 15 deaths between 1 January and 6 May, 2026,” said Dr Altaf Mossani, Director of Humanitarian Disaster Management, WHO Emergency Preparedness and Response program. “On May 14, a clearly marked United Nations vehicle was severely damaged by drone strikes in Kherson City. This is the second incident that week,” he added. Russia targeting healthcare infrastructure The 79th World Health Assembly in session. Countries raised alarm at the WHA that 202 of Ukraine’s 11,887 health facilities have been severely damaged, and 1,013 units are partially damaged. “We strongly condemn Russia’s ongoing war of aggression against Ukraine and the deliberate escalation of attacks targeting civilians and civilian infrastructure, including health care facilities, and we are deeply alarmed by the sharp increase in attacks on the health infrastructure since the last World Health Assembly,” Moldova’s representative told the WHA. Civilian attacks also drew sharp criticism, leaving Russia isolated during the discussion. “Russia’s attacks on energy infrastructure and other civilian targets, such as hospitals, elderly homes, or kindergartens, became increasingly vicious and brutal,” said Germany’s delegate. “On average, it has been said already, there have been more than 3,000 Russian attacks directly affecting health care institutions, two each day.” Ghana empathised with countries that are receiving a large number of refugees from Ukraine as a result of the conflict, resulting in an additional burden on their health systems. High drama by the Russian representative Russia’s representative to the WHA banged the desk to interrupt Ukraine’s speaker and called the WHO’s report on the health situation in Ukraine “disinformation.” Russia’s representative first moved to dismiss the debate on the report on Ukraine entirely. That request was put to a vote and defeated. Following extensive discussion on the report, Russia again moved to stop the WHA from noting the report. Russia was reminded that noting the report was merely procedural, but it requested a vote again. Once again, countries voted in favour of noting the report. At one point, the Russian representative banged the desk several times to interrupt the Ukrainian speaker, and was reminded to raise the country’s flag if she wanted to make a statement. Russia then accused the WHO of spreading misinformation. “WHO is talking only about attacks on Ukraine, ignoring the information that has been submitted to WHO on attacks on Russian facilities. So, we would ask WHO to stop misleading the world and to stop disseminating misinformation when it comes to voting on this report,” the representative accused. WHO’s report noted that there were 21 attacks on healthcare facilities in Russia, causing 17 injuries. Russia did not agree with this number. However, the Russian representative said, “more than 250 Russian facilities were attacked by Ukraine, and only 35 of them have been officially reported by WHO. And indeed, in the report, even that figure has deliberately been lowered”. Russia opposed the noting of the report by the WHA. The report was noted nevertheless, following a vote. Polio needs attention Polio remains endemic in the WHO’s Eastern Mediterranean Region (EMRO) region. WHA also discussed polio that remains an issue in several countries like Pakistan and Afghanistan. Conflicts and funding cuts have in recent years interrupted polio vaccination campaigns. In Gaza, polio made a resurgence as conflict raged. Most of these areas fall under the WHO’s Eastern Mediterranean Region (EMRO) region. “We are actually the last part of the world where that virus remains endemic, but we are doing our utmost to tackle this issue. We have seen, however, that in Afghanistan and Pakistan there have been declines in transmission trends, and we think that is a cause for optimism about wild polio virus transmission,” Libya said, making a statement on behalf of the EMRO region. Other countries reminded the WHA that polio is still a relevant issue that needs attention. “We wish to recall that polio is still a global health challenge because new cases of wild polio have been recorded in certain countries, and there are new coast cases in conflict areas. Then, hence, the need for further international effort to ensure that we have national and regional preparedness,” Oman’s representative told the WHA. Also read: Polio Eradication Imperiled by $2.3 Billion Funding Gap Image Credits: WHO Ukraine, X/WHO, WHO. WHO: Ebola Outbreak Is a Deadly Regional Threat But Not a Global Pandemic Risk 20/05/2026 Stefan Anderson The WHO has determined that the Ebola outbreak raising alarm worldwide does not pose a pandemic threat. GENEVA — The Ebola outbreak unfolding in the Democratic Republic of Congo (DRC) and Uganda poses a “low” risk globally, according to an expert committee of the World Health Organization (WHO). However, the national and regional risk is “high”, according to the International Health Regulations (IHR) Emergency Committee. Last Sunday, WHO Director-General Dr Tedros Adhanom Ghebreyesus had already declared the outbreak a public health emergency of international concern (PHEIC), the WHO’s second-highest level of alert, before convening the emergency committee. This is the first time in WHO’s history that this has occurred. Tedros was motivated by the scale and speed of the spread of the Bundibugyo virus, a rare and particularly deadly strain of Ebola, which has killed at least 131 people and infected over 500 others. The emergency meeting, convened on Tuesday to assess the threat of the current outbreak, concurred that the situation is a PHEIC but “not a pandemic emergency,” Tedros told a media briefing on Wednesday. The committee, chaired by Professor Lucille Blumberg, agreed with the Director-General’s assessment and is finalising its recommendations in the coming days. “Our prime aim was to support the decision and decide whether this is a public health emergency of international concern, and to consider whether there’s a pandemic emergency. The former was agreed to,” Blumberg said. Investigations into the outbreak’s origin Anaïs Legand speaking at the emergency press conference on the Ebola crisis. “Investigations are ongoing to ascertain when and where exactly this outbreak started,” said Anaïs Legand, a technical officer for high-threat pathogens at WHO’s health emergencies programme. “Given the scale, we are thinking that it has started probably a couple of months ago, but investigations are ongoing, and our priority is really to cut the transmission chain by implementing contact tracing, isolating and caring for all suspect and confirmed cases.” The Bundibugyo species was last seen in 2007, and there is currently no vaccine or treatment licensed for it. Investigators say the true scale of the epidemic in DRC is much larger than current case counts suggest. War, and a very long drive Dr Mohamed Yakub Janabi, WHO’s regional director for Africa. WHO officials laid out several reasons the outbreak escaped detection. The province of Ituri, where it emerged, is engulfed in war. Fighting between the DRC army and the M23 armed group has intensified in recent months, displacing more than 100,000 people. Beyond the conflict, eastern DRC is among the most challenging places in the world to mount a public health response. Health facilities are sparse, roads are limited, and much of the terrain is forested and mountainous. A previous Ebola outbreak in the same region in 2018-19 took close to two years to bring under control, even with a licensed vaccine available. Dr Mohamed Yakub Janabi, WHO’s regional director for Africa, said the combination of factors made early detection enormously difficult. “Detecting outbreaks such as Ebola in a complex setting like Ituri province in the DRC is inherently challenging,” he said. “Surveillance systems rely on a combination of community reporting, local health facilities, lab confirmation, and partner coordination.” Samples from the outbreak zone must travel 1,700 kilometres to reach the Institut National de Recherche Biomédicale in Kinshasa, the only facility in the country with the capacity to test for Bundibugyo. The distance to the capital is comparable to London to Warsaw – a roughly a 24-hour drive on smooth European roads, a far cry from the remote jungle tracks and dirt roads of Ituri. “In remote or insecure areas, it can take time for cases to be recognised and samples transported,” Janabi said. Symptoms mistaken for endemic diseases Nearly 7 tonnes of emergency medical supplies and equipment along with a team of 35 experts from WHO and the DRC’s health ministry, arrived today in Bunia from Kinshasa to support frontline #Ebola response in Ituri Province. The Bundibugyo strain’s early symptoms also overlap with diseases endemic to eastern DRC, leading health workers to mistake initial cases for more common illnesses. “Nonspecific early symptoms, for instance, if you take malaria and typhoid, the early symptoms are the same,” Tedros said. “The region is very endemic to those diseases, so the health workers will associate the early signs with malaria or typhoid, and they can’t diagnose based on the symptoms. They may start treating that.” Dr Abdi Mahamud, WHO’s director for health emergency alert and response operations, said the diagnostic challenge would have tripped up better-resourced systems. “This outbreak is happening in a highly endemic [setting for] other diseases that present similar symptoms – malaria, dysentery, and others,” he said. “If you don’t have that high index of suspicion, if you don’t have the right facility to test, even in high-income countries, you will have that delay in the start of an outbreak.” Diagnostic tests routinely used across the region added another layer of delay. The Bundibugyo strain belongs to a different genus, Orthoebolavirus, than the more common Zaire strain that most existing tests are optimised to detect. “There was a problem linked to the traditional test we use,” Tedros said. “The traditional test is optimised with Zaire, and the same sample was taken and tested, but since the test kit is optimised with Zaire, [Bundibugyo] could not be detected.” No vaccine, but a pipeline Vasee Moorthy, WHO’s research and development lead on the current outbreak, laid out the state of the vaccine pipeline for the Bundibugyo strain. The Bundibugyo strain has no licensed vaccine or therapeutic. WHO’s research and development lead, Vasee Moorthy, said a pipeline of candidates is being accelerated but remains months away. Moorthy said the most promising candidate is an rVSV Bundibugyo vaccine, the equivalent for this strain of Ervebo, the licensed Merck vaccine used against the more common Zaire Ebola strain since 2019. “There are no doses of this which are currently available for clinical trial, so this needs to be prioritised,” Moorthy said. “The information that we have is that this is likely to take six to nine months.” A second candidate, built on the ChAdOx1 platform used in the AstraZeneca COVID-19 vaccine, is being developed by Oxford and the Serum Institute of India. “They are manufacturing that as we speak, but there is no animal data to support [its efficacy],” Moorthy said. “It is possible that doses of that could be available for clinical trial in two to three months, but there is a lot of uncertainty about that.” Even in the most optimistic scenario, neither candidate is likely to be available to materially shape the trajectory of the current outbreak. In the meantime, the response is being built around the basics: safe treatment centres, patient referral pathways, contact tracing, and the protection of health workers, among whom the first confirmed case in the outbreak was identified. “The protection of healthcare workers and families is absolutely paramount,” Blumberg said. “The people in the area and those who respond need to be kept safe and allowed to be able to do what they need to do in a critical time such as this.” Tedros: Rubio suffers ‘lack of understanding’ US Secretary of State Marco Rubio. The WHO chief used the press conference to push back at US Secretary of State Marco Rubio, who said this week the agency had been “a little late to identify this thing.” The US has banned citizens of the DRC, Uganda and Sudan from entry, closed its only dedicated Ebola lab, withdrawn from the WHO, and defunded the agency. “On what the Secretary said, it could be from a lack of understanding of how IHR works, and the responsibilities of WHO and other entities,” Tedros said. “We don’t replace the country’s work, we only support them, so that’s why there could be some lack of understanding.” Tedros suggested conflict in the affected region was a more fundamental factor in the delay than anything WHO could have done differently. “Health facilities cannot work optimally when there is conflict and when the health workers are also fleeing as part of the community which is displaced,” he said. “It affects the whole surveillance system, and not only that, but it also affects access.” “I think that’s what we should understand, the secretary or others.” Asked repeatedly whether US funding cuts to DRC surveillance programmes had contributed to the outbreak going undetected, Tedros declined to draw a direct line. “We don’t need to jump to conclusions before we understand the whole complexity. It would be very difficult to associate it with funding alone,” he said, noting that the diagnostic gap was a question of the wrong tests being administered rather than supply. Legand echoed the point, noting the issue stems from test type, not supply: “For the time being, it’s not a supply issue. We need to ensure that the right platform with the right data arrives at the right place. This is the work that is being done as we speak.” The outbreak, meanwhile, continues to spread through a war zone with no vaccine, no cure, and a diagnostic system still catching up to the strain it now faces. Image Credits: @WHO African Region, Gage Skidmore. Grim Warning of Dwindling Funds for Emergencies as States Vote on Attacks in Lebanon and Iran 20/05/2026 Kerry Cullinan Dr Annette Heinzelmann, emergency director for the WHO Eastern Mediterranean Region (EMRO) The grim impossibility of addressing rising health emergencies with dwindling budgets was raised at the World Health Assembly (WHA) on Tuesday – amid votes on attacks on healthcare in Lebanon and Israel. “Outbreaks are accelerating, while the systems designed to stop them are being weakened,” warned Dr Annette Heinzelmann, emergency director for the WHO Eastern Mediterranean Region (EMRO), during a discussion of health emergencies in Committee A. “The gap between needs and resources is now unsustainable. The WHO Health Emergency Programme faced a $553 million funding gap in 2024 and 2025. The contingency fund for emergencies entered 2026 with just $19.5 million, while our regional emergency workforce has been cut by half. We cannot continue confronting expanding emergencies with shrinking capacity.” In EMRO, 117 million people need humanitarian assistance; there are 14 graded emergencies, 44 active outbreaks, and more than 50 public health events across 17 member states. “Conflict, displacement, climate shock, economic collapse, and diseases are colliding into a single expanding poly crisis,” Heinzelmann warned, speaking on behalf of the regional director. “Across Gaza, Sudan, Yemen, Somalia, and Afghanistan, and amid escalation affecting Iran, Syria, and Lebanon, WHO is sustaining trauma care, delivering medicines, reinforcing surveillance, and supporting governments to manage growing public health risks.” Votes on Lebanon and Iran Regional conflict is compounding the EMRO health crises. Lebanon received overwhelming support from the majority of member states in the wake of Israeli attacks on its health infrastructure – but there was little support for Iran’s appeal for support against similar attacks. Ninety-five member states voted in favour of a resolution that noted “a health emergency in Lebanon resulting from ongoing and recently intensified hostilities” and called for “the full protection of healthcare in Lebanon, including patients, health personnel, facilities and transport”. Only Israel and Honduras opposed the resolution, which did not name Israel as the aggressor. Voting on the resolution in support of Lebanon, following attacks on its health care by Israel. However, Iran’s resolution, condemning recent attacks on patients and health infrastructure, including on the Pasteur Institute – was defeated. The resolution did not mention Israel and the United States as the aggressors. Only 19 countries supported Iran, 30 voted against, and a whopping 58 countries abstained. Several countries cited Iran’s attacks against its own citizens and Gulf states, and the blockade of the Strait of Hormuz, preventing the flow of medical supplies, as reasons for not supporting the resolution. Voting on the resolution in support of Iran, in the wake of US and Israeli attacks on its health infrastructure. Haemorrhagic fever, extreme weather Voting came at the end of a discussion on the WHO’s involvement in health emergencies in the WHA’s Committee A. In 2025, WHO responded to 50 emergencies in 82 countries and territories, of which 20 were Grade 3 emergencies requiring the highest level of organisation-wide support, the organisation reported. Disease outbreaks included viral haemorrhagic fever: Sudan virus disease in Uganda; Marburg in Tanzania and Ethiopia; Ebola in the Democratic Republic of the Congo (DRC) and Rift Valley fever in Mauritania and Senegal. Mpox was declared a public health emergency of international concern (PHEIC), affecting 98 countries, with 52 974 confirmed cases – 84% in Africa – and 215 deaths. Thirty-three countries reported cholera outbreaks involving over 614 828 cases and 7,598 deaths. Angola, the DRC and Sudan had the highest cases. The WHO provided over 58 million doses of “emergency vaccines” for cholera, meningitis, yellow fever and Ebola. Challenges included “limited surveillance capacities and insufficient production of critical vaccines”. Three out of four emergencies were either caused or exacerbated by extreme weather events such as flooding, droughts and cyclones. Earthquakes in Afghanistan and Myanmar, severe Pacific typhoons and three category-5 hurricanes, including Hurricane Melissa, caused death and damage. The global cost of natural disasters is estimated at over $ 200 billion annually. So great was the demand for WHO’s assistance that its Contingency Fund for Emergencies was left with $19.5 million by the end of the year. Attacks on healthcare The severely destroyed Al-Shifa hospital in Gaza City, Palestine, in February 2025. Last year, the WHO verified 1,351 attacks on healthcare, resulting in 925 health facilities damaged or destroyed. The Independent Oversight and Advisory Committee (IOAC) for the WHO Health Emergencies Programme reports a “significant and alarming escalation” in these attacks that are likely to “underestimate the true scale of the crisis as reporting is uneven”. EMRO’s Heinzelmann said that almost 40% of these attacks occurred in her region, accounting for almost 90% of related deaths. “Attacks on healthcare must stop, humanitarian access must be guaranteed, and financing for preparedness and emergency response must increase now, not after the next global crisis is already underway,” she urged. Several member states, including Jordan, Switzerland, Australia, urged an end to attacks on health facilities and personnel and respect for international humanitarian law. Lack of financing The IOAC noted its deep concern at the “dramatic reductions in official development assistance from major donors”. During the 2008 global economic recession, the WHO “deprioritised” its emergency-related teams and reduced the workforce – but paid a high price during the Ebola outbreak in West Africa, “which resulted in over 11,000 lives lost and posed an existential threat to WHO”, noted the IOAC. “It is the IOAC’s responsibility to ensure that past weaknesses are not reprised and that WHO’s emergency capacities remain safeguarded.” In the WHO’s 2026‒2027 budget, the base budget of the emergencies programme has been set at $918.5 million, with 51% for country offices, 22% for regional offices and 27% for headquarters. Image Credits: Nour Alsaqqa/ MSF. WHO is Alarmed at ‘Scale and Speed’ of Ebola Outbreak as Hantavirus Threat Recedes 19/05/2026 Disha Shetty & Stefan Anderson Dr Tedros Adhanom Ghebreyesus is currently serving his second five-year term as WHO Director-General. His mandate expires on August 15, 2027. GENEVA — The outbreak of a deadly strain of Ebola for which there is no vaccine is accelerating through the Democratic Republic of Congo (DRC) and Uganda at a “scale and speed” alarming the World Health Organization (WHO), as cases climb and authorities scramble to contain the spread. “I’m deeply concerned about the scale and speed of the epidemic,” WHO chief Dr Tedros Adhanom Ghebreyesus told the 79th World Health Assembly on Tuesday, addressing delegates from 192 nations gathered in Geneva. More than 500 suspected cases and 130 suspected deaths beyond the confirmed caseload have been reported. Tedros said the figures would change as field operations scale up, including strengthening surveillance, contact tracing, and laboratory testing. “So far, 30 cases have been confirmed in the DRC from the northern province of Ituri,” he added. “Uganda has also informed WHO of two confirmed cases in the capital of Kampala, including one death among two individuals who travelled from DRC, and there is one US citizen confirmed positive and transferred to Germany.” “This epidemic is caused by Bundibugyo, a species of Ebola virus for which there are no vaccines or therapeutics,” Tedros said. Diagnostic tests in the region were designed for a different strain of Ebola and missed early infections, resulting in a four-week gap before the outbreak was detected. Ongoing shortages of diagnostic equipment on the frontlines mean the true size of the outbreak remains unknown. “In the absence of a vaccine, there are many other measures countries, of course, can take to stop the spread of this virus and save lives, even without medical countermeasures, including risk communication and community engagement,” Tedros said, commending Uganda for postponing its annual Martyrs’ Day celebrations, which can draw up to two million people. The Ebola virus kills up to half of those it infects, making any outbreak particularly dangerous. In response to the outbreak, the United States banned citizens from the DRC, Uganda and Sudan from entering the US on Monday. Also read: Tedros: ‘We Live in Difficult, Dangerous and Divisive Times’ ‘Did not do this lightly’ Ongoing 79th session of the WHA in Geneva, Switzerland. The rapid spiral led Tedros to declare the outbreak a public health emergency of international concern (PHEIC) on Sunday, the first time a Director-General has done so before convening an emergency committee. “I did not do this lightly,” he told the assembly. “I did it in accordance with Article 12 of the International Health Regulations, after consulting the ministers of health of both countries.” The emergency committee will meet later on Tuesday to advise on what response measures countries should adopt, as there is no vaccine and no cure for the strain of Ebola now spreading. The first confirmed case was a health worker, meaning the virus was already moving through medical settings before anyone knew it was there. After heavy criticism of the WHO’s slow handling of the 2014 West African Ebola epidemic, the agency’s chief appears unwilling to allow a repeat of history. Tedros said an additional $3.4 million was released from the WHO’s Contingency Fund for Emergencies, bringing the total committed to the response to $3.9 million. “WHO has a team on the ground supporting national authorities to respond,” he said. “We have deployed people, supplies, equipment, and funds.” LIVE: @DrTedros‘ address to the #WHA79 delegates https://t.co/IUGcXQ3cLe — World Health Organization (WHO) (@WHO) May 19, 2026 Deadly delays leave authorities flying blind Ebola health worker in protective gear. File image. Cases have surfaced in densely populated urban areas, including the Ugandan capital Kampala and the eastern DRC city of Goma, home to millions of people and serving as major hubs for cross-border trade and movement. The outbreak is likely to have originated in DRC’s Ituri province, a high-traffic mining area on the borders of South Sudan and Uganda, which “increases the risk of regional exportation and cross-border transmission”, according to the WHO. Fighting in the area between the DRC army and M23, an Islamist armed group, has intensified since late 2025 and escalated significantly over the past two months. More than 100,000 people have been newly displaced by the conflict, Tedros told the assembly – potentially carrying the virus with them as they go, far from the reach of surveillance teams and into communities with little capacity to identify or isolate new cases. “In Ebola outbreaks, you know what displacement means,” Tedros said. “The area is also a mining zone with high levels of population movement that increase the risk of further spread.” Local funeral practices, which involve close contact and touching the deceased, also accelerated transmission before authorities knew the outbreak was happening. The current outbreak is the third recorded outbreak of Bundibugyo, first identified in 2007. Hantavirus contained There are no known vaccines or therapeutics for this strain of Ebola making containment a challenge. The picture is markedly different for hantavirus, which Tedros also addressed. Two weeks ago, the hantavirus outbreak aboard the MV Hondius cruise ship, sparked international panic and wall-to-wall news coverage, but it has now been brought under control, Tedros told the assembly. “WHO’s assessment continues to be that the risk of hantavirus globally is low,” Tedros said. The ship docked in Rotterdam on Sunday, with the crew now in quarantine until 29 June. Passengers, who have been repatriated, will be monitored until 21 June. “So far, there are 11 reported cases, including three deaths, and no deaths have been reported since the second of May, when WHO was first informed of the outbreak on the ship. Those numbers have changed little since the outbreak was first reported to WHO two weeks ago,” Tedros said. The two outbreaks, emerging within two weeks of each other, served as a reminder of WHO’s core function, Tedros told the assembly. “The outbreaks of Ebola and Hantavirus in the past two weeks show why international threats need an international response,” he said. “They show why the world needs the international health regulations and why it needs WHO.” WHO successes: tobacco and taxes Tedros also highlighted WHO’s wins in his address, including the decline in tobacco use. “Tobacco use has dropped by one-third globally and continues to decline in 140 countries. With support from WHO, Maldives became the first country to adopt a generational tobacco ban for people born from 2007. This year, the United Kingdom followed suit, banning the sale of tobacco to anyone born from 2009 onwards,” he said. Since 2025, the WHO has been encouraging countries to tax tobacco, alcohol, and sugary drinks by at least 50% by 2035. “In the past 12 months, India, Jamaica, Malaysia, Mauritius, Mexico, Montenegro, Viet Nam, Saudi Arabia, Sierra Leone and Zambia were among countries that either announced, introduced or increased taxes on one or more of these products,” Tedros said. WHO’s advocacy to increase the rate of breastfeeding globally has also yielded positive results, with almost half of children worldwide being breastfed for at least for six months, Tedros said. A billion more people now have access to safe drinking water compared to just a decade ago, but the levels of violence against women have remained stagnant for two decades. However, the shortage of healthcare workers is hampering progress: “The world is facing a shortage of 11 million health workers by 2030, with the biggest gaps in the African and Eastern Mediterranean regions. More than half the gap is a shortage of nurses,” Tedros said. The world is also set to miss every one of the 52 health-related Sustainable Development Goal targets by 2030, the WHO revealed on the eve of the WHA. Malaria cases are rising, maternal deaths are still occurring at nearly three times the targeted rate and childhood vaccination coverage is plateauing or falling in some regions, and progress on global health goals has slowed, stalled or reversed across virtually every measure since 2015, according to the 2026 World Health Statistics report. Image Credits: WHO/Christopher Black , WHO/X, Africa CDC , WHO/X. Undocumented Migrants Fall Through Europe’s Healthcare Cracks, Joint Research Shows 19/05/2026 Felix Sassmannshausen Undocumented migrants navigate precarious conditions, often lacking health safety nets, despite contributing to informal economies. As Europe grapples with shifting demographics and an influx of migration, researchers are mapping how undocumented migrants navigate the administrative cracks of the continent’s healthcare systems – helping to fill a critical data gap identified by the World Health Organization. Inside the neoclassical venue of La Pastorale in Geneva, around 30 participants from six European universities convened on Monday on the sidelines of the World Health Assembly to dissect an expanding public health crisis related to the healthcare of immigrants, whose status and lack of resources means they often seek care in the shadows of the formal system – or fall through the cracks altogether until an emergency. The Geneva Health Forum event highlighted how complex administrative barriers keep undocumented migrant children and the elderly across the continent from accessing essential healthcare, leaving untreated chronic conditions, severe mental health crises, and emergencies to strain local resources. Professors Claudine Burton-Jeangros and Yves Jackson of the University of Geneva. The “Growing and ageing in the shadows” (GRACE) project, co-directed by Professor of Medicine Yves Jackson and health sociologist Professor Claudine Burton-Jeangros of the University of Geneva, explores these disparities as part of the European University Alliance (4EU+). The consortium unites scholars from the universities of Geneva, Heidelberg, Prague, Milan, Paris Sorbonne, and Copenhagen. Mapping the barriers and needs in Europe’s cities remains exceptionally difficult, as a lack of information and personnel, coupled with a profound fear of discrimination or deportation, drives undocumented migrants away from clinical settings and creates severe data deficits. The scale of this blind spot is particularly evident among minors; in Germany, for example, population estimates for undocumented children range wildly from a few thousand to over 100,000, the researchers noted. To enable evidence-based policymaking, the GRACE consortium navigates these blind spots by conducting in-depth interviews with frontline healthcare providers, social workers, and non-governmental actors to uncover the practical realities these vulnerable groups experience. While the results presented on Monday were preliminary, the consortium projects final results by the end of the year. They aim to use the findings to inform and advocate to policymakers on how to improve healthcare access. Fragmented bureaucracies erode rights of undocumented migrants WHO data on inclusion of refugee and migrant health aspects in national policies, legislation strategies or plans across thematic areas in the European Region. Access to equitable healthcare is a fundamental human right, reinforced by international frameworks such as the WHO Global Action Plan and the 2026 Progress Declaration of the International Migration Review Forum (IMRF) – the primary UN platform for tracking global migration commitments. Although the WHO notes significant recent progress – such as the WHO European Region’s action plan to improve legal access to care – these theoretical rights continue to routinely erode within the continent’s complex bureaucracies. In universal healthcare systems like Denmark’s – where the uninsured population also includes European Union citizens who have simply fallen out of the formal labour market – the mandate for a central registration number excludes those without formal residency documents. Lacking this registration number, undocumented individuals are forced to rely on a parallel, privately funded network of volunteer-run clinics for even the most basic medical care. Even in jurisdictions with progressive entitlements specifically designed for undocumented populations, such as France – where, notably, children cannot legally be classified as undocumented – administrative labyrinths and illegal discrimination by providers severely limit practical access. Although the French State Medical Aid guarantees free access to essential care after three months of residency, eligible patients are still frequently turned away by providers who illegally refuse to treat those relying on state support. University of Geneva researchers Srilak Weerawardane and Emma Perneger present preliminary findings. Germany also sees a growing number of uninsured migrants falling through the cracks. And this is not surprising since it enforces a severe legal Catch-22, the researchers found: while doctors maintain confidentiality, social welfare offices must report undocumented patients to immigration authorities if public funds cover their care. Additionally, hospitals frequently deny expensive treatments to avoid unpaid hospital bills. Ultimately, this systemic threat breeds a profound fear of deportation, driving undocumented migrants away from clinics entirely. Switzerland’s mandatory healthcare system grants all residents the right and legal obligation to purchase expensive insurance. Undocumented migrants – strictly excluding asylum seekers with pending applications – cannot opt out but face severe barriers to state subsidies. Forced to pay out of pocket, they accumulate massive debt, which accounts for an estimated 90% of their total arrears in Geneva. University of Geneva researchers concluded this financial burden traps individuals in poverty and paralyses future regularisation attempts, since being debt-free is a primary requirement for legal residency. Healthcare hinges on relationships instead of rights Locked out of formal systems, undocumented migrants rely on informal networks and alternative routes for essential healthcare. Because official avenues remain blocked, fragmented NGO clinics and volunteer doctors often serve as the primary safety net for basic care, the research team from the University of Copenhagen explained. To bridge the gap between theoretical rights and practical access, social workers must frequently intervene to defend marginalised patients, while physicians in countries like the Czech Republic utilise personal discretion to classify treatments as “acute care” to legally compel hospitals to provide treatment. Ultimately, receiving medical attention often depends on the willingness of individual healthcare providers to bypass restrictive frameworks. As a result, securing essential treatment is often reduced to a matter of luck, depending heavily on the informal networks of the doctors and the specific resources of the patients themselves. Heidelberg University researchers Manuela Orjuela-Grimm and Veronika Wiemker discuss their research on healthcare barriers. “It’s really contingent on personal relationships and healthcare providers… instead of being a right,” Veronika Wiemker, a researcher at the Heidelberg University on the situation in Germany, reflecting the shared reality across the continent. Faced with such systemic exclusion, undocumented migrants utilise alternative routes to care. To treat their conditions, individuals proactively stockpile medicine, consult online forums or artificial intelligence, and rely on transnational healthcare – such as travelling across borders for treatment or using telemedicine to maintain remote consultations with doctors in their countries of origin, as the researchers from Prague’s Charles University found. Young migrants navigate fragmented care Driven under the administrative radar, undocumented children face severe healthcare fragmentation, missing crucial developmental screenings and continuous medical support. The situation for undocumented children is particularly dire, despite being specially protected under international provisions. As undocumented parents often lack official birth certificates, their newborns remain largely under the administrative radar. The living conditions for these youngest migrants are frequently severe; in France alone, researchers from Paris Sorbonne University report that an estimated 3,000 homeless newborns and their mothers are discharged from hospitals directly onto the streets each year. Sorbonne University researchers Fanny Teissandier and Andrea Tortelli outline their methodology. Without stable housing or formal documentation, young migrants across the continent frequently miss out on crucial immunisations and preventive measures, mental health support, and basic dental care. While school-aged children occasionally receive basic entry assessments or see school nurses – as is the practice in countries like Germany and Denmark – the ongoing absence of holistic, continuous care exposes them to severe developmental risks and untreated chronic conditions. Unaccompanied minors endure even deeper vulnerability, often surviving on the streets while facing malnutrition and severe trauma. Despite being theoretically protected by local authorities, these youths remain highly vulnerable to exploitation, sex work, and chronic stress. Ultimately, the transition to adulthood introduces a severe, continent-wide cliff edge for these adolescents. Upon turning 18, temporary legal protections abruptly dissolve – either plunging the young adults into mandatory insurance systems they cannot afford or stripping them of their rights entirely. Ageing populations undergo unique crises Elderly undocumented migrants often endure accelerated ageing and complete exclusion from formal European long-term healthcare networks. The plight of the elderly introduces an entirely distinct set of challenges for local administrators, revealing severe gaps in long-term care. While some older migrants are newly arrived parents joining their children, many others are former labourers who planned to briefly work abroad but ultimately remained for decades. After years of surviving precarious, physically demanding jobs in the informal economy, these individuals frequently experience “accelerated ageing”, untreated chronic pain, and rapid cognitive decline. Furthermore, returning to their countries of origin is rarely a viable solution, as many have lived in Europe for well over a decade and no longer possess any social ties or family networks back home. Their vulnerability is compounded by European health systems that intrinsically tie medical entitlements to formal employment. Once these individuals age out of the workforce or lose their physical capacity to continue their demanding labour, they lose their economic value – frequently stripping them of their eligibility for public health subsidies and plunging them into poverty. This loss of economic value and legal status leaves elderly undocumented migrants completely excluded from formal long-term care solutions. Fearing that elderly, homeless migrants will become permanent “bed blockers” with no follow-up care options, hospitals in countries like France sometimes even deny them access to inpatient admission. Fear fuels harmful data gaps The bureaucratic ‘Chicken and Egg’ cycle: Financial burden and fear drive clinical avoidance, creating a data deficit that fuels policy paralysis. Beyond the immediate health consequences, the overarching fear of deportation forces individuals to “pretend not to be there.” Because undocumented migrants often actively avoid clinics, they remain completely hidden from formal health frameworks, creating a massive data blind spot for policymakers. Closing this gap is a global mandate, forming the core of the third and fifth priorities of the WHO Global Action Plan regarding migration health research and data. WHO’s Daniel Míč emphasises data to bridge divides. Daniel Míč, representing the World Health Organization (WHO) Special Initiative on Health and Migration, stressed that this dynamic creates a bureaucratic “chicken and egg” scenario. “If you are in a vulnerable situation, and you are afraid of being deported, or you are afraid of being punished by the system that you seek health or care from, there’s a problem,” he warned, noting that capturing necessary public health data becomes difficult when fear drives individuals away from the frontline clinics that would otherwise document their conditions. This data deficit is further compounded by the fact that defining who exactly qualifies as an “undocumented migrant” remains a major challenge. Because each national system applies its own administrative labels, the practical barriers these individuals face are dictated entirely by the bureaucracy of the country they reside in. Ultimately, “we will understand the challenges only if we have the data,” Míč said, stressing that concrete evidence is the only way to bridge political divides and present actionable solutions to policymakers. To close this harmful data gap, the GRACE consortium plans to synthesise its preliminary findings into targeted case studies and scientific reports by the end of the year. Recognising the immense value of this frontline research guiding European member states in building inclusive healthcare systems, Míč expressed a readiness to resume dialogue with the 4EU+ Alliance, hoping to translate previous discussions into a concrete collaboration. More Countries Refer to Refugees in Health Policies, but Access and Data Gaps Persist Image Credits: Adhitya Ginanjar/Unsplash, Tim Mossholder/Unsplash/HPW, University of Geneve/HUG, WHO/HPW, Felix Sassmannshausen/HPW, Beth Macdonald/Unsplash. Member States Support Extending Talks on Pandemic Agreement Annex, Propose New ‘Method’ 19/05/2026 Kerry Cullinan Pakistan’s Adeel Khokhar All World Health Organization (WHO) member states supported the extension of talks on the last outstanding piece of the Pandemic Agreement, the Pathogen Access and Benefit-Sharing (PABS) annex, at the World Health Assembly’s (WHA) Committee A on Monday. A draft PABS annex was due to have been presented to the WHA for approval, but instead, a report from the World Health Organization (WHO) Director General notes that member states need more time to reach an agreement. The PABS annex will govern how dangerous pathogens are shared during public health emergencies and how to share any medical products (benefits) produced as a result of manufacturers getting access to this information. A draft annex will either be presented at next year’s WHA or at a special WHA if agreement is reached beforehand, according to the report. Several of the many member states speaking on PABS in Committee A expressed confidence that the annex would be completed by the end of the year. However, divisions between developed and developing countries remained stark. Pakistan warned that the PABS negotiations should not be concluded in a way that “preserves the commercial privileges of a handful of manufacturers”. Pakistan’s representative told the committee: “We are witnessing a sustained effort by some member states to hollow out Article 12 [of the Pandemic Agreement], which clearly establishes the principle of equal footing” between sharing dangerous pathogens and sharing any benefits that manufacturers accrue from such knowledge. “We will not sign off on a multilateral system success story that serves the interests of industry over the health security of billions,” he added. ‘Conducive to R&D’ Malaysia’s representative in Committee A. On the other end of the spectrum, the European Union warned that a PABS agreement should not stifle research and development. “The Pandemic Agreement, as well as the revised IHR [International Health Regulations], contain important provisions that will significantly increase our capacity to confront pandemic emergencies and do so in a more equitable manner,” said the European Union. “The PABS system has an important role to play in this context, but we need to ensure that the system is also conducive to innovation, and research and development for medical countermeasures, then it can lead to a robust uptake by the private sector.” African countries, represented by South Africa, explained once again their demands for an equitable PABS system, including that the annex should include legally binding contracts between the WHO and manufacturers. Impetus for a global PABS system comes from the need to correct the inequities of the COVID-19 pandemic, when developing countries were initially unable to get vaccines – even for healthworkers – as these had all been bought by wealthy countries. As Namibia reminded the committee: “We negotiated the Pandemic Agreement because the world watched developing countries bury their loved ones due to COVID-19 while vaccines sat unused in warehouses elsewhere. That memory must anchor every line that we now draft.” “The credibility of this agreement now rests on the PABS annex. If access obligations read ‘shall’ while benefit-sharing obligations read ‘options’, and ‘where available’, we will have written inequity into international laws with our own hands.” “Benefit-sharing obligations must be legally binding and enforceable,” said Nigeria. “Technology transfer and non-exclusive licensing and local production partnerships must be obligations manufacturers sign onto, not options they select from a menu.” Malaysia emphasises that annex must clearly spell out the rights and obligations of parties, and be “operationally implementable”. Referring to the current hantavirus and Ebola outbreaks, Spain urged the completion of the annex so that the Pandemic Agreement could come into force and provide a solid regulatory framework “to prevent, prepare, and respond to health emergencies”. New methods for future talks? After six formal meetings and several informal sessions, the Intergovernmental Working Group (IGWG) will reconvene in July. However, Colombia stated that the extension of the negotiations on the PABS annex “will only make sense if it allows for a more balanced result, which is technically solid and useful for global public health. ” Colombia’s representative said that the main barrier is that the “rules of intellectual property applied to public health become a barrier to access and the production of vaccines, treatments, and diagnostics, just as happened during the COVID 19 pandemic.” Colombia proposed new “working methods” for the talks, including that they are open rather than behind closed doors, and “a progressive step-by-step approach” to the text, using “the concept of progressive consensus.” Colombia has previously suggested voting on contentious issues. Meanwhile, civil society observer Knowledge Ecology International (KEI) also proposed that negotiators “should consider new approaches, including some features of the benefit-sharing agreement in the new Law of the Sea Treaty, for areas beyond national jurisdiction. “In that agreement, governments take responsibility for the enforcement of benefit-sharing, and the triggers for benefit-sharing are downstream, on the filing or patents or the registration or sale of products.” Posts navigation Older postsNewer posts
EXCLUSIVE: World Health Assembly to Suspend USA’s Voting Rights, Retains Iran’s 21/05/2026 Felix Sassmannshausen & Elaine Ruth Fletcher Delegates attend the WHA Committee B meeting in the Assembly Hall at the Palais des Nations on Thursday after the decision to restore Iranian voting rights. WHO member states on Thursday agreed to suspend the voting rights of the United States in the World Health Assembly as of May 2027 if some $280 million in outstanding 2024–25 dues remain unpaid – despite the US announcement of withdrawal last year. In the same resolution, the suspension of Iran’s voting rights was averted after it caught up on outstanding debts. The decision by WHA’s Committee B, which was approved by consensus and without any debate, signals that member states won’t recognize the US announced withdrawal from WHO in 2025 until the back dues are paid, in accordance with a Congressional decision made at the time when the US joined WHO in 1948. Former WHO Legal Counsel, Gian Luca Burci, described the little-noticed technical decision as politically and legally “consequential,” in a comment to Health Policy Watch. “Even with all the unavoidable ambiguities in such an unusual situation, WHO has not accepted its withdrawal because the US has not fulfilled the terms that they [the US] themselves imposed back in 1948. So, at least on the basis of the advice of the WHO Secretariat to the Executive Board in February, for WHO the US is still a member until it pays its assessed contribution.” The self-declared American exit in January 2025 forced the global health body to reduce its upcoming base budget by 21%, to $4.2 billion, leading to layoffs of nearly 25% of WHO staff in a convulsive year of internal programme cuts and reorganization. According to the WHO Constitution, there is no real provision for member states to withdraw. The sole exception was the US, which made the right to withdraw a condition of joining the global health body in 1948, a stipulation that WHO accepted at the time. However, according to the US’s own rules set by Congress, that right would only be effective if outstanding dues were paid, stating: “The United States reserves its right to withdraw from the organization on a one-year notice, provided, however, that the financial obligations of the United States to the organization shall be met in full for the organization’s current fiscal year.” And, if the following limbo continues, more years of unpaid US dues would technically pile up in 2026 – until the issue is otherwise resolved. WHA to decide on voting rights and Argentina’s exit Tomorrow, the Assembly is also set to address the self-declared departure of Argentina last year in what is likely to lead to a more prolonged debate. Draft decisions currently circulating propose two contradictory paths forward. A proposal put forward by Paraguay would formally “recognize” Argentina’s withdrawal – despite the absence of a legal exit ramp in the WHO constitution. However, a competing draft decision proposed by a separate group of countries, including Germany, takes a decidedly more passive approach. This alternate draft merely “takes note of the request from the UN legal counsel for a WHO clarification on the status of Argentina’s request to withdraw,” Burci explained. This manoeuvre intentionally leaves “the situation ambiguous because the membership is divided on whether Argentina has the right to withdraw, and so effectively the WHA doesn’t take any concrete decision.” If delegates were to adopt Paraguay’s proposal, it would set a significant legal precedent. The WHO Constitution currently contains no provision for a member state to withdraw, and the organization has never formally accepted such a departure in its history. When seven Soviet-bloc nations attempted to withdraw in 1949 and 1950, the organization refused to accept their exit. The WHO instead treated these states as “inactive members”. When the countries sought to resume active participation a few years later, the World Health Assembly allowed them to return by submitting a fraction of their unpaid dues, completely bypassing the need for a formal re-accession process. Looking ahead, the silent committee approval of the American suspension could, nonetheless, provoke more debate – and diplomatic fallout on the issue at Saturday’s final, plenary session. Typically, the decisions of the WHA’s two Committees (A and B) are merely gavelled to approval in rapid succession in the final plenary, with no further debate. But nothing about the US withdrawal from WHO has been typical. See related story: Stars and Stripes No Longer Flying at WHO – But US Can’t Really Leave Until Dues are Paid, Agency Says US suspension set for next year along with nine developing nations Along with the United States, the draft resolution also noted the suspension by 2027 of nine developing nations due to unpaid dues, including: Burundi, Côte d’Ivoire, Djibouti, Equatorial Guinea, Nigeria, Panama, São Tomé and Príncipe, Timor-Leste, and Turkmenistan. Strikingly, while African delegates urged members to pay their debts, the committee approved the penalty measure without any direct debate or remark regarding Iran or the ongoing US withdrawal. In the morning proceedings, the WHO Secretariat formally proposed amendments, striking Iran from the penalty list, alongside Grenada. “Grenada and Iran, Islamic Republic of, have made sufficient payment to clear their arrears, therefore are no longer at risk of losing voting privileges,” said the WHO Controller during the session. Before the assembly, Iran owed $3.29 million in arrears that triggered an automatic suspension warning under Article Seven of the WHO Constitution. Furthermore, Tehran carried a $7.15 million remaining balance under a special long-term settlement arrangement. However, it remains unclear exactly how much Tehran actually paid, as officials only confirmed the sum was “sufficient” to avert the penalty. According to the draft resolution A79-17, the voting rights of nine other countries, including Afghanistan, Dominica, Myanmar, Saint Lucia, Somalia, South Sudan, Sudan, Venezuela and Yemen were already suspended at the time of the opening of this year’s World Health Assembly, and will remain so until their outstanding dues are paid. Image Credits: Felix Sassmannshausen/HPW. Stopping Outbreaks at Source: Pandemic Preparedness Stumbles at Local Level 21/05/2026 Kerry Cullinan Health workers in the DRC put together protective gear during an Ebola outbreak in 2019. The world is not ready for the next pandemic – and it won’t be unless local capacity is strengthened, global health experts agreed at an event in Geneva on Tuesday. Does anyone brief cruise ship captains, cruise operators and passengers from Argentina that hantavirus is an endemic virus? asked Helen Clark, co-chair of the Independent Panel for Pandemic Preparedness and Response. “We can have perfect rules, but if we’re not risk-informed, if we’re not alert to the possibility of endemic viruses emerging, none of it is going to count for much,” said Clark, at an event co-hosted by the Independent Panel and the Global Health Centre‘s International Geneva Global Health Platform on Tuesday, alongside the World Health Assembly. Clark stressed that pandemic preparedness involves countries and people knowing their risk: “What are you looking out for? What are you preparing for?” But Dr Mariângela Simão, Brazil’s Secretary of Health and Environmental Surveillance, said that local health facilities “need to have access to diagnostics to help timely intervention”. She noted that hantavirus can be similar to dengue to start with, while dengue, chikungunya, and Zika all have similar characteristics in early infection. The current Ebola outbreak in the Democratic Republic of Congo (DRC) took over a month to detect, with a long journey from “village communities to specialised labs”, said Dr Edem Adzogenu, Global Emissary for the Accra Reset, Africa’s plan to move from aid dependency to health sovereignty. “The inability to detect was simply because of the unavailability of a broad-spectrum diagnostic,” he added. ”What that tells us is, no matter how much preparation you put in place, if it’s not comprehensive, you miss that process. “We’re talking about a country that, since 1976, has had cyclical outbreaks of Ebola, and still does not have the diagnostics to deal with detection at source.” Richard Horton (moderator) and panellists Els Torreele, Dr Mariângela Simão, Maria Guevara and Helen Clark. Mpox response ‘failed miserably’ Els Torreele, an advisor to The Independent Panel, recently completed research into the mpox outbreak – and describes the mpox response as having “failed miserably”. “We need to stop outbreaks when and where they occur, and this is the repeated lesson that we don’t seem to be able to learn,” said Torreele. The world realised that the global stockpiles of smallpox vaccines are effective against mpox – but during the international mpox outbreak in 2022, these were “made available mostly in the Americas and in Europe”, she said, adding that “none of these vaccines actually arrived at the endemic area”. “When the second mpox public health emergency of international concern (PHEIC) was declared [in 2024], we knew there was an effective vaccine, and again it wasn’t made available [immediately],” she pointed out. “WHO pre-qualification was requested, even though the vaccine was registered by the FDA, EMA, and had been shown in the global outbreak to be effective, so delay upon delay.” When vaccines eventually arrived in the DRC and other hot spots, “it was too little, too late because, in an epidemic response, vaccinating the right people at the right moment is critical to curb the pandemic”. Officials in one of the countries affected by the outbreak told Torreele that their vaccines arrived had arrived “when we didn’t have cases anymore”. In addition, only around 23% of all mpox cases were ultimately confirmed in the DRC because it took too long to get samples to Kinshasa and regional capitals for testing. Maria Guevara, international medical secretary for Médecins Sans Frontières (MSF), described the DRC’s health system as “broken”. “If you look at the 2024 national immunisation numbers data, their measles coverage is 55% Why? Because the vaccines aren’t coming there, even if there are existing supplies,” she said, adding that conflict made several areas “inaccessible”, and that there are also “administrative barriers” Two MSF Ebola treatment centres were burnt down in 2019 because community members didn’t trust them, Guevara pointed out. No trust, no PABS agreement Panellists Qatar’s Dr Hanan Al Kuwari, Edem Adzogenu, Global Emissary for the Accra Reset. and WHO’s Olla Shideed. Trust is a key ingredient in pandemic preparedness, said Hanan Al Kuwari, advisor to Qatar’s Prime Minister for Public Health Affairs. The lack of it is hampering agreement on the pathogen access and benefit-sharing (PABS) annex to the Pandemic Agreement. “Trust was weakened and jeopardised by specific facts during COVID-19. When South Africa rapidly sequenced and shared the Omicron variant, exactly what the global health agreements asked countries to do, more than 50 countries responded with immediate travel bans,” said Al Kuwari. “The TRIPS waiver, which could have enabled local vaccine production in the countries that needed it most [during COVID-19], did not receive the support required, reflecting the difficult tensions between global equity commitments and industrial needs. “Vaccines were not distributed equally, and health workers in poor nations went unprotected for months. These are not system failures in the abstract sense. These were decisions whose history sits at the PABS negotiating table with every delegation. That is why regaining trust is not a diplomatic formality. It is the operational precondition for PABS to work.” She described PABS as “the core equity commitment of the entire architecture, which determines whether the country that rapidly shares a pathogen sample will actually benefit from the vaccines and treatments that follow”. Al Kuwari stressed: “Until that is resolved, the agreement cannot be signed or ratified.” The hanavirus outbreak depended on “countries sharing data rapidly and openly, as well as on a WHO that is fully funded and retaining competent staff able to interpret the evidence and inform the decision makers and the public”, she added. Olla Shideed, WHO’s unit head for health emergencies governance, said that 64 countries had spoken in favour of a PABS agreement during a WHA debate on Monday. She, along with Clark, urged countries not to wait for agreement on PABS but to start implementing the Pandemic Agreement. “Speed is of the essence. Speed in detecting speed in surveillance, speed in reporting, and speed in coordinating the action at the national, regional level, and international levels is really what helps us to move forward.” No finances Adzogenu also pointed out that the countries worst affected by the current Ebola outbreak – the DRC and Uganda – have “really serious fiscal constraints” as they are servicing debt. “There’s the manufacturing gap as well,” he said, adding that the Accra Reset aims to ensure that countries have what they need on the ground. Clark said that the United Nations High-Level Meeting on Pandemic Prevention, Preparedness and Response (PPPR), scheduled for September, could push for the conclusion of the PABS negotiations. “But I think it needs to bang a drum on finance, because we’re talking global public goods here. If a disease gets away, it knows no sovereignty, gender, or whatever. “We need new ways of funding global public goods like preparedness. Some of the bold ideas out there, like global public investment, need member-state champions. “The global public investment model talks about everybody putting into the fund with applications according to need. If everyone’s putting up the money, low-income countries will get more say [in governance].” Image Credits: John Wessels/ MSF. Pharma Industry Demands Repositioning of Medical Innovation as Strategic Investment, Not Cost 21/05/2026 Felix Sassmannshausen Global health leaders discuss strategic medical innovation. From the left: Isabelle Kumar (moderator), Monique Vledder (World Bank), Penny Heaton (Johnson & Johnson), Florika Fink-Hooijer (EU HERA), and Michael Lobritz (Roche). Amid surging geopolitical tensions, increased global health threats, and strained public budgets, global health leaders and pharmaceutical executives converged in Geneva with a unified message: medical innovation must be treated as a critical investment not a healthcare drain. Showcasing this shift, Canada unveiled strategic investments and new regulations. GENEVA – Inside the packed ballroom of the luxurious Intercontinental Hotel, during a flagship event hosted by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) on Tuesday, large screens broadcast a simple promise of continuous innovation so that “the next generation of medicines and vaccines can deliver a healthier, stronger future”. “Pharmaceutical innovation has accounted for more than 70% of the increase in life expectancy across G20 and developing countries,” said moderator Isabelle Kumar in her opening remarks. But at the same time, G20 economies are losing an estimated one trillion dollars every year to preventable health conditions, she added. Exploring solutions at scale, the panel keynotes and discussions bridged public, private, and geopolitical sectors. The high-level speakers included Canadian Minister of Health Marjorie Michel and AstraZeneca chair Michel Demaré. They were followed by a panel discussion with Monique Vledder, World Bank Group global director, Florika Fink-Hooijer, Director-General of the EU’s Health Emergency Preparedness and Response Authority (HERA), Penny Heaton of Johnson & Johnson, and Michael Lobritz of Roche. The experts acknowledged that global health architecture currently faces immense strain from escalating vulnerabilities, including ageing populations, antimicrobial resistance, and rising rates of non-communicable diseases. Consequently, leaders urged a major mindset shift, positioning sustained investments in medical innovation as vital catalysts for economic growth. Health investments’ economic potential Despite their differing mandates, the panellists reached a firm consensus: governments must abandon short-term budgeting and invest in medical innovation to secure long-term national resilience and productivity. This demands a profound departure from reactive spending toward proactive strategic investments. IFPMA Director General David Reddy. Echoing this shared conviction during his concluding remarks, IFPMA Director General David Reddy emphasised the overarching economic value of the sector. “Investing in health innovation is not a tradeoff, it’s a multiplier,” said Reddy. To explain the broader economic stakes, the World Bank’s Vledder noted that an unhealthy workforce fundamentally stalls local economies, while funds flowing into the health sector offer tremendous potential for job creation. Industry pushes for tripling of prevention budgets AstraZeneca Chair Demaré reinforced this point, stating that a healthy population experiences fewer sick days and drives higher productivity. He highlighted that establishing a healthy global population could boost the GDP by 7% by 2050 – an economic gain equivalent to the combined economies of Germany and Japan. “So we need a mindset change here to look at medicine and especially innovative medicines as an investment for the future,” said Demaré. Early diagnosis and preventative treatments could drastically reduce long-term hospital costs and boost this overall economic productivity. Currently, OECD countries allocate an average of only 3% of their healthcare budgets to prevention, a figure Demaré argued should double or triple to have a real impact. He emphasised that this shift should rely heavily on functional public-private partnerships, pointing to specific collaborative efforts, such as the Partnership for Health System Sustainability and Resilience, which assesses health systems across more than 30 countries to identify localised governance gaps and propose targeted technological solutions. Canada announces strategic investment Canadian Health Minister Marjorie Michel announced a $131 million public investment into the Pan-Canadian Pharmaceutical Alliance. In the spirit of the industries’ demands, Canada positioned itself as a pragmatic, reliable partner in the global supply chain, navigating amidst geopolitical instability and contrasting its approach with nations relying heavily on threats and tariffs – an indirect reference to the United States under President Trump. “Tariffs are not the Canadian way. Our values are anchored in respect yet viability, predictability and collaboration and the fundamental belief in talent and research,” said Michel. Breaking news on the IFPMA stage, she announced a fresh $131 million injection into the Pan-Canadian Pharmaceutical Alliance. The public investment aims to unify Canada’s fragmented healthcare system into a single market, thereby accelerating drug price negotiations and reducing administrative burdens. The government had also previously announced $1.7 billion to attract world-leading researchers, transforming the nation into a clinical trial powerhouse. By modernising clinical trial frameworks and aligning with international regulators, Canada aims to reduce the time between drug submission and approval by up to 50%. “We need a regulatory system that is timely, predictable, and grounded in science. One that fiercely protects Canadians while giving companies a clear reason to invest in Canada,” said Michel. AstraZeneca Chair Michel Demaré calls for tripling prevention budgets during an IFPMA panel discussion. Europe pivots to security amidst new threats Across the Atlantic, the EU is also heavily investing in its pharmaceutical sector to secure long-term strategic autonomy. Recent legislative moves, such as the Critical Medicines Act, aim to prevent medicine shortages, boost domestic manufacturing, and position the bloc as a global leader by fostering a competitive innovation ecosystem. However, these proactive health initiatives face a formidable obstacle: severe budget constraints compounded by escalating geopolitical conflicts. As financial resources shrink across Europe, medical innovation is increasingly losing critical funding to traditional military priorities against the backdrop of Russia’s ongoing war in Ukraine and increased geopolitical tension. “We had quite a stable budget, and then the political levels decided… we have security as a major risk. So we lost €1 billion… because indeed health got the lower priority,” said Fink-Hooijer. HERA Director-General Florika Fink-Hooijer. To maintain regional production capacity and true preparedness, Fink-Hooijer argued that European officials can no longer view medical innovation merely as an ad hoc healthcare cost. Instead, they must treat it as a foundational pillar of geopolitical defence through structured investments. Reflecting this shift in mindset, HERA actively bridges the gap between health and traditional security by establishing a dedicated unit to monitor advanced biowarfare risks. “We do have now also a civil-military unit in order to really look at that type of threat scenario… because we know that it could also be with AI abuse due to other types of artificial or intentionally produced pathogens,” Fink-Hooijer announced. Meanwhile, restricted public budgets inevitably force regulatory bodies into making high-stakes gambles on future threats. HERA recently directed its scarce resources toward developing a vaccine for the Ebola Sudan strain – a calculated strategic bet that became a bad choice in hindsight, Fink-Hooijer admitted, as it completely missed the current outbreak. Fragility, fragmentation and folly Roche’s Michael Lobritz outlined the industry’s structural vulnerabilities through what he termed the “three Fs”: fragility, fragmentation, and folly. While scientific capabilities accelerate at unprecedented rates and countries compete over production capacities, the global health architecture remains vulnerable to fragmented supply chains. Roche’s Lobritz outlined the industry’s structural weak points through what he termed the “three Fs”: fragility, fragmentation, and folly. He warned that innovation pipelines remain extremely fragile, lacking the investor capital necessary to mature early-stage compounds. Out of 14 viral families with pandemic potential, there are currently only 18 clinical compounds in development, mirroring similar capital shortages in the antimicrobial resistance market. Furthermore, fragmented ecosystems prevent diverse health sectors from coordinating effectively, leading to the dangerous folly of relying on reactive scaling during a sudden crisis without prior preparation. True resilience demands sustained, peacetime collaboration to ensure every therapeutic agent is ready before the crisis hits. Likening the pharmaceutical supply chain to a bustling restaurant kitchen handling a massive dinner rush, he emphasised the vast, unseen preparation required behind the scenes to successfully deliver the final product. “The creation of a novel medicine that changes the course of the life of an individual is not an eventuality or a certainty and needs to be supported,” concluded Lobritz. Addressing the global healthcare gap For this, governments must invest, also to ensure life-saving medical innovation actually reaches the populations that need it most, the participants argued. Outside the IFPMA ballroom, however, health equity advocates caution that framing high-cost pharmaceutical innovation and public-private partnerships as primary drivers of economic resilience can overshadow the need for fundamental strengthening of public health infrastructure, particularly in low- and middle-income countries where access to basic therapeutics remains a major obstacle. The challenge extends far beyond laboratory breakthroughs to the ultimate end-user. Outlining the World Bank’s current attempt to reach 1.5 billion people with essential health services, Vledder acknowledged that scientific innovation means little if delivery systems in fragile states remain broken. Global Health Needs More than Money – Philanthropy Can Amplify Impacts Image Credits: Felix Sassmannshausen/HPW. Russia Tries to Block Debate on Attacks on Health Facilities in Ukraine 20/05/2026 Disha Shetty Interior of a hospital room in Kherson heavily damaged during conflict, showing extensive structural destruction and debris. Neither Russia’s delegate banging her desk to interrupt Ukraine’s representative speaking at the World Health Assembly (WHA), nor her request to dismiss debate, stopped member states from condemning Russia’s attacks on Ukraine’s health system. A report by the World Health Organization’s (WHO) Director-General before delegates estimated that Russia’s aggression on Ukraine has caused 55,600 civilian casualties, including 14,999 deaths. Violence intensified in 2025 with civilian casualties going up by 31% compared to the previous year, and by 70% when compared to 2023. The WHO also documented 579 attacks on healthcare facilities that caused 19 deaths and 204 injuries among healthcare workers and patients in 2025. This was an 18% increase compared to 2024. “Since this report was published, WHO has recorded 190 new attacks on health care, with 86 injuries and 15 deaths between 1 January and 6 May, 2026,” said Dr Altaf Mossani, Director of Humanitarian Disaster Management, WHO Emergency Preparedness and Response program. “On May 14, a clearly marked United Nations vehicle was severely damaged by drone strikes in Kherson City. This is the second incident that week,” he added. Russia targeting healthcare infrastructure The 79th World Health Assembly in session. Countries raised alarm at the WHA that 202 of Ukraine’s 11,887 health facilities have been severely damaged, and 1,013 units are partially damaged. “We strongly condemn Russia’s ongoing war of aggression against Ukraine and the deliberate escalation of attacks targeting civilians and civilian infrastructure, including health care facilities, and we are deeply alarmed by the sharp increase in attacks on the health infrastructure since the last World Health Assembly,” Moldova’s representative told the WHA. Civilian attacks also drew sharp criticism, leaving Russia isolated during the discussion. “Russia’s attacks on energy infrastructure and other civilian targets, such as hospitals, elderly homes, or kindergartens, became increasingly vicious and brutal,” said Germany’s delegate. “On average, it has been said already, there have been more than 3,000 Russian attacks directly affecting health care institutions, two each day.” Ghana empathised with countries that are receiving a large number of refugees from Ukraine as a result of the conflict, resulting in an additional burden on their health systems. High drama by the Russian representative Russia’s representative to the WHA banged the desk to interrupt Ukraine’s speaker and called the WHO’s report on the health situation in Ukraine “disinformation.” Russia’s representative first moved to dismiss the debate on the report on Ukraine entirely. That request was put to a vote and defeated. Following extensive discussion on the report, Russia again moved to stop the WHA from noting the report. Russia was reminded that noting the report was merely procedural, but it requested a vote again. Once again, countries voted in favour of noting the report. At one point, the Russian representative banged the desk several times to interrupt the Ukrainian speaker, and was reminded to raise the country’s flag if she wanted to make a statement. Russia then accused the WHO of spreading misinformation. “WHO is talking only about attacks on Ukraine, ignoring the information that has been submitted to WHO on attacks on Russian facilities. So, we would ask WHO to stop misleading the world and to stop disseminating misinformation when it comes to voting on this report,” the representative accused. WHO’s report noted that there were 21 attacks on healthcare facilities in Russia, causing 17 injuries. Russia did not agree with this number. However, the Russian representative said, “more than 250 Russian facilities were attacked by Ukraine, and only 35 of them have been officially reported by WHO. And indeed, in the report, even that figure has deliberately been lowered”. Russia opposed the noting of the report by the WHA. The report was noted nevertheless, following a vote. Polio needs attention Polio remains endemic in the WHO’s Eastern Mediterranean Region (EMRO) region. WHA also discussed polio that remains an issue in several countries like Pakistan and Afghanistan. Conflicts and funding cuts have in recent years interrupted polio vaccination campaigns. In Gaza, polio made a resurgence as conflict raged. Most of these areas fall under the WHO’s Eastern Mediterranean Region (EMRO) region. “We are actually the last part of the world where that virus remains endemic, but we are doing our utmost to tackle this issue. We have seen, however, that in Afghanistan and Pakistan there have been declines in transmission trends, and we think that is a cause for optimism about wild polio virus transmission,” Libya said, making a statement on behalf of the EMRO region. Other countries reminded the WHA that polio is still a relevant issue that needs attention. “We wish to recall that polio is still a global health challenge because new cases of wild polio have been recorded in certain countries, and there are new coast cases in conflict areas. Then, hence, the need for further international effort to ensure that we have national and regional preparedness,” Oman’s representative told the WHA. Also read: Polio Eradication Imperiled by $2.3 Billion Funding Gap Image Credits: WHO Ukraine, X/WHO, WHO. WHO: Ebola Outbreak Is a Deadly Regional Threat But Not a Global Pandemic Risk 20/05/2026 Stefan Anderson The WHO has determined that the Ebola outbreak raising alarm worldwide does not pose a pandemic threat. GENEVA — The Ebola outbreak unfolding in the Democratic Republic of Congo (DRC) and Uganda poses a “low” risk globally, according to an expert committee of the World Health Organization (WHO). However, the national and regional risk is “high”, according to the International Health Regulations (IHR) Emergency Committee. Last Sunday, WHO Director-General Dr Tedros Adhanom Ghebreyesus had already declared the outbreak a public health emergency of international concern (PHEIC), the WHO’s second-highest level of alert, before convening the emergency committee. This is the first time in WHO’s history that this has occurred. Tedros was motivated by the scale and speed of the spread of the Bundibugyo virus, a rare and particularly deadly strain of Ebola, which has killed at least 131 people and infected over 500 others. The emergency meeting, convened on Tuesday to assess the threat of the current outbreak, concurred that the situation is a PHEIC but “not a pandemic emergency,” Tedros told a media briefing on Wednesday. The committee, chaired by Professor Lucille Blumberg, agreed with the Director-General’s assessment and is finalising its recommendations in the coming days. “Our prime aim was to support the decision and decide whether this is a public health emergency of international concern, and to consider whether there’s a pandemic emergency. The former was agreed to,” Blumberg said. Investigations into the outbreak’s origin Anaïs Legand speaking at the emergency press conference on the Ebola crisis. “Investigations are ongoing to ascertain when and where exactly this outbreak started,” said Anaïs Legand, a technical officer for high-threat pathogens at WHO’s health emergencies programme. “Given the scale, we are thinking that it has started probably a couple of months ago, but investigations are ongoing, and our priority is really to cut the transmission chain by implementing contact tracing, isolating and caring for all suspect and confirmed cases.” The Bundibugyo species was last seen in 2007, and there is currently no vaccine or treatment licensed for it. Investigators say the true scale of the epidemic in DRC is much larger than current case counts suggest. War, and a very long drive Dr Mohamed Yakub Janabi, WHO’s regional director for Africa. WHO officials laid out several reasons the outbreak escaped detection. The province of Ituri, where it emerged, is engulfed in war. Fighting between the DRC army and the M23 armed group has intensified in recent months, displacing more than 100,000 people. Beyond the conflict, eastern DRC is among the most challenging places in the world to mount a public health response. Health facilities are sparse, roads are limited, and much of the terrain is forested and mountainous. A previous Ebola outbreak in the same region in 2018-19 took close to two years to bring under control, even with a licensed vaccine available. Dr Mohamed Yakub Janabi, WHO’s regional director for Africa, said the combination of factors made early detection enormously difficult. “Detecting outbreaks such as Ebola in a complex setting like Ituri province in the DRC is inherently challenging,” he said. “Surveillance systems rely on a combination of community reporting, local health facilities, lab confirmation, and partner coordination.” Samples from the outbreak zone must travel 1,700 kilometres to reach the Institut National de Recherche Biomédicale in Kinshasa, the only facility in the country with the capacity to test for Bundibugyo. The distance to the capital is comparable to London to Warsaw – a roughly a 24-hour drive on smooth European roads, a far cry from the remote jungle tracks and dirt roads of Ituri. “In remote or insecure areas, it can take time for cases to be recognised and samples transported,” Janabi said. Symptoms mistaken for endemic diseases Nearly 7 tonnes of emergency medical supplies and equipment along with a team of 35 experts from WHO and the DRC’s health ministry, arrived today in Bunia from Kinshasa to support frontline #Ebola response in Ituri Province. The Bundibugyo strain’s early symptoms also overlap with diseases endemic to eastern DRC, leading health workers to mistake initial cases for more common illnesses. “Nonspecific early symptoms, for instance, if you take malaria and typhoid, the early symptoms are the same,” Tedros said. “The region is very endemic to those diseases, so the health workers will associate the early signs with malaria or typhoid, and they can’t diagnose based on the symptoms. They may start treating that.” Dr Abdi Mahamud, WHO’s director for health emergency alert and response operations, said the diagnostic challenge would have tripped up better-resourced systems. “This outbreak is happening in a highly endemic [setting for] other diseases that present similar symptoms – malaria, dysentery, and others,” he said. “If you don’t have that high index of suspicion, if you don’t have the right facility to test, even in high-income countries, you will have that delay in the start of an outbreak.” Diagnostic tests routinely used across the region added another layer of delay. The Bundibugyo strain belongs to a different genus, Orthoebolavirus, than the more common Zaire strain that most existing tests are optimised to detect. “There was a problem linked to the traditional test we use,” Tedros said. “The traditional test is optimised with Zaire, and the same sample was taken and tested, but since the test kit is optimised with Zaire, [Bundibugyo] could not be detected.” No vaccine, but a pipeline Vasee Moorthy, WHO’s research and development lead on the current outbreak, laid out the state of the vaccine pipeline for the Bundibugyo strain. The Bundibugyo strain has no licensed vaccine or therapeutic. WHO’s research and development lead, Vasee Moorthy, said a pipeline of candidates is being accelerated but remains months away. Moorthy said the most promising candidate is an rVSV Bundibugyo vaccine, the equivalent for this strain of Ervebo, the licensed Merck vaccine used against the more common Zaire Ebola strain since 2019. “There are no doses of this which are currently available for clinical trial, so this needs to be prioritised,” Moorthy said. “The information that we have is that this is likely to take six to nine months.” A second candidate, built on the ChAdOx1 platform used in the AstraZeneca COVID-19 vaccine, is being developed by Oxford and the Serum Institute of India. “They are manufacturing that as we speak, but there is no animal data to support [its efficacy],” Moorthy said. “It is possible that doses of that could be available for clinical trial in two to three months, but there is a lot of uncertainty about that.” Even in the most optimistic scenario, neither candidate is likely to be available to materially shape the trajectory of the current outbreak. In the meantime, the response is being built around the basics: safe treatment centres, patient referral pathways, contact tracing, and the protection of health workers, among whom the first confirmed case in the outbreak was identified. “The protection of healthcare workers and families is absolutely paramount,” Blumberg said. “The people in the area and those who respond need to be kept safe and allowed to be able to do what they need to do in a critical time such as this.” Tedros: Rubio suffers ‘lack of understanding’ US Secretary of State Marco Rubio. The WHO chief used the press conference to push back at US Secretary of State Marco Rubio, who said this week the agency had been “a little late to identify this thing.” The US has banned citizens of the DRC, Uganda and Sudan from entry, closed its only dedicated Ebola lab, withdrawn from the WHO, and defunded the agency. “On what the Secretary said, it could be from a lack of understanding of how IHR works, and the responsibilities of WHO and other entities,” Tedros said. “We don’t replace the country’s work, we only support them, so that’s why there could be some lack of understanding.” Tedros suggested conflict in the affected region was a more fundamental factor in the delay than anything WHO could have done differently. “Health facilities cannot work optimally when there is conflict and when the health workers are also fleeing as part of the community which is displaced,” he said. “It affects the whole surveillance system, and not only that, but it also affects access.” “I think that’s what we should understand, the secretary or others.” Asked repeatedly whether US funding cuts to DRC surveillance programmes had contributed to the outbreak going undetected, Tedros declined to draw a direct line. “We don’t need to jump to conclusions before we understand the whole complexity. It would be very difficult to associate it with funding alone,” he said, noting that the diagnostic gap was a question of the wrong tests being administered rather than supply. Legand echoed the point, noting the issue stems from test type, not supply: “For the time being, it’s not a supply issue. We need to ensure that the right platform with the right data arrives at the right place. This is the work that is being done as we speak.” The outbreak, meanwhile, continues to spread through a war zone with no vaccine, no cure, and a diagnostic system still catching up to the strain it now faces. Image Credits: @WHO African Region, Gage Skidmore. Grim Warning of Dwindling Funds for Emergencies as States Vote on Attacks in Lebanon and Iran 20/05/2026 Kerry Cullinan Dr Annette Heinzelmann, emergency director for the WHO Eastern Mediterranean Region (EMRO) The grim impossibility of addressing rising health emergencies with dwindling budgets was raised at the World Health Assembly (WHA) on Tuesday – amid votes on attacks on healthcare in Lebanon and Israel. “Outbreaks are accelerating, while the systems designed to stop them are being weakened,” warned Dr Annette Heinzelmann, emergency director for the WHO Eastern Mediterranean Region (EMRO), during a discussion of health emergencies in Committee A. “The gap between needs and resources is now unsustainable. The WHO Health Emergency Programme faced a $553 million funding gap in 2024 and 2025. The contingency fund for emergencies entered 2026 with just $19.5 million, while our regional emergency workforce has been cut by half. We cannot continue confronting expanding emergencies with shrinking capacity.” In EMRO, 117 million people need humanitarian assistance; there are 14 graded emergencies, 44 active outbreaks, and more than 50 public health events across 17 member states. “Conflict, displacement, climate shock, economic collapse, and diseases are colliding into a single expanding poly crisis,” Heinzelmann warned, speaking on behalf of the regional director. “Across Gaza, Sudan, Yemen, Somalia, and Afghanistan, and amid escalation affecting Iran, Syria, and Lebanon, WHO is sustaining trauma care, delivering medicines, reinforcing surveillance, and supporting governments to manage growing public health risks.” Votes on Lebanon and Iran Regional conflict is compounding the EMRO health crises. Lebanon received overwhelming support from the majority of member states in the wake of Israeli attacks on its health infrastructure – but there was little support for Iran’s appeal for support against similar attacks. Ninety-five member states voted in favour of a resolution that noted “a health emergency in Lebanon resulting from ongoing and recently intensified hostilities” and called for “the full protection of healthcare in Lebanon, including patients, health personnel, facilities and transport”. Only Israel and Honduras opposed the resolution, which did not name Israel as the aggressor. Voting on the resolution in support of Lebanon, following attacks on its health care by Israel. However, Iran’s resolution, condemning recent attacks on patients and health infrastructure, including on the Pasteur Institute – was defeated. The resolution did not mention Israel and the United States as the aggressors. Only 19 countries supported Iran, 30 voted against, and a whopping 58 countries abstained. Several countries cited Iran’s attacks against its own citizens and Gulf states, and the blockade of the Strait of Hormuz, preventing the flow of medical supplies, as reasons for not supporting the resolution. Voting on the resolution in support of Iran, in the wake of US and Israeli attacks on its health infrastructure. Haemorrhagic fever, extreme weather Voting came at the end of a discussion on the WHO’s involvement in health emergencies in the WHA’s Committee A. In 2025, WHO responded to 50 emergencies in 82 countries and territories, of which 20 were Grade 3 emergencies requiring the highest level of organisation-wide support, the organisation reported. Disease outbreaks included viral haemorrhagic fever: Sudan virus disease in Uganda; Marburg in Tanzania and Ethiopia; Ebola in the Democratic Republic of the Congo (DRC) and Rift Valley fever in Mauritania and Senegal. Mpox was declared a public health emergency of international concern (PHEIC), affecting 98 countries, with 52 974 confirmed cases – 84% in Africa – and 215 deaths. Thirty-three countries reported cholera outbreaks involving over 614 828 cases and 7,598 deaths. Angola, the DRC and Sudan had the highest cases. The WHO provided over 58 million doses of “emergency vaccines” for cholera, meningitis, yellow fever and Ebola. Challenges included “limited surveillance capacities and insufficient production of critical vaccines”. Three out of four emergencies were either caused or exacerbated by extreme weather events such as flooding, droughts and cyclones. Earthquakes in Afghanistan and Myanmar, severe Pacific typhoons and three category-5 hurricanes, including Hurricane Melissa, caused death and damage. The global cost of natural disasters is estimated at over $ 200 billion annually. So great was the demand for WHO’s assistance that its Contingency Fund for Emergencies was left with $19.5 million by the end of the year. Attacks on healthcare The severely destroyed Al-Shifa hospital in Gaza City, Palestine, in February 2025. Last year, the WHO verified 1,351 attacks on healthcare, resulting in 925 health facilities damaged or destroyed. The Independent Oversight and Advisory Committee (IOAC) for the WHO Health Emergencies Programme reports a “significant and alarming escalation” in these attacks that are likely to “underestimate the true scale of the crisis as reporting is uneven”. EMRO’s Heinzelmann said that almost 40% of these attacks occurred in her region, accounting for almost 90% of related deaths. “Attacks on healthcare must stop, humanitarian access must be guaranteed, and financing for preparedness and emergency response must increase now, not after the next global crisis is already underway,” she urged. Several member states, including Jordan, Switzerland, Australia, urged an end to attacks on health facilities and personnel and respect for international humanitarian law. Lack of financing The IOAC noted its deep concern at the “dramatic reductions in official development assistance from major donors”. During the 2008 global economic recession, the WHO “deprioritised” its emergency-related teams and reduced the workforce – but paid a high price during the Ebola outbreak in West Africa, “which resulted in over 11,000 lives lost and posed an existential threat to WHO”, noted the IOAC. “It is the IOAC’s responsibility to ensure that past weaknesses are not reprised and that WHO’s emergency capacities remain safeguarded.” In the WHO’s 2026‒2027 budget, the base budget of the emergencies programme has been set at $918.5 million, with 51% for country offices, 22% for regional offices and 27% for headquarters. Image Credits: Nour Alsaqqa/ MSF. WHO is Alarmed at ‘Scale and Speed’ of Ebola Outbreak as Hantavirus Threat Recedes 19/05/2026 Disha Shetty & Stefan Anderson Dr Tedros Adhanom Ghebreyesus is currently serving his second five-year term as WHO Director-General. His mandate expires on August 15, 2027. GENEVA — The outbreak of a deadly strain of Ebola for which there is no vaccine is accelerating through the Democratic Republic of Congo (DRC) and Uganda at a “scale and speed” alarming the World Health Organization (WHO), as cases climb and authorities scramble to contain the spread. “I’m deeply concerned about the scale and speed of the epidemic,” WHO chief Dr Tedros Adhanom Ghebreyesus told the 79th World Health Assembly on Tuesday, addressing delegates from 192 nations gathered in Geneva. More than 500 suspected cases and 130 suspected deaths beyond the confirmed caseload have been reported. Tedros said the figures would change as field operations scale up, including strengthening surveillance, contact tracing, and laboratory testing. “So far, 30 cases have been confirmed in the DRC from the northern province of Ituri,” he added. “Uganda has also informed WHO of two confirmed cases in the capital of Kampala, including one death among two individuals who travelled from DRC, and there is one US citizen confirmed positive and transferred to Germany.” “This epidemic is caused by Bundibugyo, a species of Ebola virus for which there are no vaccines or therapeutics,” Tedros said. Diagnostic tests in the region were designed for a different strain of Ebola and missed early infections, resulting in a four-week gap before the outbreak was detected. Ongoing shortages of diagnostic equipment on the frontlines mean the true size of the outbreak remains unknown. “In the absence of a vaccine, there are many other measures countries, of course, can take to stop the spread of this virus and save lives, even without medical countermeasures, including risk communication and community engagement,” Tedros said, commending Uganda for postponing its annual Martyrs’ Day celebrations, which can draw up to two million people. The Ebola virus kills up to half of those it infects, making any outbreak particularly dangerous. In response to the outbreak, the United States banned citizens from the DRC, Uganda and Sudan from entering the US on Monday. Also read: Tedros: ‘We Live in Difficult, Dangerous and Divisive Times’ ‘Did not do this lightly’ Ongoing 79th session of the WHA in Geneva, Switzerland. The rapid spiral led Tedros to declare the outbreak a public health emergency of international concern (PHEIC) on Sunday, the first time a Director-General has done so before convening an emergency committee. “I did not do this lightly,” he told the assembly. “I did it in accordance with Article 12 of the International Health Regulations, after consulting the ministers of health of both countries.” The emergency committee will meet later on Tuesday to advise on what response measures countries should adopt, as there is no vaccine and no cure for the strain of Ebola now spreading. The first confirmed case was a health worker, meaning the virus was already moving through medical settings before anyone knew it was there. After heavy criticism of the WHO’s slow handling of the 2014 West African Ebola epidemic, the agency’s chief appears unwilling to allow a repeat of history. Tedros said an additional $3.4 million was released from the WHO’s Contingency Fund for Emergencies, bringing the total committed to the response to $3.9 million. “WHO has a team on the ground supporting national authorities to respond,” he said. “We have deployed people, supplies, equipment, and funds.” LIVE: @DrTedros‘ address to the #WHA79 delegates https://t.co/IUGcXQ3cLe — World Health Organization (WHO) (@WHO) May 19, 2026 Deadly delays leave authorities flying blind Ebola health worker in protective gear. File image. Cases have surfaced in densely populated urban areas, including the Ugandan capital Kampala and the eastern DRC city of Goma, home to millions of people and serving as major hubs for cross-border trade and movement. The outbreak is likely to have originated in DRC’s Ituri province, a high-traffic mining area on the borders of South Sudan and Uganda, which “increases the risk of regional exportation and cross-border transmission”, according to the WHO. Fighting in the area between the DRC army and M23, an Islamist armed group, has intensified since late 2025 and escalated significantly over the past two months. More than 100,000 people have been newly displaced by the conflict, Tedros told the assembly – potentially carrying the virus with them as they go, far from the reach of surveillance teams and into communities with little capacity to identify or isolate new cases. “In Ebola outbreaks, you know what displacement means,” Tedros said. “The area is also a mining zone with high levels of population movement that increase the risk of further spread.” Local funeral practices, which involve close contact and touching the deceased, also accelerated transmission before authorities knew the outbreak was happening. The current outbreak is the third recorded outbreak of Bundibugyo, first identified in 2007. Hantavirus contained There are no known vaccines or therapeutics for this strain of Ebola making containment a challenge. The picture is markedly different for hantavirus, which Tedros also addressed. Two weeks ago, the hantavirus outbreak aboard the MV Hondius cruise ship, sparked international panic and wall-to-wall news coverage, but it has now been brought under control, Tedros told the assembly. “WHO’s assessment continues to be that the risk of hantavirus globally is low,” Tedros said. The ship docked in Rotterdam on Sunday, with the crew now in quarantine until 29 June. Passengers, who have been repatriated, will be monitored until 21 June. “So far, there are 11 reported cases, including three deaths, and no deaths have been reported since the second of May, when WHO was first informed of the outbreak on the ship. Those numbers have changed little since the outbreak was first reported to WHO two weeks ago,” Tedros said. The two outbreaks, emerging within two weeks of each other, served as a reminder of WHO’s core function, Tedros told the assembly. “The outbreaks of Ebola and Hantavirus in the past two weeks show why international threats need an international response,” he said. “They show why the world needs the international health regulations and why it needs WHO.” WHO successes: tobacco and taxes Tedros also highlighted WHO’s wins in his address, including the decline in tobacco use. “Tobacco use has dropped by one-third globally and continues to decline in 140 countries. With support from WHO, Maldives became the first country to adopt a generational tobacco ban for people born from 2007. This year, the United Kingdom followed suit, banning the sale of tobacco to anyone born from 2009 onwards,” he said. Since 2025, the WHO has been encouraging countries to tax tobacco, alcohol, and sugary drinks by at least 50% by 2035. “In the past 12 months, India, Jamaica, Malaysia, Mauritius, Mexico, Montenegro, Viet Nam, Saudi Arabia, Sierra Leone and Zambia were among countries that either announced, introduced or increased taxes on one or more of these products,” Tedros said. WHO’s advocacy to increase the rate of breastfeeding globally has also yielded positive results, with almost half of children worldwide being breastfed for at least for six months, Tedros said. A billion more people now have access to safe drinking water compared to just a decade ago, but the levels of violence against women have remained stagnant for two decades. However, the shortage of healthcare workers is hampering progress: “The world is facing a shortage of 11 million health workers by 2030, with the biggest gaps in the African and Eastern Mediterranean regions. More than half the gap is a shortage of nurses,” Tedros said. The world is also set to miss every one of the 52 health-related Sustainable Development Goal targets by 2030, the WHO revealed on the eve of the WHA. Malaria cases are rising, maternal deaths are still occurring at nearly three times the targeted rate and childhood vaccination coverage is plateauing or falling in some regions, and progress on global health goals has slowed, stalled or reversed across virtually every measure since 2015, according to the 2026 World Health Statistics report. Image Credits: WHO/Christopher Black , WHO/X, Africa CDC , WHO/X. Undocumented Migrants Fall Through Europe’s Healthcare Cracks, Joint Research Shows 19/05/2026 Felix Sassmannshausen Undocumented migrants navigate precarious conditions, often lacking health safety nets, despite contributing to informal economies. As Europe grapples with shifting demographics and an influx of migration, researchers are mapping how undocumented migrants navigate the administrative cracks of the continent’s healthcare systems – helping to fill a critical data gap identified by the World Health Organization. Inside the neoclassical venue of La Pastorale in Geneva, around 30 participants from six European universities convened on Monday on the sidelines of the World Health Assembly to dissect an expanding public health crisis related to the healthcare of immigrants, whose status and lack of resources means they often seek care in the shadows of the formal system – or fall through the cracks altogether until an emergency. The Geneva Health Forum event highlighted how complex administrative barriers keep undocumented migrant children and the elderly across the continent from accessing essential healthcare, leaving untreated chronic conditions, severe mental health crises, and emergencies to strain local resources. Professors Claudine Burton-Jeangros and Yves Jackson of the University of Geneva. The “Growing and ageing in the shadows” (GRACE) project, co-directed by Professor of Medicine Yves Jackson and health sociologist Professor Claudine Burton-Jeangros of the University of Geneva, explores these disparities as part of the European University Alliance (4EU+). The consortium unites scholars from the universities of Geneva, Heidelberg, Prague, Milan, Paris Sorbonne, and Copenhagen. Mapping the barriers and needs in Europe’s cities remains exceptionally difficult, as a lack of information and personnel, coupled with a profound fear of discrimination or deportation, drives undocumented migrants away from clinical settings and creates severe data deficits. The scale of this blind spot is particularly evident among minors; in Germany, for example, population estimates for undocumented children range wildly from a few thousand to over 100,000, the researchers noted. To enable evidence-based policymaking, the GRACE consortium navigates these blind spots by conducting in-depth interviews with frontline healthcare providers, social workers, and non-governmental actors to uncover the practical realities these vulnerable groups experience. While the results presented on Monday were preliminary, the consortium projects final results by the end of the year. They aim to use the findings to inform and advocate to policymakers on how to improve healthcare access. Fragmented bureaucracies erode rights of undocumented migrants WHO data on inclusion of refugee and migrant health aspects in national policies, legislation strategies or plans across thematic areas in the European Region. Access to equitable healthcare is a fundamental human right, reinforced by international frameworks such as the WHO Global Action Plan and the 2026 Progress Declaration of the International Migration Review Forum (IMRF) – the primary UN platform for tracking global migration commitments. Although the WHO notes significant recent progress – such as the WHO European Region’s action plan to improve legal access to care – these theoretical rights continue to routinely erode within the continent’s complex bureaucracies. In universal healthcare systems like Denmark’s – where the uninsured population also includes European Union citizens who have simply fallen out of the formal labour market – the mandate for a central registration number excludes those without formal residency documents. Lacking this registration number, undocumented individuals are forced to rely on a parallel, privately funded network of volunteer-run clinics for even the most basic medical care. Even in jurisdictions with progressive entitlements specifically designed for undocumented populations, such as France – where, notably, children cannot legally be classified as undocumented – administrative labyrinths and illegal discrimination by providers severely limit practical access. Although the French State Medical Aid guarantees free access to essential care after three months of residency, eligible patients are still frequently turned away by providers who illegally refuse to treat those relying on state support. University of Geneva researchers Srilak Weerawardane and Emma Perneger present preliminary findings. Germany also sees a growing number of uninsured migrants falling through the cracks. And this is not surprising since it enforces a severe legal Catch-22, the researchers found: while doctors maintain confidentiality, social welfare offices must report undocumented patients to immigration authorities if public funds cover their care. Additionally, hospitals frequently deny expensive treatments to avoid unpaid hospital bills. Ultimately, this systemic threat breeds a profound fear of deportation, driving undocumented migrants away from clinics entirely. Switzerland’s mandatory healthcare system grants all residents the right and legal obligation to purchase expensive insurance. Undocumented migrants – strictly excluding asylum seekers with pending applications – cannot opt out but face severe barriers to state subsidies. Forced to pay out of pocket, they accumulate massive debt, which accounts for an estimated 90% of their total arrears in Geneva. University of Geneva researchers concluded this financial burden traps individuals in poverty and paralyses future regularisation attempts, since being debt-free is a primary requirement for legal residency. Healthcare hinges on relationships instead of rights Locked out of formal systems, undocumented migrants rely on informal networks and alternative routes for essential healthcare. Because official avenues remain blocked, fragmented NGO clinics and volunteer doctors often serve as the primary safety net for basic care, the research team from the University of Copenhagen explained. To bridge the gap between theoretical rights and practical access, social workers must frequently intervene to defend marginalised patients, while physicians in countries like the Czech Republic utilise personal discretion to classify treatments as “acute care” to legally compel hospitals to provide treatment. Ultimately, receiving medical attention often depends on the willingness of individual healthcare providers to bypass restrictive frameworks. As a result, securing essential treatment is often reduced to a matter of luck, depending heavily on the informal networks of the doctors and the specific resources of the patients themselves. Heidelberg University researchers Manuela Orjuela-Grimm and Veronika Wiemker discuss their research on healthcare barriers. “It’s really contingent on personal relationships and healthcare providers… instead of being a right,” Veronika Wiemker, a researcher at the Heidelberg University on the situation in Germany, reflecting the shared reality across the continent. Faced with such systemic exclusion, undocumented migrants utilise alternative routes to care. To treat their conditions, individuals proactively stockpile medicine, consult online forums or artificial intelligence, and rely on transnational healthcare – such as travelling across borders for treatment or using telemedicine to maintain remote consultations with doctors in their countries of origin, as the researchers from Prague’s Charles University found. Young migrants navigate fragmented care Driven under the administrative radar, undocumented children face severe healthcare fragmentation, missing crucial developmental screenings and continuous medical support. The situation for undocumented children is particularly dire, despite being specially protected under international provisions. As undocumented parents often lack official birth certificates, their newborns remain largely under the administrative radar. The living conditions for these youngest migrants are frequently severe; in France alone, researchers from Paris Sorbonne University report that an estimated 3,000 homeless newborns and their mothers are discharged from hospitals directly onto the streets each year. Sorbonne University researchers Fanny Teissandier and Andrea Tortelli outline their methodology. Without stable housing or formal documentation, young migrants across the continent frequently miss out on crucial immunisations and preventive measures, mental health support, and basic dental care. While school-aged children occasionally receive basic entry assessments or see school nurses – as is the practice in countries like Germany and Denmark – the ongoing absence of holistic, continuous care exposes them to severe developmental risks and untreated chronic conditions. Unaccompanied minors endure even deeper vulnerability, often surviving on the streets while facing malnutrition and severe trauma. Despite being theoretically protected by local authorities, these youths remain highly vulnerable to exploitation, sex work, and chronic stress. Ultimately, the transition to adulthood introduces a severe, continent-wide cliff edge for these adolescents. Upon turning 18, temporary legal protections abruptly dissolve – either plunging the young adults into mandatory insurance systems they cannot afford or stripping them of their rights entirely. Ageing populations undergo unique crises Elderly undocumented migrants often endure accelerated ageing and complete exclusion from formal European long-term healthcare networks. The plight of the elderly introduces an entirely distinct set of challenges for local administrators, revealing severe gaps in long-term care. While some older migrants are newly arrived parents joining their children, many others are former labourers who planned to briefly work abroad but ultimately remained for decades. After years of surviving precarious, physically demanding jobs in the informal economy, these individuals frequently experience “accelerated ageing”, untreated chronic pain, and rapid cognitive decline. Furthermore, returning to their countries of origin is rarely a viable solution, as many have lived in Europe for well over a decade and no longer possess any social ties or family networks back home. Their vulnerability is compounded by European health systems that intrinsically tie medical entitlements to formal employment. Once these individuals age out of the workforce or lose their physical capacity to continue their demanding labour, they lose their economic value – frequently stripping them of their eligibility for public health subsidies and plunging them into poverty. This loss of economic value and legal status leaves elderly undocumented migrants completely excluded from formal long-term care solutions. Fearing that elderly, homeless migrants will become permanent “bed blockers” with no follow-up care options, hospitals in countries like France sometimes even deny them access to inpatient admission. Fear fuels harmful data gaps The bureaucratic ‘Chicken and Egg’ cycle: Financial burden and fear drive clinical avoidance, creating a data deficit that fuels policy paralysis. Beyond the immediate health consequences, the overarching fear of deportation forces individuals to “pretend not to be there.” Because undocumented migrants often actively avoid clinics, they remain completely hidden from formal health frameworks, creating a massive data blind spot for policymakers. Closing this gap is a global mandate, forming the core of the third and fifth priorities of the WHO Global Action Plan regarding migration health research and data. WHO’s Daniel Míč emphasises data to bridge divides. Daniel Míč, representing the World Health Organization (WHO) Special Initiative on Health and Migration, stressed that this dynamic creates a bureaucratic “chicken and egg” scenario. “If you are in a vulnerable situation, and you are afraid of being deported, or you are afraid of being punished by the system that you seek health or care from, there’s a problem,” he warned, noting that capturing necessary public health data becomes difficult when fear drives individuals away from the frontline clinics that would otherwise document their conditions. This data deficit is further compounded by the fact that defining who exactly qualifies as an “undocumented migrant” remains a major challenge. Because each national system applies its own administrative labels, the practical barriers these individuals face are dictated entirely by the bureaucracy of the country they reside in. Ultimately, “we will understand the challenges only if we have the data,” Míč said, stressing that concrete evidence is the only way to bridge political divides and present actionable solutions to policymakers. To close this harmful data gap, the GRACE consortium plans to synthesise its preliminary findings into targeted case studies and scientific reports by the end of the year. Recognising the immense value of this frontline research guiding European member states in building inclusive healthcare systems, Míč expressed a readiness to resume dialogue with the 4EU+ Alliance, hoping to translate previous discussions into a concrete collaboration. More Countries Refer to Refugees in Health Policies, but Access and Data Gaps Persist Image Credits: Adhitya Ginanjar/Unsplash, Tim Mossholder/Unsplash/HPW, University of Geneve/HUG, WHO/HPW, Felix Sassmannshausen/HPW, Beth Macdonald/Unsplash. Member States Support Extending Talks on Pandemic Agreement Annex, Propose New ‘Method’ 19/05/2026 Kerry Cullinan Pakistan’s Adeel Khokhar All World Health Organization (WHO) member states supported the extension of talks on the last outstanding piece of the Pandemic Agreement, the Pathogen Access and Benefit-Sharing (PABS) annex, at the World Health Assembly’s (WHA) Committee A on Monday. A draft PABS annex was due to have been presented to the WHA for approval, but instead, a report from the World Health Organization (WHO) Director General notes that member states need more time to reach an agreement. The PABS annex will govern how dangerous pathogens are shared during public health emergencies and how to share any medical products (benefits) produced as a result of manufacturers getting access to this information. A draft annex will either be presented at next year’s WHA or at a special WHA if agreement is reached beforehand, according to the report. Several of the many member states speaking on PABS in Committee A expressed confidence that the annex would be completed by the end of the year. However, divisions between developed and developing countries remained stark. Pakistan warned that the PABS negotiations should not be concluded in a way that “preserves the commercial privileges of a handful of manufacturers”. Pakistan’s representative told the committee: “We are witnessing a sustained effort by some member states to hollow out Article 12 [of the Pandemic Agreement], which clearly establishes the principle of equal footing” between sharing dangerous pathogens and sharing any benefits that manufacturers accrue from such knowledge. “We will not sign off on a multilateral system success story that serves the interests of industry over the health security of billions,” he added. ‘Conducive to R&D’ Malaysia’s representative in Committee A. On the other end of the spectrum, the European Union warned that a PABS agreement should not stifle research and development. “The Pandemic Agreement, as well as the revised IHR [International Health Regulations], contain important provisions that will significantly increase our capacity to confront pandemic emergencies and do so in a more equitable manner,” said the European Union. “The PABS system has an important role to play in this context, but we need to ensure that the system is also conducive to innovation, and research and development for medical countermeasures, then it can lead to a robust uptake by the private sector.” African countries, represented by South Africa, explained once again their demands for an equitable PABS system, including that the annex should include legally binding contracts between the WHO and manufacturers. Impetus for a global PABS system comes from the need to correct the inequities of the COVID-19 pandemic, when developing countries were initially unable to get vaccines – even for healthworkers – as these had all been bought by wealthy countries. As Namibia reminded the committee: “We negotiated the Pandemic Agreement because the world watched developing countries bury their loved ones due to COVID-19 while vaccines sat unused in warehouses elsewhere. That memory must anchor every line that we now draft.” “The credibility of this agreement now rests on the PABS annex. If access obligations read ‘shall’ while benefit-sharing obligations read ‘options’, and ‘where available’, we will have written inequity into international laws with our own hands.” “Benefit-sharing obligations must be legally binding and enforceable,” said Nigeria. “Technology transfer and non-exclusive licensing and local production partnerships must be obligations manufacturers sign onto, not options they select from a menu.” Malaysia emphasises that annex must clearly spell out the rights and obligations of parties, and be “operationally implementable”. Referring to the current hantavirus and Ebola outbreaks, Spain urged the completion of the annex so that the Pandemic Agreement could come into force and provide a solid regulatory framework “to prevent, prepare, and respond to health emergencies”. New methods for future talks? After six formal meetings and several informal sessions, the Intergovernmental Working Group (IGWG) will reconvene in July. However, Colombia stated that the extension of the negotiations on the PABS annex “will only make sense if it allows for a more balanced result, which is technically solid and useful for global public health. ” Colombia’s representative said that the main barrier is that the “rules of intellectual property applied to public health become a barrier to access and the production of vaccines, treatments, and diagnostics, just as happened during the COVID 19 pandemic.” Colombia proposed new “working methods” for the talks, including that they are open rather than behind closed doors, and “a progressive step-by-step approach” to the text, using “the concept of progressive consensus.” Colombia has previously suggested voting on contentious issues. Meanwhile, civil society observer Knowledge Ecology International (KEI) also proposed that negotiators “should consider new approaches, including some features of the benefit-sharing agreement in the new Law of the Sea Treaty, for areas beyond national jurisdiction. “In that agreement, governments take responsibility for the enforcement of benefit-sharing, and the triggers for benefit-sharing are downstream, on the filing or patents or the registration or sale of products.” Posts navigation Older postsNewer posts
Stopping Outbreaks at Source: Pandemic Preparedness Stumbles at Local Level 21/05/2026 Kerry Cullinan Health workers in the DRC put together protective gear during an Ebola outbreak in 2019. The world is not ready for the next pandemic – and it won’t be unless local capacity is strengthened, global health experts agreed at an event in Geneva on Tuesday. Does anyone brief cruise ship captains, cruise operators and passengers from Argentina that hantavirus is an endemic virus? asked Helen Clark, co-chair of the Independent Panel for Pandemic Preparedness and Response. “We can have perfect rules, but if we’re not risk-informed, if we’re not alert to the possibility of endemic viruses emerging, none of it is going to count for much,” said Clark, at an event co-hosted by the Independent Panel and the Global Health Centre‘s International Geneva Global Health Platform on Tuesday, alongside the World Health Assembly. Clark stressed that pandemic preparedness involves countries and people knowing their risk: “What are you looking out for? What are you preparing for?” But Dr Mariângela Simão, Brazil’s Secretary of Health and Environmental Surveillance, said that local health facilities “need to have access to diagnostics to help timely intervention”. She noted that hantavirus can be similar to dengue to start with, while dengue, chikungunya, and Zika all have similar characteristics in early infection. The current Ebola outbreak in the Democratic Republic of Congo (DRC) took over a month to detect, with a long journey from “village communities to specialised labs”, said Dr Edem Adzogenu, Global Emissary for the Accra Reset, Africa’s plan to move from aid dependency to health sovereignty. “The inability to detect was simply because of the unavailability of a broad-spectrum diagnostic,” he added. ”What that tells us is, no matter how much preparation you put in place, if it’s not comprehensive, you miss that process. “We’re talking about a country that, since 1976, has had cyclical outbreaks of Ebola, and still does not have the diagnostics to deal with detection at source.” Richard Horton (moderator) and panellists Els Torreele, Dr Mariângela Simão, Maria Guevara and Helen Clark. Mpox response ‘failed miserably’ Els Torreele, an advisor to The Independent Panel, recently completed research into the mpox outbreak – and describes the mpox response as having “failed miserably”. “We need to stop outbreaks when and where they occur, and this is the repeated lesson that we don’t seem to be able to learn,” said Torreele. The world realised that the global stockpiles of smallpox vaccines are effective against mpox – but during the international mpox outbreak in 2022, these were “made available mostly in the Americas and in Europe”, she said, adding that “none of these vaccines actually arrived at the endemic area”. “When the second mpox public health emergency of international concern (PHEIC) was declared [in 2024], we knew there was an effective vaccine, and again it wasn’t made available [immediately],” she pointed out. “WHO pre-qualification was requested, even though the vaccine was registered by the FDA, EMA, and had been shown in the global outbreak to be effective, so delay upon delay.” When vaccines eventually arrived in the DRC and other hot spots, “it was too little, too late because, in an epidemic response, vaccinating the right people at the right moment is critical to curb the pandemic”. Officials in one of the countries affected by the outbreak told Torreele that their vaccines arrived had arrived “when we didn’t have cases anymore”. In addition, only around 23% of all mpox cases were ultimately confirmed in the DRC because it took too long to get samples to Kinshasa and regional capitals for testing. Maria Guevara, international medical secretary for Médecins Sans Frontières (MSF), described the DRC’s health system as “broken”. “If you look at the 2024 national immunisation numbers data, their measles coverage is 55% Why? Because the vaccines aren’t coming there, even if there are existing supplies,” she said, adding that conflict made several areas “inaccessible”, and that there are also “administrative barriers” Two MSF Ebola treatment centres were burnt down in 2019 because community members didn’t trust them, Guevara pointed out. No trust, no PABS agreement Panellists Qatar’s Dr Hanan Al Kuwari, Edem Adzogenu, Global Emissary for the Accra Reset. and WHO’s Olla Shideed. Trust is a key ingredient in pandemic preparedness, said Hanan Al Kuwari, advisor to Qatar’s Prime Minister for Public Health Affairs. The lack of it is hampering agreement on the pathogen access and benefit-sharing (PABS) annex to the Pandemic Agreement. “Trust was weakened and jeopardised by specific facts during COVID-19. When South Africa rapidly sequenced and shared the Omicron variant, exactly what the global health agreements asked countries to do, more than 50 countries responded with immediate travel bans,” said Al Kuwari. “The TRIPS waiver, which could have enabled local vaccine production in the countries that needed it most [during COVID-19], did not receive the support required, reflecting the difficult tensions between global equity commitments and industrial needs. “Vaccines were not distributed equally, and health workers in poor nations went unprotected for months. These are not system failures in the abstract sense. These were decisions whose history sits at the PABS negotiating table with every delegation. That is why regaining trust is not a diplomatic formality. It is the operational precondition for PABS to work.” She described PABS as “the core equity commitment of the entire architecture, which determines whether the country that rapidly shares a pathogen sample will actually benefit from the vaccines and treatments that follow”. Al Kuwari stressed: “Until that is resolved, the agreement cannot be signed or ratified.” The hanavirus outbreak depended on “countries sharing data rapidly and openly, as well as on a WHO that is fully funded and retaining competent staff able to interpret the evidence and inform the decision makers and the public”, she added. Olla Shideed, WHO’s unit head for health emergencies governance, said that 64 countries had spoken in favour of a PABS agreement during a WHA debate on Monday. She, along with Clark, urged countries not to wait for agreement on PABS but to start implementing the Pandemic Agreement. “Speed is of the essence. Speed in detecting speed in surveillance, speed in reporting, and speed in coordinating the action at the national, regional level, and international levels is really what helps us to move forward.” No finances Adzogenu also pointed out that the countries worst affected by the current Ebola outbreak – the DRC and Uganda – have “really serious fiscal constraints” as they are servicing debt. “There’s the manufacturing gap as well,” he said, adding that the Accra Reset aims to ensure that countries have what they need on the ground. Clark said that the United Nations High-Level Meeting on Pandemic Prevention, Preparedness and Response (PPPR), scheduled for September, could push for the conclusion of the PABS negotiations. “But I think it needs to bang a drum on finance, because we’re talking global public goods here. If a disease gets away, it knows no sovereignty, gender, or whatever. “We need new ways of funding global public goods like preparedness. Some of the bold ideas out there, like global public investment, need member-state champions. “The global public investment model talks about everybody putting into the fund with applications according to need. If everyone’s putting up the money, low-income countries will get more say [in governance].” Image Credits: John Wessels/ MSF. Pharma Industry Demands Repositioning of Medical Innovation as Strategic Investment, Not Cost 21/05/2026 Felix Sassmannshausen Global health leaders discuss strategic medical innovation. From the left: Isabelle Kumar (moderator), Monique Vledder (World Bank), Penny Heaton (Johnson & Johnson), Florika Fink-Hooijer (EU HERA), and Michael Lobritz (Roche). Amid surging geopolitical tensions, increased global health threats, and strained public budgets, global health leaders and pharmaceutical executives converged in Geneva with a unified message: medical innovation must be treated as a critical investment not a healthcare drain. Showcasing this shift, Canada unveiled strategic investments and new regulations. GENEVA – Inside the packed ballroom of the luxurious Intercontinental Hotel, during a flagship event hosted by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) on Tuesday, large screens broadcast a simple promise of continuous innovation so that “the next generation of medicines and vaccines can deliver a healthier, stronger future”. “Pharmaceutical innovation has accounted for more than 70% of the increase in life expectancy across G20 and developing countries,” said moderator Isabelle Kumar in her opening remarks. But at the same time, G20 economies are losing an estimated one trillion dollars every year to preventable health conditions, she added. Exploring solutions at scale, the panel keynotes and discussions bridged public, private, and geopolitical sectors. The high-level speakers included Canadian Minister of Health Marjorie Michel and AstraZeneca chair Michel Demaré. They were followed by a panel discussion with Monique Vledder, World Bank Group global director, Florika Fink-Hooijer, Director-General of the EU’s Health Emergency Preparedness and Response Authority (HERA), Penny Heaton of Johnson & Johnson, and Michael Lobritz of Roche. The experts acknowledged that global health architecture currently faces immense strain from escalating vulnerabilities, including ageing populations, antimicrobial resistance, and rising rates of non-communicable diseases. Consequently, leaders urged a major mindset shift, positioning sustained investments in medical innovation as vital catalysts for economic growth. Health investments’ economic potential Despite their differing mandates, the panellists reached a firm consensus: governments must abandon short-term budgeting and invest in medical innovation to secure long-term national resilience and productivity. This demands a profound departure from reactive spending toward proactive strategic investments. IFPMA Director General David Reddy. Echoing this shared conviction during his concluding remarks, IFPMA Director General David Reddy emphasised the overarching economic value of the sector. “Investing in health innovation is not a tradeoff, it’s a multiplier,” said Reddy. To explain the broader economic stakes, the World Bank’s Vledder noted that an unhealthy workforce fundamentally stalls local economies, while funds flowing into the health sector offer tremendous potential for job creation. Industry pushes for tripling of prevention budgets AstraZeneca Chair Demaré reinforced this point, stating that a healthy population experiences fewer sick days and drives higher productivity. He highlighted that establishing a healthy global population could boost the GDP by 7% by 2050 – an economic gain equivalent to the combined economies of Germany and Japan. “So we need a mindset change here to look at medicine and especially innovative medicines as an investment for the future,” said Demaré. Early diagnosis and preventative treatments could drastically reduce long-term hospital costs and boost this overall economic productivity. Currently, OECD countries allocate an average of only 3% of their healthcare budgets to prevention, a figure Demaré argued should double or triple to have a real impact. He emphasised that this shift should rely heavily on functional public-private partnerships, pointing to specific collaborative efforts, such as the Partnership for Health System Sustainability and Resilience, which assesses health systems across more than 30 countries to identify localised governance gaps and propose targeted technological solutions. Canada announces strategic investment Canadian Health Minister Marjorie Michel announced a $131 million public investment into the Pan-Canadian Pharmaceutical Alliance. In the spirit of the industries’ demands, Canada positioned itself as a pragmatic, reliable partner in the global supply chain, navigating amidst geopolitical instability and contrasting its approach with nations relying heavily on threats and tariffs – an indirect reference to the United States under President Trump. “Tariffs are not the Canadian way. Our values are anchored in respect yet viability, predictability and collaboration and the fundamental belief in talent and research,” said Michel. Breaking news on the IFPMA stage, she announced a fresh $131 million injection into the Pan-Canadian Pharmaceutical Alliance. The public investment aims to unify Canada’s fragmented healthcare system into a single market, thereby accelerating drug price negotiations and reducing administrative burdens. The government had also previously announced $1.7 billion to attract world-leading researchers, transforming the nation into a clinical trial powerhouse. By modernising clinical trial frameworks and aligning with international regulators, Canada aims to reduce the time between drug submission and approval by up to 50%. “We need a regulatory system that is timely, predictable, and grounded in science. One that fiercely protects Canadians while giving companies a clear reason to invest in Canada,” said Michel. AstraZeneca Chair Michel Demaré calls for tripling prevention budgets during an IFPMA panel discussion. Europe pivots to security amidst new threats Across the Atlantic, the EU is also heavily investing in its pharmaceutical sector to secure long-term strategic autonomy. Recent legislative moves, such as the Critical Medicines Act, aim to prevent medicine shortages, boost domestic manufacturing, and position the bloc as a global leader by fostering a competitive innovation ecosystem. However, these proactive health initiatives face a formidable obstacle: severe budget constraints compounded by escalating geopolitical conflicts. As financial resources shrink across Europe, medical innovation is increasingly losing critical funding to traditional military priorities against the backdrop of Russia’s ongoing war in Ukraine and increased geopolitical tension. “We had quite a stable budget, and then the political levels decided… we have security as a major risk. So we lost €1 billion… because indeed health got the lower priority,” said Fink-Hooijer. HERA Director-General Florika Fink-Hooijer. To maintain regional production capacity and true preparedness, Fink-Hooijer argued that European officials can no longer view medical innovation merely as an ad hoc healthcare cost. Instead, they must treat it as a foundational pillar of geopolitical defence through structured investments. Reflecting this shift in mindset, HERA actively bridges the gap between health and traditional security by establishing a dedicated unit to monitor advanced biowarfare risks. “We do have now also a civil-military unit in order to really look at that type of threat scenario… because we know that it could also be with AI abuse due to other types of artificial or intentionally produced pathogens,” Fink-Hooijer announced. Meanwhile, restricted public budgets inevitably force regulatory bodies into making high-stakes gambles on future threats. HERA recently directed its scarce resources toward developing a vaccine for the Ebola Sudan strain – a calculated strategic bet that became a bad choice in hindsight, Fink-Hooijer admitted, as it completely missed the current outbreak. Fragility, fragmentation and folly Roche’s Michael Lobritz outlined the industry’s structural vulnerabilities through what he termed the “three Fs”: fragility, fragmentation, and folly. While scientific capabilities accelerate at unprecedented rates and countries compete over production capacities, the global health architecture remains vulnerable to fragmented supply chains. Roche’s Lobritz outlined the industry’s structural weak points through what he termed the “three Fs”: fragility, fragmentation, and folly. He warned that innovation pipelines remain extremely fragile, lacking the investor capital necessary to mature early-stage compounds. Out of 14 viral families with pandemic potential, there are currently only 18 clinical compounds in development, mirroring similar capital shortages in the antimicrobial resistance market. Furthermore, fragmented ecosystems prevent diverse health sectors from coordinating effectively, leading to the dangerous folly of relying on reactive scaling during a sudden crisis without prior preparation. True resilience demands sustained, peacetime collaboration to ensure every therapeutic agent is ready before the crisis hits. Likening the pharmaceutical supply chain to a bustling restaurant kitchen handling a massive dinner rush, he emphasised the vast, unseen preparation required behind the scenes to successfully deliver the final product. “The creation of a novel medicine that changes the course of the life of an individual is not an eventuality or a certainty and needs to be supported,” concluded Lobritz. Addressing the global healthcare gap For this, governments must invest, also to ensure life-saving medical innovation actually reaches the populations that need it most, the participants argued. Outside the IFPMA ballroom, however, health equity advocates caution that framing high-cost pharmaceutical innovation and public-private partnerships as primary drivers of economic resilience can overshadow the need for fundamental strengthening of public health infrastructure, particularly in low- and middle-income countries where access to basic therapeutics remains a major obstacle. The challenge extends far beyond laboratory breakthroughs to the ultimate end-user. Outlining the World Bank’s current attempt to reach 1.5 billion people with essential health services, Vledder acknowledged that scientific innovation means little if delivery systems in fragile states remain broken. Global Health Needs More than Money – Philanthropy Can Amplify Impacts Image Credits: Felix Sassmannshausen/HPW. Russia Tries to Block Debate on Attacks on Health Facilities in Ukraine 20/05/2026 Disha Shetty Interior of a hospital room in Kherson heavily damaged during conflict, showing extensive structural destruction and debris. Neither Russia’s delegate banging her desk to interrupt Ukraine’s representative speaking at the World Health Assembly (WHA), nor her request to dismiss debate, stopped member states from condemning Russia’s attacks on Ukraine’s health system. A report by the World Health Organization’s (WHO) Director-General before delegates estimated that Russia’s aggression on Ukraine has caused 55,600 civilian casualties, including 14,999 deaths. Violence intensified in 2025 with civilian casualties going up by 31% compared to the previous year, and by 70% when compared to 2023. The WHO also documented 579 attacks on healthcare facilities that caused 19 deaths and 204 injuries among healthcare workers and patients in 2025. This was an 18% increase compared to 2024. “Since this report was published, WHO has recorded 190 new attacks on health care, with 86 injuries and 15 deaths between 1 January and 6 May, 2026,” said Dr Altaf Mossani, Director of Humanitarian Disaster Management, WHO Emergency Preparedness and Response program. “On May 14, a clearly marked United Nations vehicle was severely damaged by drone strikes in Kherson City. This is the second incident that week,” he added. Russia targeting healthcare infrastructure The 79th World Health Assembly in session. Countries raised alarm at the WHA that 202 of Ukraine’s 11,887 health facilities have been severely damaged, and 1,013 units are partially damaged. “We strongly condemn Russia’s ongoing war of aggression against Ukraine and the deliberate escalation of attacks targeting civilians and civilian infrastructure, including health care facilities, and we are deeply alarmed by the sharp increase in attacks on the health infrastructure since the last World Health Assembly,” Moldova’s representative told the WHA. Civilian attacks also drew sharp criticism, leaving Russia isolated during the discussion. “Russia’s attacks on energy infrastructure and other civilian targets, such as hospitals, elderly homes, or kindergartens, became increasingly vicious and brutal,” said Germany’s delegate. “On average, it has been said already, there have been more than 3,000 Russian attacks directly affecting health care institutions, two each day.” Ghana empathised with countries that are receiving a large number of refugees from Ukraine as a result of the conflict, resulting in an additional burden on their health systems. High drama by the Russian representative Russia’s representative to the WHA banged the desk to interrupt Ukraine’s speaker and called the WHO’s report on the health situation in Ukraine “disinformation.” Russia’s representative first moved to dismiss the debate on the report on Ukraine entirely. That request was put to a vote and defeated. Following extensive discussion on the report, Russia again moved to stop the WHA from noting the report. Russia was reminded that noting the report was merely procedural, but it requested a vote again. Once again, countries voted in favour of noting the report. At one point, the Russian representative banged the desk several times to interrupt the Ukrainian speaker, and was reminded to raise the country’s flag if she wanted to make a statement. Russia then accused the WHO of spreading misinformation. “WHO is talking only about attacks on Ukraine, ignoring the information that has been submitted to WHO on attacks on Russian facilities. So, we would ask WHO to stop misleading the world and to stop disseminating misinformation when it comes to voting on this report,” the representative accused. WHO’s report noted that there were 21 attacks on healthcare facilities in Russia, causing 17 injuries. Russia did not agree with this number. However, the Russian representative said, “more than 250 Russian facilities were attacked by Ukraine, and only 35 of them have been officially reported by WHO. And indeed, in the report, even that figure has deliberately been lowered”. Russia opposed the noting of the report by the WHA. The report was noted nevertheless, following a vote. Polio needs attention Polio remains endemic in the WHO’s Eastern Mediterranean Region (EMRO) region. WHA also discussed polio that remains an issue in several countries like Pakistan and Afghanistan. Conflicts and funding cuts have in recent years interrupted polio vaccination campaigns. In Gaza, polio made a resurgence as conflict raged. Most of these areas fall under the WHO’s Eastern Mediterranean Region (EMRO) region. “We are actually the last part of the world where that virus remains endemic, but we are doing our utmost to tackle this issue. We have seen, however, that in Afghanistan and Pakistan there have been declines in transmission trends, and we think that is a cause for optimism about wild polio virus transmission,” Libya said, making a statement on behalf of the EMRO region. Other countries reminded the WHA that polio is still a relevant issue that needs attention. “We wish to recall that polio is still a global health challenge because new cases of wild polio have been recorded in certain countries, and there are new coast cases in conflict areas. Then, hence, the need for further international effort to ensure that we have national and regional preparedness,” Oman’s representative told the WHA. Also read: Polio Eradication Imperiled by $2.3 Billion Funding Gap Image Credits: WHO Ukraine, X/WHO, WHO. WHO: Ebola Outbreak Is a Deadly Regional Threat But Not a Global Pandemic Risk 20/05/2026 Stefan Anderson The WHO has determined that the Ebola outbreak raising alarm worldwide does not pose a pandemic threat. GENEVA — The Ebola outbreak unfolding in the Democratic Republic of Congo (DRC) and Uganda poses a “low” risk globally, according to an expert committee of the World Health Organization (WHO). However, the national and regional risk is “high”, according to the International Health Regulations (IHR) Emergency Committee. Last Sunday, WHO Director-General Dr Tedros Adhanom Ghebreyesus had already declared the outbreak a public health emergency of international concern (PHEIC), the WHO’s second-highest level of alert, before convening the emergency committee. This is the first time in WHO’s history that this has occurred. Tedros was motivated by the scale and speed of the spread of the Bundibugyo virus, a rare and particularly deadly strain of Ebola, which has killed at least 131 people and infected over 500 others. The emergency meeting, convened on Tuesday to assess the threat of the current outbreak, concurred that the situation is a PHEIC but “not a pandemic emergency,” Tedros told a media briefing on Wednesday. The committee, chaired by Professor Lucille Blumberg, agreed with the Director-General’s assessment and is finalising its recommendations in the coming days. “Our prime aim was to support the decision and decide whether this is a public health emergency of international concern, and to consider whether there’s a pandemic emergency. The former was agreed to,” Blumberg said. Investigations into the outbreak’s origin Anaïs Legand speaking at the emergency press conference on the Ebola crisis. “Investigations are ongoing to ascertain when and where exactly this outbreak started,” said Anaïs Legand, a technical officer for high-threat pathogens at WHO’s health emergencies programme. “Given the scale, we are thinking that it has started probably a couple of months ago, but investigations are ongoing, and our priority is really to cut the transmission chain by implementing contact tracing, isolating and caring for all suspect and confirmed cases.” The Bundibugyo species was last seen in 2007, and there is currently no vaccine or treatment licensed for it. Investigators say the true scale of the epidemic in DRC is much larger than current case counts suggest. War, and a very long drive Dr Mohamed Yakub Janabi, WHO’s regional director for Africa. WHO officials laid out several reasons the outbreak escaped detection. The province of Ituri, where it emerged, is engulfed in war. Fighting between the DRC army and the M23 armed group has intensified in recent months, displacing more than 100,000 people. Beyond the conflict, eastern DRC is among the most challenging places in the world to mount a public health response. Health facilities are sparse, roads are limited, and much of the terrain is forested and mountainous. A previous Ebola outbreak in the same region in 2018-19 took close to two years to bring under control, even with a licensed vaccine available. Dr Mohamed Yakub Janabi, WHO’s regional director for Africa, said the combination of factors made early detection enormously difficult. “Detecting outbreaks such as Ebola in a complex setting like Ituri province in the DRC is inherently challenging,” he said. “Surveillance systems rely on a combination of community reporting, local health facilities, lab confirmation, and partner coordination.” Samples from the outbreak zone must travel 1,700 kilometres to reach the Institut National de Recherche Biomédicale in Kinshasa, the only facility in the country with the capacity to test for Bundibugyo. The distance to the capital is comparable to London to Warsaw – a roughly a 24-hour drive on smooth European roads, a far cry from the remote jungle tracks and dirt roads of Ituri. “In remote or insecure areas, it can take time for cases to be recognised and samples transported,” Janabi said. Symptoms mistaken for endemic diseases Nearly 7 tonnes of emergency medical supplies and equipment along with a team of 35 experts from WHO and the DRC’s health ministry, arrived today in Bunia from Kinshasa to support frontline #Ebola response in Ituri Province. The Bundibugyo strain’s early symptoms also overlap with diseases endemic to eastern DRC, leading health workers to mistake initial cases for more common illnesses. “Nonspecific early symptoms, for instance, if you take malaria and typhoid, the early symptoms are the same,” Tedros said. “The region is very endemic to those diseases, so the health workers will associate the early signs with malaria or typhoid, and they can’t diagnose based on the symptoms. They may start treating that.” Dr Abdi Mahamud, WHO’s director for health emergency alert and response operations, said the diagnostic challenge would have tripped up better-resourced systems. “This outbreak is happening in a highly endemic [setting for] other diseases that present similar symptoms – malaria, dysentery, and others,” he said. “If you don’t have that high index of suspicion, if you don’t have the right facility to test, even in high-income countries, you will have that delay in the start of an outbreak.” Diagnostic tests routinely used across the region added another layer of delay. The Bundibugyo strain belongs to a different genus, Orthoebolavirus, than the more common Zaire strain that most existing tests are optimised to detect. “There was a problem linked to the traditional test we use,” Tedros said. “The traditional test is optimised with Zaire, and the same sample was taken and tested, but since the test kit is optimised with Zaire, [Bundibugyo] could not be detected.” No vaccine, but a pipeline Vasee Moorthy, WHO’s research and development lead on the current outbreak, laid out the state of the vaccine pipeline for the Bundibugyo strain. The Bundibugyo strain has no licensed vaccine or therapeutic. WHO’s research and development lead, Vasee Moorthy, said a pipeline of candidates is being accelerated but remains months away. Moorthy said the most promising candidate is an rVSV Bundibugyo vaccine, the equivalent for this strain of Ervebo, the licensed Merck vaccine used against the more common Zaire Ebola strain since 2019. “There are no doses of this which are currently available for clinical trial, so this needs to be prioritised,” Moorthy said. “The information that we have is that this is likely to take six to nine months.” A second candidate, built on the ChAdOx1 platform used in the AstraZeneca COVID-19 vaccine, is being developed by Oxford and the Serum Institute of India. “They are manufacturing that as we speak, but there is no animal data to support [its efficacy],” Moorthy said. “It is possible that doses of that could be available for clinical trial in two to three months, but there is a lot of uncertainty about that.” Even in the most optimistic scenario, neither candidate is likely to be available to materially shape the trajectory of the current outbreak. In the meantime, the response is being built around the basics: safe treatment centres, patient referral pathways, contact tracing, and the protection of health workers, among whom the first confirmed case in the outbreak was identified. “The protection of healthcare workers and families is absolutely paramount,” Blumberg said. “The people in the area and those who respond need to be kept safe and allowed to be able to do what they need to do in a critical time such as this.” Tedros: Rubio suffers ‘lack of understanding’ US Secretary of State Marco Rubio. The WHO chief used the press conference to push back at US Secretary of State Marco Rubio, who said this week the agency had been “a little late to identify this thing.” The US has banned citizens of the DRC, Uganda and Sudan from entry, closed its only dedicated Ebola lab, withdrawn from the WHO, and defunded the agency. “On what the Secretary said, it could be from a lack of understanding of how IHR works, and the responsibilities of WHO and other entities,” Tedros said. “We don’t replace the country’s work, we only support them, so that’s why there could be some lack of understanding.” Tedros suggested conflict in the affected region was a more fundamental factor in the delay than anything WHO could have done differently. “Health facilities cannot work optimally when there is conflict and when the health workers are also fleeing as part of the community which is displaced,” he said. “It affects the whole surveillance system, and not only that, but it also affects access.” “I think that’s what we should understand, the secretary or others.” Asked repeatedly whether US funding cuts to DRC surveillance programmes had contributed to the outbreak going undetected, Tedros declined to draw a direct line. “We don’t need to jump to conclusions before we understand the whole complexity. It would be very difficult to associate it with funding alone,” he said, noting that the diagnostic gap was a question of the wrong tests being administered rather than supply. Legand echoed the point, noting the issue stems from test type, not supply: “For the time being, it’s not a supply issue. We need to ensure that the right platform with the right data arrives at the right place. This is the work that is being done as we speak.” The outbreak, meanwhile, continues to spread through a war zone with no vaccine, no cure, and a diagnostic system still catching up to the strain it now faces. Image Credits: @WHO African Region, Gage Skidmore. Grim Warning of Dwindling Funds for Emergencies as States Vote on Attacks in Lebanon and Iran 20/05/2026 Kerry Cullinan Dr Annette Heinzelmann, emergency director for the WHO Eastern Mediterranean Region (EMRO) The grim impossibility of addressing rising health emergencies with dwindling budgets was raised at the World Health Assembly (WHA) on Tuesday – amid votes on attacks on healthcare in Lebanon and Israel. “Outbreaks are accelerating, while the systems designed to stop them are being weakened,” warned Dr Annette Heinzelmann, emergency director for the WHO Eastern Mediterranean Region (EMRO), during a discussion of health emergencies in Committee A. “The gap between needs and resources is now unsustainable. The WHO Health Emergency Programme faced a $553 million funding gap in 2024 and 2025. The contingency fund for emergencies entered 2026 with just $19.5 million, while our regional emergency workforce has been cut by half. We cannot continue confronting expanding emergencies with shrinking capacity.” In EMRO, 117 million people need humanitarian assistance; there are 14 graded emergencies, 44 active outbreaks, and more than 50 public health events across 17 member states. “Conflict, displacement, climate shock, economic collapse, and diseases are colliding into a single expanding poly crisis,” Heinzelmann warned, speaking on behalf of the regional director. “Across Gaza, Sudan, Yemen, Somalia, and Afghanistan, and amid escalation affecting Iran, Syria, and Lebanon, WHO is sustaining trauma care, delivering medicines, reinforcing surveillance, and supporting governments to manage growing public health risks.” Votes on Lebanon and Iran Regional conflict is compounding the EMRO health crises. Lebanon received overwhelming support from the majority of member states in the wake of Israeli attacks on its health infrastructure – but there was little support for Iran’s appeal for support against similar attacks. Ninety-five member states voted in favour of a resolution that noted “a health emergency in Lebanon resulting from ongoing and recently intensified hostilities” and called for “the full protection of healthcare in Lebanon, including patients, health personnel, facilities and transport”. Only Israel and Honduras opposed the resolution, which did not name Israel as the aggressor. Voting on the resolution in support of Lebanon, following attacks on its health care by Israel. However, Iran’s resolution, condemning recent attacks on patients and health infrastructure, including on the Pasteur Institute – was defeated. The resolution did not mention Israel and the United States as the aggressors. Only 19 countries supported Iran, 30 voted against, and a whopping 58 countries abstained. Several countries cited Iran’s attacks against its own citizens and Gulf states, and the blockade of the Strait of Hormuz, preventing the flow of medical supplies, as reasons for not supporting the resolution. Voting on the resolution in support of Iran, in the wake of US and Israeli attacks on its health infrastructure. Haemorrhagic fever, extreme weather Voting came at the end of a discussion on the WHO’s involvement in health emergencies in the WHA’s Committee A. In 2025, WHO responded to 50 emergencies in 82 countries and territories, of which 20 were Grade 3 emergencies requiring the highest level of organisation-wide support, the organisation reported. Disease outbreaks included viral haemorrhagic fever: Sudan virus disease in Uganda; Marburg in Tanzania and Ethiopia; Ebola in the Democratic Republic of the Congo (DRC) and Rift Valley fever in Mauritania and Senegal. Mpox was declared a public health emergency of international concern (PHEIC), affecting 98 countries, with 52 974 confirmed cases – 84% in Africa – and 215 deaths. Thirty-three countries reported cholera outbreaks involving over 614 828 cases and 7,598 deaths. Angola, the DRC and Sudan had the highest cases. The WHO provided over 58 million doses of “emergency vaccines” for cholera, meningitis, yellow fever and Ebola. Challenges included “limited surveillance capacities and insufficient production of critical vaccines”. Three out of four emergencies were either caused or exacerbated by extreme weather events such as flooding, droughts and cyclones. Earthquakes in Afghanistan and Myanmar, severe Pacific typhoons and three category-5 hurricanes, including Hurricane Melissa, caused death and damage. The global cost of natural disasters is estimated at over $ 200 billion annually. So great was the demand for WHO’s assistance that its Contingency Fund for Emergencies was left with $19.5 million by the end of the year. Attacks on healthcare The severely destroyed Al-Shifa hospital in Gaza City, Palestine, in February 2025. Last year, the WHO verified 1,351 attacks on healthcare, resulting in 925 health facilities damaged or destroyed. The Independent Oversight and Advisory Committee (IOAC) for the WHO Health Emergencies Programme reports a “significant and alarming escalation” in these attacks that are likely to “underestimate the true scale of the crisis as reporting is uneven”. EMRO’s Heinzelmann said that almost 40% of these attacks occurred in her region, accounting for almost 90% of related deaths. “Attacks on healthcare must stop, humanitarian access must be guaranteed, and financing for preparedness and emergency response must increase now, not after the next global crisis is already underway,” she urged. Several member states, including Jordan, Switzerland, Australia, urged an end to attacks on health facilities and personnel and respect for international humanitarian law. Lack of financing The IOAC noted its deep concern at the “dramatic reductions in official development assistance from major donors”. During the 2008 global economic recession, the WHO “deprioritised” its emergency-related teams and reduced the workforce – but paid a high price during the Ebola outbreak in West Africa, “which resulted in over 11,000 lives lost and posed an existential threat to WHO”, noted the IOAC. “It is the IOAC’s responsibility to ensure that past weaknesses are not reprised and that WHO’s emergency capacities remain safeguarded.” In the WHO’s 2026‒2027 budget, the base budget of the emergencies programme has been set at $918.5 million, with 51% for country offices, 22% for regional offices and 27% for headquarters. Image Credits: Nour Alsaqqa/ MSF. WHO is Alarmed at ‘Scale and Speed’ of Ebola Outbreak as Hantavirus Threat Recedes 19/05/2026 Disha Shetty & Stefan Anderson Dr Tedros Adhanom Ghebreyesus is currently serving his second five-year term as WHO Director-General. His mandate expires on August 15, 2027. GENEVA — The outbreak of a deadly strain of Ebola for which there is no vaccine is accelerating through the Democratic Republic of Congo (DRC) and Uganda at a “scale and speed” alarming the World Health Organization (WHO), as cases climb and authorities scramble to contain the spread. “I’m deeply concerned about the scale and speed of the epidemic,” WHO chief Dr Tedros Adhanom Ghebreyesus told the 79th World Health Assembly on Tuesday, addressing delegates from 192 nations gathered in Geneva. More than 500 suspected cases and 130 suspected deaths beyond the confirmed caseload have been reported. Tedros said the figures would change as field operations scale up, including strengthening surveillance, contact tracing, and laboratory testing. “So far, 30 cases have been confirmed in the DRC from the northern province of Ituri,” he added. “Uganda has also informed WHO of two confirmed cases in the capital of Kampala, including one death among two individuals who travelled from DRC, and there is one US citizen confirmed positive and transferred to Germany.” “This epidemic is caused by Bundibugyo, a species of Ebola virus for which there are no vaccines or therapeutics,” Tedros said. Diagnostic tests in the region were designed for a different strain of Ebola and missed early infections, resulting in a four-week gap before the outbreak was detected. Ongoing shortages of diagnostic equipment on the frontlines mean the true size of the outbreak remains unknown. “In the absence of a vaccine, there are many other measures countries, of course, can take to stop the spread of this virus and save lives, even without medical countermeasures, including risk communication and community engagement,” Tedros said, commending Uganda for postponing its annual Martyrs’ Day celebrations, which can draw up to two million people. The Ebola virus kills up to half of those it infects, making any outbreak particularly dangerous. In response to the outbreak, the United States banned citizens from the DRC, Uganda and Sudan from entering the US on Monday. Also read: Tedros: ‘We Live in Difficult, Dangerous and Divisive Times’ ‘Did not do this lightly’ Ongoing 79th session of the WHA in Geneva, Switzerland. The rapid spiral led Tedros to declare the outbreak a public health emergency of international concern (PHEIC) on Sunday, the first time a Director-General has done so before convening an emergency committee. “I did not do this lightly,” he told the assembly. “I did it in accordance with Article 12 of the International Health Regulations, after consulting the ministers of health of both countries.” The emergency committee will meet later on Tuesday to advise on what response measures countries should adopt, as there is no vaccine and no cure for the strain of Ebola now spreading. The first confirmed case was a health worker, meaning the virus was already moving through medical settings before anyone knew it was there. After heavy criticism of the WHO’s slow handling of the 2014 West African Ebola epidemic, the agency’s chief appears unwilling to allow a repeat of history. Tedros said an additional $3.4 million was released from the WHO’s Contingency Fund for Emergencies, bringing the total committed to the response to $3.9 million. “WHO has a team on the ground supporting national authorities to respond,” he said. “We have deployed people, supplies, equipment, and funds.” LIVE: @DrTedros‘ address to the #WHA79 delegates https://t.co/IUGcXQ3cLe — World Health Organization (WHO) (@WHO) May 19, 2026 Deadly delays leave authorities flying blind Ebola health worker in protective gear. File image. Cases have surfaced in densely populated urban areas, including the Ugandan capital Kampala and the eastern DRC city of Goma, home to millions of people and serving as major hubs for cross-border trade and movement. The outbreak is likely to have originated in DRC’s Ituri province, a high-traffic mining area on the borders of South Sudan and Uganda, which “increases the risk of regional exportation and cross-border transmission”, according to the WHO. Fighting in the area between the DRC army and M23, an Islamist armed group, has intensified since late 2025 and escalated significantly over the past two months. More than 100,000 people have been newly displaced by the conflict, Tedros told the assembly – potentially carrying the virus with them as they go, far from the reach of surveillance teams and into communities with little capacity to identify or isolate new cases. “In Ebola outbreaks, you know what displacement means,” Tedros said. “The area is also a mining zone with high levels of population movement that increase the risk of further spread.” Local funeral practices, which involve close contact and touching the deceased, also accelerated transmission before authorities knew the outbreak was happening. The current outbreak is the third recorded outbreak of Bundibugyo, first identified in 2007. Hantavirus contained There are no known vaccines or therapeutics for this strain of Ebola making containment a challenge. The picture is markedly different for hantavirus, which Tedros also addressed. Two weeks ago, the hantavirus outbreak aboard the MV Hondius cruise ship, sparked international panic and wall-to-wall news coverage, but it has now been brought under control, Tedros told the assembly. “WHO’s assessment continues to be that the risk of hantavirus globally is low,” Tedros said. The ship docked in Rotterdam on Sunday, with the crew now in quarantine until 29 June. Passengers, who have been repatriated, will be monitored until 21 June. “So far, there are 11 reported cases, including three deaths, and no deaths have been reported since the second of May, when WHO was first informed of the outbreak on the ship. Those numbers have changed little since the outbreak was first reported to WHO two weeks ago,” Tedros said. The two outbreaks, emerging within two weeks of each other, served as a reminder of WHO’s core function, Tedros told the assembly. “The outbreaks of Ebola and Hantavirus in the past two weeks show why international threats need an international response,” he said. “They show why the world needs the international health regulations and why it needs WHO.” WHO successes: tobacco and taxes Tedros also highlighted WHO’s wins in his address, including the decline in tobacco use. “Tobacco use has dropped by one-third globally and continues to decline in 140 countries. With support from WHO, Maldives became the first country to adopt a generational tobacco ban for people born from 2007. This year, the United Kingdom followed suit, banning the sale of tobacco to anyone born from 2009 onwards,” he said. Since 2025, the WHO has been encouraging countries to tax tobacco, alcohol, and sugary drinks by at least 50% by 2035. “In the past 12 months, India, Jamaica, Malaysia, Mauritius, Mexico, Montenegro, Viet Nam, Saudi Arabia, Sierra Leone and Zambia were among countries that either announced, introduced or increased taxes on one or more of these products,” Tedros said. WHO’s advocacy to increase the rate of breastfeeding globally has also yielded positive results, with almost half of children worldwide being breastfed for at least for six months, Tedros said. A billion more people now have access to safe drinking water compared to just a decade ago, but the levels of violence against women have remained stagnant for two decades. However, the shortage of healthcare workers is hampering progress: “The world is facing a shortage of 11 million health workers by 2030, with the biggest gaps in the African and Eastern Mediterranean regions. More than half the gap is a shortage of nurses,” Tedros said. The world is also set to miss every one of the 52 health-related Sustainable Development Goal targets by 2030, the WHO revealed on the eve of the WHA. Malaria cases are rising, maternal deaths are still occurring at nearly three times the targeted rate and childhood vaccination coverage is plateauing or falling in some regions, and progress on global health goals has slowed, stalled or reversed across virtually every measure since 2015, according to the 2026 World Health Statistics report. Image Credits: WHO/Christopher Black , WHO/X, Africa CDC , WHO/X. Undocumented Migrants Fall Through Europe’s Healthcare Cracks, Joint Research Shows 19/05/2026 Felix Sassmannshausen Undocumented migrants navigate precarious conditions, often lacking health safety nets, despite contributing to informal economies. As Europe grapples with shifting demographics and an influx of migration, researchers are mapping how undocumented migrants navigate the administrative cracks of the continent’s healthcare systems – helping to fill a critical data gap identified by the World Health Organization. Inside the neoclassical venue of La Pastorale in Geneva, around 30 participants from six European universities convened on Monday on the sidelines of the World Health Assembly to dissect an expanding public health crisis related to the healthcare of immigrants, whose status and lack of resources means they often seek care in the shadows of the formal system – or fall through the cracks altogether until an emergency. The Geneva Health Forum event highlighted how complex administrative barriers keep undocumented migrant children and the elderly across the continent from accessing essential healthcare, leaving untreated chronic conditions, severe mental health crises, and emergencies to strain local resources. Professors Claudine Burton-Jeangros and Yves Jackson of the University of Geneva. The “Growing and ageing in the shadows” (GRACE) project, co-directed by Professor of Medicine Yves Jackson and health sociologist Professor Claudine Burton-Jeangros of the University of Geneva, explores these disparities as part of the European University Alliance (4EU+). The consortium unites scholars from the universities of Geneva, Heidelberg, Prague, Milan, Paris Sorbonne, and Copenhagen. Mapping the barriers and needs in Europe’s cities remains exceptionally difficult, as a lack of information and personnel, coupled with a profound fear of discrimination or deportation, drives undocumented migrants away from clinical settings and creates severe data deficits. The scale of this blind spot is particularly evident among minors; in Germany, for example, population estimates for undocumented children range wildly from a few thousand to over 100,000, the researchers noted. To enable evidence-based policymaking, the GRACE consortium navigates these blind spots by conducting in-depth interviews with frontline healthcare providers, social workers, and non-governmental actors to uncover the practical realities these vulnerable groups experience. While the results presented on Monday were preliminary, the consortium projects final results by the end of the year. They aim to use the findings to inform and advocate to policymakers on how to improve healthcare access. Fragmented bureaucracies erode rights of undocumented migrants WHO data on inclusion of refugee and migrant health aspects in national policies, legislation strategies or plans across thematic areas in the European Region. Access to equitable healthcare is a fundamental human right, reinforced by international frameworks such as the WHO Global Action Plan and the 2026 Progress Declaration of the International Migration Review Forum (IMRF) – the primary UN platform for tracking global migration commitments. Although the WHO notes significant recent progress – such as the WHO European Region’s action plan to improve legal access to care – these theoretical rights continue to routinely erode within the continent’s complex bureaucracies. In universal healthcare systems like Denmark’s – where the uninsured population also includes European Union citizens who have simply fallen out of the formal labour market – the mandate for a central registration number excludes those without formal residency documents. Lacking this registration number, undocumented individuals are forced to rely on a parallel, privately funded network of volunteer-run clinics for even the most basic medical care. Even in jurisdictions with progressive entitlements specifically designed for undocumented populations, such as France – where, notably, children cannot legally be classified as undocumented – administrative labyrinths and illegal discrimination by providers severely limit practical access. Although the French State Medical Aid guarantees free access to essential care after three months of residency, eligible patients are still frequently turned away by providers who illegally refuse to treat those relying on state support. University of Geneva researchers Srilak Weerawardane and Emma Perneger present preliminary findings. Germany also sees a growing number of uninsured migrants falling through the cracks. And this is not surprising since it enforces a severe legal Catch-22, the researchers found: while doctors maintain confidentiality, social welfare offices must report undocumented patients to immigration authorities if public funds cover their care. Additionally, hospitals frequently deny expensive treatments to avoid unpaid hospital bills. Ultimately, this systemic threat breeds a profound fear of deportation, driving undocumented migrants away from clinics entirely. Switzerland’s mandatory healthcare system grants all residents the right and legal obligation to purchase expensive insurance. Undocumented migrants – strictly excluding asylum seekers with pending applications – cannot opt out but face severe barriers to state subsidies. Forced to pay out of pocket, they accumulate massive debt, which accounts for an estimated 90% of their total arrears in Geneva. University of Geneva researchers concluded this financial burden traps individuals in poverty and paralyses future regularisation attempts, since being debt-free is a primary requirement for legal residency. Healthcare hinges on relationships instead of rights Locked out of formal systems, undocumented migrants rely on informal networks and alternative routes for essential healthcare. Because official avenues remain blocked, fragmented NGO clinics and volunteer doctors often serve as the primary safety net for basic care, the research team from the University of Copenhagen explained. To bridge the gap between theoretical rights and practical access, social workers must frequently intervene to defend marginalised patients, while physicians in countries like the Czech Republic utilise personal discretion to classify treatments as “acute care” to legally compel hospitals to provide treatment. Ultimately, receiving medical attention often depends on the willingness of individual healthcare providers to bypass restrictive frameworks. As a result, securing essential treatment is often reduced to a matter of luck, depending heavily on the informal networks of the doctors and the specific resources of the patients themselves. Heidelberg University researchers Manuela Orjuela-Grimm and Veronika Wiemker discuss their research on healthcare barriers. “It’s really contingent on personal relationships and healthcare providers… instead of being a right,” Veronika Wiemker, a researcher at the Heidelberg University on the situation in Germany, reflecting the shared reality across the continent. Faced with such systemic exclusion, undocumented migrants utilise alternative routes to care. To treat their conditions, individuals proactively stockpile medicine, consult online forums or artificial intelligence, and rely on transnational healthcare – such as travelling across borders for treatment or using telemedicine to maintain remote consultations with doctors in their countries of origin, as the researchers from Prague’s Charles University found. Young migrants navigate fragmented care Driven under the administrative radar, undocumented children face severe healthcare fragmentation, missing crucial developmental screenings and continuous medical support. The situation for undocumented children is particularly dire, despite being specially protected under international provisions. As undocumented parents often lack official birth certificates, their newborns remain largely under the administrative radar. The living conditions for these youngest migrants are frequently severe; in France alone, researchers from Paris Sorbonne University report that an estimated 3,000 homeless newborns and their mothers are discharged from hospitals directly onto the streets each year. Sorbonne University researchers Fanny Teissandier and Andrea Tortelli outline their methodology. Without stable housing or formal documentation, young migrants across the continent frequently miss out on crucial immunisations and preventive measures, mental health support, and basic dental care. While school-aged children occasionally receive basic entry assessments or see school nurses – as is the practice in countries like Germany and Denmark – the ongoing absence of holistic, continuous care exposes them to severe developmental risks and untreated chronic conditions. Unaccompanied minors endure even deeper vulnerability, often surviving on the streets while facing malnutrition and severe trauma. Despite being theoretically protected by local authorities, these youths remain highly vulnerable to exploitation, sex work, and chronic stress. Ultimately, the transition to adulthood introduces a severe, continent-wide cliff edge for these adolescents. Upon turning 18, temporary legal protections abruptly dissolve – either plunging the young adults into mandatory insurance systems they cannot afford or stripping them of their rights entirely. Ageing populations undergo unique crises Elderly undocumented migrants often endure accelerated ageing and complete exclusion from formal European long-term healthcare networks. The plight of the elderly introduces an entirely distinct set of challenges for local administrators, revealing severe gaps in long-term care. While some older migrants are newly arrived parents joining their children, many others are former labourers who planned to briefly work abroad but ultimately remained for decades. After years of surviving precarious, physically demanding jobs in the informal economy, these individuals frequently experience “accelerated ageing”, untreated chronic pain, and rapid cognitive decline. Furthermore, returning to their countries of origin is rarely a viable solution, as many have lived in Europe for well over a decade and no longer possess any social ties or family networks back home. Their vulnerability is compounded by European health systems that intrinsically tie medical entitlements to formal employment. Once these individuals age out of the workforce or lose their physical capacity to continue their demanding labour, they lose their economic value – frequently stripping them of their eligibility for public health subsidies and plunging them into poverty. This loss of economic value and legal status leaves elderly undocumented migrants completely excluded from formal long-term care solutions. Fearing that elderly, homeless migrants will become permanent “bed blockers” with no follow-up care options, hospitals in countries like France sometimes even deny them access to inpatient admission. Fear fuels harmful data gaps The bureaucratic ‘Chicken and Egg’ cycle: Financial burden and fear drive clinical avoidance, creating a data deficit that fuels policy paralysis. Beyond the immediate health consequences, the overarching fear of deportation forces individuals to “pretend not to be there.” Because undocumented migrants often actively avoid clinics, they remain completely hidden from formal health frameworks, creating a massive data blind spot for policymakers. Closing this gap is a global mandate, forming the core of the third and fifth priorities of the WHO Global Action Plan regarding migration health research and data. WHO’s Daniel Míč emphasises data to bridge divides. Daniel Míč, representing the World Health Organization (WHO) Special Initiative on Health and Migration, stressed that this dynamic creates a bureaucratic “chicken and egg” scenario. “If you are in a vulnerable situation, and you are afraid of being deported, or you are afraid of being punished by the system that you seek health or care from, there’s a problem,” he warned, noting that capturing necessary public health data becomes difficult when fear drives individuals away from the frontline clinics that would otherwise document their conditions. This data deficit is further compounded by the fact that defining who exactly qualifies as an “undocumented migrant” remains a major challenge. Because each national system applies its own administrative labels, the practical barriers these individuals face are dictated entirely by the bureaucracy of the country they reside in. Ultimately, “we will understand the challenges only if we have the data,” Míč said, stressing that concrete evidence is the only way to bridge political divides and present actionable solutions to policymakers. To close this harmful data gap, the GRACE consortium plans to synthesise its preliminary findings into targeted case studies and scientific reports by the end of the year. Recognising the immense value of this frontline research guiding European member states in building inclusive healthcare systems, Míč expressed a readiness to resume dialogue with the 4EU+ Alliance, hoping to translate previous discussions into a concrete collaboration. More Countries Refer to Refugees in Health Policies, but Access and Data Gaps Persist Image Credits: Adhitya Ginanjar/Unsplash, Tim Mossholder/Unsplash/HPW, University of Geneve/HUG, WHO/HPW, Felix Sassmannshausen/HPW, Beth Macdonald/Unsplash. Member States Support Extending Talks on Pandemic Agreement Annex, Propose New ‘Method’ 19/05/2026 Kerry Cullinan Pakistan’s Adeel Khokhar All World Health Organization (WHO) member states supported the extension of talks on the last outstanding piece of the Pandemic Agreement, the Pathogen Access and Benefit-Sharing (PABS) annex, at the World Health Assembly’s (WHA) Committee A on Monday. A draft PABS annex was due to have been presented to the WHA for approval, but instead, a report from the World Health Organization (WHO) Director General notes that member states need more time to reach an agreement. The PABS annex will govern how dangerous pathogens are shared during public health emergencies and how to share any medical products (benefits) produced as a result of manufacturers getting access to this information. A draft annex will either be presented at next year’s WHA or at a special WHA if agreement is reached beforehand, according to the report. Several of the many member states speaking on PABS in Committee A expressed confidence that the annex would be completed by the end of the year. However, divisions between developed and developing countries remained stark. Pakistan warned that the PABS negotiations should not be concluded in a way that “preserves the commercial privileges of a handful of manufacturers”. Pakistan’s representative told the committee: “We are witnessing a sustained effort by some member states to hollow out Article 12 [of the Pandemic Agreement], which clearly establishes the principle of equal footing” between sharing dangerous pathogens and sharing any benefits that manufacturers accrue from such knowledge. “We will not sign off on a multilateral system success story that serves the interests of industry over the health security of billions,” he added. ‘Conducive to R&D’ Malaysia’s representative in Committee A. On the other end of the spectrum, the European Union warned that a PABS agreement should not stifle research and development. “The Pandemic Agreement, as well as the revised IHR [International Health Regulations], contain important provisions that will significantly increase our capacity to confront pandemic emergencies and do so in a more equitable manner,” said the European Union. “The PABS system has an important role to play in this context, but we need to ensure that the system is also conducive to innovation, and research and development for medical countermeasures, then it can lead to a robust uptake by the private sector.” African countries, represented by South Africa, explained once again their demands for an equitable PABS system, including that the annex should include legally binding contracts between the WHO and manufacturers. Impetus for a global PABS system comes from the need to correct the inequities of the COVID-19 pandemic, when developing countries were initially unable to get vaccines – even for healthworkers – as these had all been bought by wealthy countries. As Namibia reminded the committee: “We negotiated the Pandemic Agreement because the world watched developing countries bury their loved ones due to COVID-19 while vaccines sat unused in warehouses elsewhere. That memory must anchor every line that we now draft.” “The credibility of this agreement now rests on the PABS annex. If access obligations read ‘shall’ while benefit-sharing obligations read ‘options’, and ‘where available’, we will have written inequity into international laws with our own hands.” “Benefit-sharing obligations must be legally binding and enforceable,” said Nigeria. “Technology transfer and non-exclusive licensing and local production partnerships must be obligations manufacturers sign onto, not options they select from a menu.” Malaysia emphasises that annex must clearly spell out the rights and obligations of parties, and be “operationally implementable”. Referring to the current hantavirus and Ebola outbreaks, Spain urged the completion of the annex so that the Pandemic Agreement could come into force and provide a solid regulatory framework “to prevent, prepare, and respond to health emergencies”. New methods for future talks? After six formal meetings and several informal sessions, the Intergovernmental Working Group (IGWG) will reconvene in July. However, Colombia stated that the extension of the negotiations on the PABS annex “will only make sense if it allows for a more balanced result, which is technically solid and useful for global public health. ” Colombia’s representative said that the main barrier is that the “rules of intellectual property applied to public health become a barrier to access and the production of vaccines, treatments, and diagnostics, just as happened during the COVID 19 pandemic.” Colombia proposed new “working methods” for the talks, including that they are open rather than behind closed doors, and “a progressive step-by-step approach” to the text, using “the concept of progressive consensus.” Colombia has previously suggested voting on contentious issues. Meanwhile, civil society observer Knowledge Ecology International (KEI) also proposed that negotiators “should consider new approaches, including some features of the benefit-sharing agreement in the new Law of the Sea Treaty, for areas beyond national jurisdiction. “In that agreement, governments take responsibility for the enforcement of benefit-sharing, and the triggers for benefit-sharing are downstream, on the filing or patents or the registration or sale of products.” Posts navigation Older postsNewer posts
Pharma Industry Demands Repositioning of Medical Innovation as Strategic Investment, Not Cost 21/05/2026 Felix Sassmannshausen Global health leaders discuss strategic medical innovation. From the left: Isabelle Kumar (moderator), Monique Vledder (World Bank), Penny Heaton (Johnson & Johnson), Florika Fink-Hooijer (EU HERA), and Michael Lobritz (Roche). Amid surging geopolitical tensions, increased global health threats, and strained public budgets, global health leaders and pharmaceutical executives converged in Geneva with a unified message: medical innovation must be treated as a critical investment not a healthcare drain. Showcasing this shift, Canada unveiled strategic investments and new regulations. GENEVA – Inside the packed ballroom of the luxurious Intercontinental Hotel, during a flagship event hosted by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) on Tuesday, large screens broadcast a simple promise of continuous innovation so that “the next generation of medicines and vaccines can deliver a healthier, stronger future”. “Pharmaceutical innovation has accounted for more than 70% of the increase in life expectancy across G20 and developing countries,” said moderator Isabelle Kumar in her opening remarks. But at the same time, G20 economies are losing an estimated one trillion dollars every year to preventable health conditions, she added. Exploring solutions at scale, the panel keynotes and discussions bridged public, private, and geopolitical sectors. The high-level speakers included Canadian Minister of Health Marjorie Michel and AstraZeneca chair Michel Demaré. They were followed by a panel discussion with Monique Vledder, World Bank Group global director, Florika Fink-Hooijer, Director-General of the EU’s Health Emergency Preparedness and Response Authority (HERA), Penny Heaton of Johnson & Johnson, and Michael Lobritz of Roche. The experts acknowledged that global health architecture currently faces immense strain from escalating vulnerabilities, including ageing populations, antimicrobial resistance, and rising rates of non-communicable diseases. Consequently, leaders urged a major mindset shift, positioning sustained investments in medical innovation as vital catalysts for economic growth. Health investments’ economic potential Despite their differing mandates, the panellists reached a firm consensus: governments must abandon short-term budgeting and invest in medical innovation to secure long-term national resilience and productivity. This demands a profound departure from reactive spending toward proactive strategic investments. IFPMA Director General David Reddy. Echoing this shared conviction during his concluding remarks, IFPMA Director General David Reddy emphasised the overarching economic value of the sector. “Investing in health innovation is not a tradeoff, it’s a multiplier,” said Reddy. To explain the broader economic stakes, the World Bank’s Vledder noted that an unhealthy workforce fundamentally stalls local economies, while funds flowing into the health sector offer tremendous potential for job creation. Industry pushes for tripling of prevention budgets AstraZeneca Chair Demaré reinforced this point, stating that a healthy population experiences fewer sick days and drives higher productivity. He highlighted that establishing a healthy global population could boost the GDP by 7% by 2050 – an economic gain equivalent to the combined economies of Germany and Japan. “So we need a mindset change here to look at medicine and especially innovative medicines as an investment for the future,” said Demaré. Early diagnosis and preventative treatments could drastically reduce long-term hospital costs and boost this overall economic productivity. Currently, OECD countries allocate an average of only 3% of their healthcare budgets to prevention, a figure Demaré argued should double or triple to have a real impact. He emphasised that this shift should rely heavily on functional public-private partnerships, pointing to specific collaborative efforts, such as the Partnership for Health System Sustainability and Resilience, which assesses health systems across more than 30 countries to identify localised governance gaps and propose targeted technological solutions. Canada announces strategic investment Canadian Health Minister Marjorie Michel announced a $131 million public investment into the Pan-Canadian Pharmaceutical Alliance. In the spirit of the industries’ demands, Canada positioned itself as a pragmatic, reliable partner in the global supply chain, navigating amidst geopolitical instability and contrasting its approach with nations relying heavily on threats and tariffs – an indirect reference to the United States under President Trump. “Tariffs are not the Canadian way. Our values are anchored in respect yet viability, predictability and collaboration and the fundamental belief in talent and research,” said Michel. Breaking news on the IFPMA stage, she announced a fresh $131 million injection into the Pan-Canadian Pharmaceutical Alliance. The public investment aims to unify Canada’s fragmented healthcare system into a single market, thereby accelerating drug price negotiations and reducing administrative burdens. The government had also previously announced $1.7 billion to attract world-leading researchers, transforming the nation into a clinical trial powerhouse. By modernising clinical trial frameworks and aligning with international regulators, Canada aims to reduce the time between drug submission and approval by up to 50%. “We need a regulatory system that is timely, predictable, and grounded in science. One that fiercely protects Canadians while giving companies a clear reason to invest in Canada,” said Michel. AstraZeneca Chair Michel Demaré calls for tripling prevention budgets during an IFPMA panel discussion. Europe pivots to security amidst new threats Across the Atlantic, the EU is also heavily investing in its pharmaceutical sector to secure long-term strategic autonomy. Recent legislative moves, such as the Critical Medicines Act, aim to prevent medicine shortages, boost domestic manufacturing, and position the bloc as a global leader by fostering a competitive innovation ecosystem. However, these proactive health initiatives face a formidable obstacle: severe budget constraints compounded by escalating geopolitical conflicts. As financial resources shrink across Europe, medical innovation is increasingly losing critical funding to traditional military priorities against the backdrop of Russia’s ongoing war in Ukraine and increased geopolitical tension. “We had quite a stable budget, and then the political levels decided… we have security as a major risk. So we lost €1 billion… because indeed health got the lower priority,” said Fink-Hooijer. HERA Director-General Florika Fink-Hooijer. To maintain regional production capacity and true preparedness, Fink-Hooijer argued that European officials can no longer view medical innovation merely as an ad hoc healthcare cost. Instead, they must treat it as a foundational pillar of geopolitical defence through structured investments. Reflecting this shift in mindset, HERA actively bridges the gap between health and traditional security by establishing a dedicated unit to monitor advanced biowarfare risks. “We do have now also a civil-military unit in order to really look at that type of threat scenario… because we know that it could also be with AI abuse due to other types of artificial or intentionally produced pathogens,” Fink-Hooijer announced. Meanwhile, restricted public budgets inevitably force regulatory bodies into making high-stakes gambles on future threats. HERA recently directed its scarce resources toward developing a vaccine for the Ebola Sudan strain – a calculated strategic bet that became a bad choice in hindsight, Fink-Hooijer admitted, as it completely missed the current outbreak. Fragility, fragmentation and folly Roche’s Michael Lobritz outlined the industry’s structural vulnerabilities through what he termed the “three Fs”: fragility, fragmentation, and folly. While scientific capabilities accelerate at unprecedented rates and countries compete over production capacities, the global health architecture remains vulnerable to fragmented supply chains. Roche’s Lobritz outlined the industry’s structural weak points through what he termed the “three Fs”: fragility, fragmentation, and folly. He warned that innovation pipelines remain extremely fragile, lacking the investor capital necessary to mature early-stage compounds. Out of 14 viral families with pandemic potential, there are currently only 18 clinical compounds in development, mirroring similar capital shortages in the antimicrobial resistance market. Furthermore, fragmented ecosystems prevent diverse health sectors from coordinating effectively, leading to the dangerous folly of relying on reactive scaling during a sudden crisis without prior preparation. True resilience demands sustained, peacetime collaboration to ensure every therapeutic agent is ready before the crisis hits. Likening the pharmaceutical supply chain to a bustling restaurant kitchen handling a massive dinner rush, he emphasised the vast, unseen preparation required behind the scenes to successfully deliver the final product. “The creation of a novel medicine that changes the course of the life of an individual is not an eventuality or a certainty and needs to be supported,” concluded Lobritz. Addressing the global healthcare gap For this, governments must invest, also to ensure life-saving medical innovation actually reaches the populations that need it most, the participants argued. Outside the IFPMA ballroom, however, health equity advocates caution that framing high-cost pharmaceutical innovation and public-private partnerships as primary drivers of economic resilience can overshadow the need for fundamental strengthening of public health infrastructure, particularly in low- and middle-income countries where access to basic therapeutics remains a major obstacle. The challenge extends far beyond laboratory breakthroughs to the ultimate end-user. Outlining the World Bank’s current attempt to reach 1.5 billion people with essential health services, Vledder acknowledged that scientific innovation means little if delivery systems in fragile states remain broken. Global Health Needs More than Money – Philanthropy Can Amplify Impacts Image Credits: Felix Sassmannshausen/HPW. Russia Tries to Block Debate on Attacks on Health Facilities in Ukraine 20/05/2026 Disha Shetty Interior of a hospital room in Kherson heavily damaged during conflict, showing extensive structural destruction and debris. Neither Russia’s delegate banging her desk to interrupt Ukraine’s representative speaking at the World Health Assembly (WHA), nor her request to dismiss debate, stopped member states from condemning Russia’s attacks on Ukraine’s health system. A report by the World Health Organization’s (WHO) Director-General before delegates estimated that Russia’s aggression on Ukraine has caused 55,600 civilian casualties, including 14,999 deaths. Violence intensified in 2025 with civilian casualties going up by 31% compared to the previous year, and by 70% when compared to 2023. The WHO also documented 579 attacks on healthcare facilities that caused 19 deaths and 204 injuries among healthcare workers and patients in 2025. This was an 18% increase compared to 2024. “Since this report was published, WHO has recorded 190 new attacks on health care, with 86 injuries and 15 deaths between 1 January and 6 May, 2026,” said Dr Altaf Mossani, Director of Humanitarian Disaster Management, WHO Emergency Preparedness and Response program. “On May 14, a clearly marked United Nations vehicle was severely damaged by drone strikes in Kherson City. This is the second incident that week,” he added. Russia targeting healthcare infrastructure The 79th World Health Assembly in session. Countries raised alarm at the WHA that 202 of Ukraine’s 11,887 health facilities have been severely damaged, and 1,013 units are partially damaged. “We strongly condemn Russia’s ongoing war of aggression against Ukraine and the deliberate escalation of attacks targeting civilians and civilian infrastructure, including health care facilities, and we are deeply alarmed by the sharp increase in attacks on the health infrastructure since the last World Health Assembly,” Moldova’s representative told the WHA. Civilian attacks also drew sharp criticism, leaving Russia isolated during the discussion. “Russia’s attacks on energy infrastructure and other civilian targets, such as hospitals, elderly homes, or kindergartens, became increasingly vicious and brutal,” said Germany’s delegate. “On average, it has been said already, there have been more than 3,000 Russian attacks directly affecting health care institutions, two each day.” Ghana empathised with countries that are receiving a large number of refugees from Ukraine as a result of the conflict, resulting in an additional burden on their health systems. High drama by the Russian representative Russia’s representative to the WHA banged the desk to interrupt Ukraine’s speaker and called the WHO’s report on the health situation in Ukraine “disinformation.” Russia’s representative first moved to dismiss the debate on the report on Ukraine entirely. That request was put to a vote and defeated. Following extensive discussion on the report, Russia again moved to stop the WHA from noting the report. Russia was reminded that noting the report was merely procedural, but it requested a vote again. Once again, countries voted in favour of noting the report. At one point, the Russian representative banged the desk several times to interrupt the Ukrainian speaker, and was reminded to raise the country’s flag if she wanted to make a statement. Russia then accused the WHO of spreading misinformation. “WHO is talking only about attacks on Ukraine, ignoring the information that has been submitted to WHO on attacks on Russian facilities. So, we would ask WHO to stop misleading the world and to stop disseminating misinformation when it comes to voting on this report,” the representative accused. WHO’s report noted that there were 21 attacks on healthcare facilities in Russia, causing 17 injuries. Russia did not agree with this number. However, the Russian representative said, “more than 250 Russian facilities were attacked by Ukraine, and only 35 of them have been officially reported by WHO. And indeed, in the report, even that figure has deliberately been lowered”. Russia opposed the noting of the report by the WHA. The report was noted nevertheless, following a vote. Polio needs attention Polio remains endemic in the WHO’s Eastern Mediterranean Region (EMRO) region. WHA also discussed polio that remains an issue in several countries like Pakistan and Afghanistan. Conflicts and funding cuts have in recent years interrupted polio vaccination campaigns. In Gaza, polio made a resurgence as conflict raged. Most of these areas fall under the WHO’s Eastern Mediterranean Region (EMRO) region. “We are actually the last part of the world where that virus remains endemic, but we are doing our utmost to tackle this issue. We have seen, however, that in Afghanistan and Pakistan there have been declines in transmission trends, and we think that is a cause for optimism about wild polio virus transmission,” Libya said, making a statement on behalf of the EMRO region. Other countries reminded the WHA that polio is still a relevant issue that needs attention. “We wish to recall that polio is still a global health challenge because new cases of wild polio have been recorded in certain countries, and there are new coast cases in conflict areas. Then, hence, the need for further international effort to ensure that we have national and regional preparedness,” Oman’s representative told the WHA. Also read: Polio Eradication Imperiled by $2.3 Billion Funding Gap Image Credits: WHO Ukraine, X/WHO, WHO. WHO: Ebola Outbreak Is a Deadly Regional Threat But Not a Global Pandemic Risk 20/05/2026 Stefan Anderson The WHO has determined that the Ebola outbreak raising alarm worldwide does not pose a pandemic threat. GENEVA — The Ebola outbreak unfolding in the Democratic Republic of Congo (DRC) and Uganda poses a “low” risk globally, according to an expert committee of the World Health Organization (WHO). However, the national and regional risk is “high”, according to the International Health Regulations (IHR) Emergency Committee. Last Sunday, WHO Director-General Dr Tedros Adhanom Ghebreyesus had already declared the outbreak a public health emergency of international concern (PHEIC), the WHO’s second-highest level of alert, before convening the emergency committee. This is the first time in WHO’s history that this has occurred. Tedros was motivated by the scale and speed of the spread of the Bundibugyo virus, a rare and particularly deadly strain of Ebola, which has killed at least 131 people and infected over 500 others. The emergency meeting, convened on Tuesday to assess the threat of the current outbreak, concurred that the situation is a PHEIC but “not a pandemic emergency,” Tedros told a media briefing on Wednesday. The committee, chaired by Professor Lucille Blumberg, agreed with the Director-General’s assessment and is finalising its recommendations in the coming days. “Our prime aim was to support the decision and decide whether this is a public health emergency of international concern, and to consider whether there’s a pandemic emergency. The former was agreed to,” Blumberg said. Investigations into the outbreak’s origin Anaïs Legand speaking at the emergency press conference on the Ebola crisis. “Investigations are ongoing to ascertain when and where exactly this outbreak started,” said Anaïs Legand, a technical officer for high-threat pathogens at WHO’s health emergencies programme. “Given the scale, we are thinking that it has started probably a couple of months ago, but investigations are ongoing, and our priority is really to cut the transmission chain by implementing contact tracing, isolating and caring for all suspect and confirmed cases.” The Bundibugyo species was last seen in 2007, and there is currently no vaccine or treatment licensed for it. Investigators say the true scale of the epidemic in DRC is much larger than current case counts suggest. War, and a very long drive Dr Mohamed Yakub Janabi, WHO’s regional director for Africa. WHO officials laid out several reasons the outbreak escaped detection. The province of Ituri, where it emerged, is engulfed in war. Fighting between the DRC army and the M23 armed group has intensified in recent months, displacing more than 100,000 people. Beyond the conflict, eastern DRC is among the most challenging places in the world to mount a public health response. Health facilities are sparse, roads are limited, and much of the terrain is forested and mountainous. A previous Ebola outbreak in the same region in 2018-19 took close to two years to bring under control, even with a licensed vaccine available. Dr Mohamed Yakub Janabi, WHO’s regional director for Africa, said the combination of factors made early detection enormously difficult. “Detecting outbreaks such as Ebola in a complex setting like Ituri province in the DRC is inherently challenging,” he said. “Surveillance systems rely on a combination of community reporting, local health facilities, lab confirmation, and partner coordination.” Samples from the outbreak zone must travel 1,700 kilometres to reach the Institut National de Recherche Biomédicale in Kinshasa, the only facility in the country with the capacity to test for Bundibugyo. The distance to the capital is comparable to London to Warsaw – a roughly a 24-hour drive on smooth European roads, a far cry from the remote jungle tracks and dirt roads of Ituri. “In remote or insecure areas, it can take time for cases to be recognised and samples transported,” Janabi said. Symptoms mistaken for endemic diseases Nearly 7 tonnes of emergency medical supplies and equipment along with a team of 35 experts from WHO and the DRC’s health ministry, arrived today in Bunia from Kinshasa to support frontline #Ebola response in Ituri Province. The Bundibugyo strain’s early symptoms also overlap with diseases endemic to eastern DRC, leading health workers to mistake initial cases for more common illnesses. “Nonspecific early symptoms, for instance, if you take malaria and typhoid, the early symptoms are the same,” Tedros said. “The region is very endemic to those diseases, so the health workers will associate the early signs with malaria or typhoid, and they can’t diagnose based on the symptoms. They may start treating that.” Dr Abdi Mahamud, WHO’s director for health emergency alert and response operations, said the diagnostic challenge would have tripped up better-resourced systems. “This outbreak is happening in a highly endemic [setting for] other diseases that present similar symptoms – malaria, dysentery, and others,” he said. “If you don’t have that high index of suspicion, if you don’t have the right facility to test, even in high-income countries, you will have that delay in the start of an outbreak.” Diagnostic tests routinely used across the region added another layer of delay. The Bundibugyo strain belongs to a different genus, Orthoebolavirus, than the more common Zaire strain that most existing tests are optimised to detect. “There was a problem linked to the traditional test we use,” Tedros said. “The traditional test is optimised with Zaire, and the same sample was taken and tested, but since the test kit is optimised with Zaire, [Bundibugyo] could not be detected.” No vaccine, but a pipeline Vasee Moorthy, WHO’s research and development lead on the current outbreak, laid out the state of the vaccine pipeline for the Bundibugyo strain. The Bundibugyo strain has no licensed vaccine or therapeutic. WHO’s research and development lead, Vasee Moorthy, said a pipeline of candidates is being accelerated but remains months away. Moorthy said the most promising candidate is an rVSV Bundibugyo vaccine, the equivalent for this strain of Ervebo, the licensed Merck vaccine used against the more common Zaire Ebola strain since 2019. “There are no doses of this which are currently available for clinical trial, so this needs to be prioritised,” Moorthy said. “The information that we have is that this is likely to take six to nine months.” A second candidate, built on the ChAdOx1 platform used in the AstraZeneca COVID-19 vaccine, is being developed by Oxford and the Serum Institute of India. “They are manufacturing that as we speak, but there is no animal data to support [its efficacy],” Moorthy said. “It is possible that doses of that could be available for clinical trial in two to three months, but there is a lot of uncertainty about that.” Even in the most optimistic scenario, neither candidate is likely to be available to materially shape the trajectory of the current outbreak. In the meantime, the response is being built around the basics: safe treatment centres, patient referral pathways, contact tracing, and the protection of health workers, among whom the first confirmed case in the outbreak was identified. “The protection of healthcare workers and families is absolutely paramount,” Blumberg said. “The people in the area and those who respond need to be kept safe and allowed to be able to do what they need to do in a critical time such as this.” Tedros: Rubio suffers ‘lack of understanding’ US Secretary of State Marco Rubio. The WHO chief used the press conference to push back at US Secretary of State Marco Rubio, who said this week the agency had been “a little late to identify this thing.” The US has banned citizens of the DRC, Uganda and Sudan from entry, closed its only dedicated Ebola lab, withdrawn from the WHO, and defunded the agency. “On what the Secretary said, it could be from a lack of understanding of how IHR works, and the responsibilities of WHO and other entities,” Tedros said. “We don’t replace the country’s work, we only support them, so that’s why there could be some lack of understanding.” Tedros suggested conflict in the affected region was a more fundamental factor in the delay than anything WHO could have done differently. “Health facilities cannot work optimally when there is conflict and when the health workers are also fleeing as part of the community which is displaced,” he said. “It affects the whole surveillance system, and not only that, but it also affects access.” “I think that’s what we should understand, the secretary or others.” Asked repeatedly whether US funding cuts to DRC surveillance programmes had contributed to the outbreak going undetected, Tedros declined to draw a direct line. “We don’t need to jump to conclusions before we understand the whole complexity. It would be very difficult to associate it with funding alone,” he said, noting that the diagnostic gap was a question of the wrong tests being administered rather than supply. Legand echoed the point, noting the issue stems from test type, not supply: “For the time being, it’s not a supply issue. We need to ensure that the right platform with the right data arrives at the right place. This is the work that is being done as we speak.” The outbreak, meanwhile, continues to spread through a war zone with no vaccine, no cure, and a diagnostic system still catching up to the strain it now faces. Image Credits: @WHO African Region, Gage Skidmore. Grim Warning of Dwindling Funds for Emergencies as States Vote on Attacks in Lebanon and Iran 20/05/2026 Kerry Cullinan Dr Annette Heinzelmann, emergency director for the WHO Eastern Mediterranean Region (EMRO) The grim impossibility of addressing rising health emergencies with dwindling budgets was raised at the World Health Assembly (WHA) on Tuesday – amid votes on attacks on healthcare in Lebanon and Israel. “Outbreaks are accelerating, while the systems designed to stop them are being weakened,” warned Dr Annette Heinzelmann, emergency director for the WHO Eastern Mediterranean Region (EMRO), during a discussion of health emergencies in Committee A. “The gap between needs and resources is now unsustainable. The WHO Health Emergency Programme faced a $553 million funding gap in 2024 and 2025. The contingency fund for emergencies entered 2026 with just $19.5 million, while our regional emergency workforce has been cut by half. We cannot continue confronting expanding emergencies with shrinking capacity.” In EMRO, 117 million people need humanitarian assistance; there are 14 graded emergencies, 44 active outbreaks, and more than 50 public health events across 17 member states. “Conflict, displacement, climate shock, economic collapse, and diseases are colliding into a single expanding poly crisis,” Heinzelmann warned, speaking on behalf of the regional director. “Across Gaza, Sudan, Yemen, Somalia, and Afghanistan, and amid escalation affecting Iran, Syria, and Lebanon, WHO is sustaining trauma care, delivering medicines, reinforcing surveillance, and supporting governments to manage growing public health risks.” Votes on Lebanon and Iran Regional conflict is compounding the EMRO health crises. Lebanon received overwhelming support from the majority of member states in the wake of Israeli attacks on its health infrastructure – but there was little support for Iran’s appeal for support against similar attacks. Ninety-five member states voted in favour of a resolution that noted “a health emergency in Lebanon resulting from ongoing and recently intensified hostilities” and called for “the full protection of healthcare in Lebanon, including patients, health personnel, facilities and transport”. Only Israel and Honduras opposed the resolution, which did not name Israel as the aggressor. Voting on the resolution in support of Lebanon, following attacks on its health care by Israel. However, Iran’s resolution, condemning recent attacks on patients and health infrastructure, including on the Pasteur Institute – was defeated. The resolution did not mention Israel and the United States as the aggressors. Only 19 countries supported Iran, 30 voted against, and a whopping 58 countries abstained. Several countries cited Iran’s attacks against its own citizens and Gulf states, and the blockade of the Strait of Hormuz, preventing the flow of medical supplies, as reasons for not supporting the resolution. Voting on the resolution in support of Iran, in the wake of US and Israeli attacks on its health infrastructure. Haemorrhagic fever, extreme weather Voting came at the end of a discussion on the WHO’s involvement in health emergencies in the WHA’s Committee A. In 2025, WHO responded to 50 emergencies in 82 countries and territories, of which 20 were Grade 3 emergencies requiring the highest level of organisation-wide support, the organisation reported. Disease outbreaks included viral haemorrhagic fever: Sudan virus disease in Uganda; Marburg in Tanzania and Ethiopia; Ebola in the Democratic Republic of the Congo (DRC) and Rift Valley fever in Mauritania and Senegal. Mpox was declared a public health emergency of international concern (PHEIC), affecting 98 countries, with 52 974 confirmed cases – 84% in Africa – and 215 deaths. Thirty-three countries reported cholera outbreaks involving over 614 828 cases and 7,598 deaths. Angola, the DRC and Sudan had the highest cases. The WHO provided over 58 million doses of “emergency vaccines” for cholera, meningitis, yellow fever and Ebola. Challenges included “limited surveillance capacities and insufficient production of critical vaccines”. Three out of four emergencies were either caused or exacerbated by extreme weather events such as flooding, droughts and cyclones. Earthquakes in Afghanistan and Myanmar, severe Pacific typhoons and three category-5 hurricanes, including Hurricane Melissa, caused death and damage. The global cost of natural disasters is estimated at over $ 200 billion annually. So great was the demand for WHO’s assistance that its Contingency Fund for Emergencies was left with $19.5 million by the end of the year. Attacks on healthcare The severely destroyed Al-Shifa hospital in Gaza City, Palestine, in February 2025. Last year, the WHO verified 1,351 attacks on healthcare, resulting in 925 health facilities damaged or destroyed. The Independent Oversight and Advisory Committee (IOAC) for the WHO Health Emergencies Programme reports a “significant and alarming escalation” in these attacks that are likely to “underestimate the true scale of the crisis as reporting is uneven”. EMRO’s Heinzelmann said that almost 40% of these attacks occurred in her region, accounting for almost 90% of related deaths. “Attacks on healthcare must stop, humanitarian access must be guaranteed, and financing for preparedness and emergency response must increase now, not after the next global crisis is already underway,” she urged. Several member states, including Jordan, Switzerland, Australia, urged an end to attacks on health facilities and personnel and respect for international humanitarian law. Lack of financing The IOAC noted its deep concern at the “dramatic reductions in official development assistance from major donors”. During the 2008 global economic recession, the WHO “deprioritised” its emergency-related teams and reduced the workforce – but paid a high price during the Ebola outbreak in West Africa, “which resulted in over 11,000 lives lost and posed an existential threat to WHO”, noted the IOAC. “It is the IOAC’s responsibility to ensure that past weaknesses are not reprised and that WHO’s emergency capacities remain safeguarded.” In the WHO’s 2026‒2027 budget, the base budget of the emergencies programme has been set at $918.5 million, with 51% for country offices, 22% for regional offices and 27% for headquarters. Image Credits: Nour Alsaqqa/ MSF. WHO is Alarmed at ‘Scale and Speed’ of Ebola Outbreak as Hantavirus Threat Recedes 19/05/2026 Disha Shetty & Stefan Anderson Dr Tedros Adhanom Ghebreyesus is currently serving his second five-year term as WHO Director-General. His mandate expires on August 15, 2027. GENEVA — The outbreak of a deadly strain of Ebola for which there is no vaccine is accelerating through the Democratic Republic of Congo (DRC) and Uganda at a “scale and speed” alarming the World Health Organization (WHO), as cases climb and authorities scramble to contain the spread. “I’m deeply concerned about the scale and speed of the epidemic,” WHO chief Dr Tedros Adhanom Ghebreyesus told the 79th World Health Assembly on Tuesday, addressing delegates from 192 nations gathered in Geneva. More than 500 suspected cases and 130 suspected deaths beyond the confirmed caseload have been reported. Tedros said the figures would change as field operations scale up, including strengthening surveillance, contact tracing, and laboratory testing. “So far, 30 cases have been confirmed in the DRC from the northern province of Ituri,” he added. “Uganda has also informed WHO of two confirmed cases in the capital of Kampala, including one death among two individuals who travelled from DRC, and there is one US citizen confirmed positive and transferred to Germany.” “This epidemic is caused by Bundibugyo, a species of Ebola virus for which there are no vaccines or therapeutics,” Tedros said. Diagnostic tests in the region were designed for a different strain of Ebola and missed early infections, resulting in a four-week gap before the outbreak was detected. Ongoing shortages of diagnostic equipment on the frontlines mean the true size of the outbreak remains unknown. “In the absence of a vaccine, there are many other measures countries, of course, can take to stop the spread of this virus and save lives, even without medical countermeasures, including risk communication and community engagement,” Tedros said, commending Uganda for postponing its annual Martyrs’ Day celebrations, which can draw up to two million people. The Ebola virus kills up to half of those it infects, making any outbreak particularly dangerous. In response to the outbreak, the United States banned citizens from the DRC, Uganda and Sudan from entering the US on Monday. Also read: Tedros: ‘We Live in Difficult, Dangerous and Divisive Times’ ‘Did not do this lightly’ Ongoing 79th session of the WHA in Geneva, Switzerland. The rapid spiral led Tedros to declare the outbreak a public health emergency of international concern (PHEIC) on Sunday, the first time a Director-General has done so before convening an emergency committee. “I did not do this lightly,” he told the assembly. “I did it in accordance with Article 12 of the International Health Regulations, after consulting the ministers of health of both countries.” The emergency committee will meet later on Tuesday to advise on what response measures countries should adopt, as there is no vaccine and no cure for the strain of Ebola now spreading. The first confirmed case was a health worker, meaning the virus was already moving through medical settings before anyone knew it was there. After heavy criticism of the WHO’s slow handling of the 2014 West African Ebola epidemic, the agency’s chief appears unwilling to allow a repeat of history. Tedros said an additional $3.4 million was released from the WHO’s Contingency Fund for Emergencies, bringing the total committed to the response to $3.9 million. “WHO has a team on the ground supporting national authorities to respond,” he said. “We have deployed people, supplies, equipment, and funds.” LIVE: @DrTedros‘ address to the #WHA79 delegates https://t.co/IUGcXQ3cLe — World Health Organization (WHO) (@WHO) May 19, 2026 Deadly delays leave authorities flying blind Ebola health worker in protective gear. File image. Cases have surfaced in densely populated urban areas, including the Ugandan capital Kampala and the eastern DRC city of Goma, home to millions of people and serving as major hubs for cross-border trade and movement. The outbreak is likely to have originated in DRC’s Ituri province, a high-traffic mining area on the borders of South Sudan and Uganda, which “increases the risk of regional exportation and cross-border transmission”, according to the WHO. Fighting in the area between the DRC army and M23, an Islamist armed group, has intensified since late 2025 and escalated significantly over the past two months. More than 100,000 people have been newly displaced by the conflict, Tedros told the assembly – potentially carrying the virus with them as they go, far from the reach of surveillance teams and into communities with little capacity to identify or isolate new cases. “In Ebola outbreaks, you know what displacement means,” Tedros said. “The area is also a mining zone with high levels of population movement that increase the risk of further spread.” Local funeral practices, which involve close contact and touching the deceased, also accelerated transmission before authorities knew the outbreak was happening. The current outbreak is the third recorded outbreak of Bundibugyo, first identified in 2007. Hantavirus contained There are no known vaccines or therapeutics for this strain of Ebola making containment a challenge. The picture is markedly different for hantavirus, which Tedros also addressed. Two weeks ago, the hantavirus outbreak aboard the MV Hondius cruise ship, sparked international panic and wall-to-wall news coverage, but it has now been brought under control, Tedros told the assembly. “WHO’s assessment continues to be that the risk of hantavirus globally is low,” Tedros said. The ship docked in Rotterdam on Sunday, with the crew now in quarantine until 29 June. Passengers, who have been repatriated, will be monitored until 21 June. “So far, there are 11 reported cases, including three deaths, and no deaths have been reported since the second of May, when WHO was first informed of the outbreak on the ship. Those numbers have changed little since the outbreak was first reported to WHO two weeks ago,” Tedros said. The two outbreaks, emerging within two weeks of each other, served as a reminder of WHO’s core function, Tedros told the assembly. “The outbreaks of Ebola and Hantavirus in the past two weeks show why international threats need an international response,” he said. “They show why the world needs the international health regulations and why it needs WHO.” WHO successes: tobacco and taxes Tedros also highlighted WHO’s wins in his address, including the decline in tobacco use. “Tobacco use has dropped by one-third globally and continues to decline in 140 countries. With support from WHO, Maldives became the first country to adopt a generational tobacco ban for people born from 2007. This year, the United Kingdom followed suit, banning the sale of tobacco to anyone born from 2009 onwards,” he said. Since 2025, the WHO has been encouraging countries to tax tobacco, alcohol, and sugary drinks by at least 50% by 2035. “In the past 12 months, India, Jamaica, Malaysia, Mauritius, Mexico, Montenegro, Viet Nam, Saudi Arabia, Sierra Leone and Zambia were among countries that either announced, introduced or increased taxes on one or more of these products,” Tedros said. WHO’s advocacy to increase the rate of breastfeeding globally has also yielded positive results, with almost half of children worldwide being breastfed for at least for six months, Tedros said. A billion more people now have access to safe drinking water compared to just a decade ago, but the levels of violence against women have remained stagnant for two decades. However, the shortage of healthcare workers is hampering progress: “The world is facing a shortage of 11 million health workers by 2030, with the biggest gaps in the African and Eastern Mediterranean regions. More than half the gap is a shortage of nurses,” Tedros said. The world is also set to miss every one of the 52 health-related Sustainable Development Goal targets by 2030, the WHO revealed on the eve of the WHA. Malaria cases are rising, maternal deaths are still occurring at nearly three times the targeted rate and childhood vaccination coverage is plateauing or falling in some regions, and progress on global health goals has slowed, stalled or reversed across virtually every measure since 2015, according to the 2026 World Health Statistics report. Image Credits: WHO/Christopher Black , WHO/X, Africa CDC , WHO/X. Undocumented Migrants Fall Through Europe’s Healthcare Cracks, Joint Research Shows 19/05/2026 Felix Sassmannshausen Undocumented migrants navigate precarious conditions, often lacking health safety nets, despite contributing to informal economies. As Europe grapples with shifting demographics and an influx of migration, researchers are mapping how undocumented migrants navigate the administrative cracks of the continent’s healthcare systems – helping to fill a critical data gap identified by the World Health Organization. Inside the neoclassical venue of La Pastorale in Geneva, around 30 participants from six European universities convened on Monday on the sidelines of the World Health Assembly to dissect an expanding public health crisis related to the healthcare of immigrants, whose status and lack of resources means they often seek care in the shadows of the formal system – or fall through the cracks altogether until an emergency. The Geneva Health Forum event highlighted how complex administrative barriers keep undocumented migrant children and the elderly across the continent from accessing essential healthcare, leaving untreated chronic conditions, severe mental health crises, and emergencies to strain local resources. Professors Claudine Burton-Jeangros and Yves Jackson of the University of Geneva. The “Growing and ageing in the shadows” (GRACE) project, co-directed by Professor of Medicine Yves Jackson and health sociologist Professor Claudine Burton-Jeangros of the University of Geneva, explores these disparities as part of the European University Alliance (4EU+). The consortium unites scholars from the universities of Geneva, Heidelberg, Prague, Milan, Paris Sorbonne, and Copenhagen. Mapping the barriers and needs in Europe’s cities remains exceptionally difficult, as a lack of information and personnel, coupled with a profound fear of discrimination or deportation, drives undocumented migrants away from clinical settings and creates severe data deficits. The scale of this blind spot is particularly evident among minors; in Germany, for example, population estimates for undocumented children range wildly from a few thousand to over 100,000, the researchers noted. To enable evidence-based policymaking, the GRACE consortium navigates these blind spots by conducting in-depth interviews with frontline healthcare providers, social workers, and non-governmental actors to uncover the practical realities these vulnerable groups experience. While the results presented on Monday were preliminary, the consortium projects final results by the end of the year. They aim to use the findings to inform and advocate to policymakers on how to improve healthcare access. Fragmented bureaucracies erode rights of undocumented migrants WHO data on inclusion of refugee and migrant health aspects in national policies, legislation strategies or plans across thematic areas in the European Region. Access to equitable healthcare is a fundamental human right, reinforced by international frameworks such as the WHO Global Action Plan and the 2026 Progress Declaration of the International Migration Review Forum (IMRF) – the primary UN platform for tracking global migration commitments. Although the WHO notes significant recent progress – such as the WHO European Region’s action plan to improve legal access to care – these theoretical rights continue to routinely erode within the continent’s complex bureaucracies. In universal healthcare systems like Denmark’s – where the uninsured population also includes European Union citizens who have simply fallen out of the formal labour market – the mandate for a central registration number excludes those without formal residency documents. Lacking this registration number, undocumented individuals are forced to rely on a parallel, privately funded network of volunteer-run clinics for even the most basic medical care. Even in jurisdictions with progressive entitlements specifically designed for undocumented populations, such as France – where, notably, children cannot legally be classified as undocumented – administrative labyrinths and illegal discrimination by providers severely limit practical access. Although the French State Medical Aid guarantees free access to essential care after three months of residency, eligible patients are still frequently turned away by providers who illegally refuse to treat those relying on state support. University of Geneva researchers Srilak Weerawardane and Emma Perneger present preliminary findings. Germany also sees a growing number of uninsured migrants falling through the cracks. And this is not surprising since it enforces a severe legal Catch-22, the researchers found: while doctors maintain confidentiality, social welfare offices must report undocumented patients to immigration authorities if public funds cover their care. Additionally, hospitals frequently deny expensive treatments to avoid unpaid hospital bills. Ultimately, this systemic threat breeds a profound fear of deportation, driving undocumented migrants away from clinics entirely. Switzerland’s mandatory healthcare system grants all residents the right and legal obligation to purchase expensive insurance. Undocumented migrants – strictly excluding asylum seekers with pending applications – cannot opt out but face severe barriers to state subsidies. Forced to pay out of pocket, they accumulate massive debt, which accounts for an estimated 90% of their total arrears in Geneva. University of Geneva researchers concluded this financial burden traps individuals in poverty and paralyses future regularisation attempts, since being debt-free is a primary requirement for legal residency. Healthcare hinges on relationships instead of rights Locked out of formal systems, undocumented migrants rely on informal networks and alternative routes for essential healthcare. Because official avenues remain blocked, fragmented NGO clinics and volunteer doctors often serve as the primary safety net for basic care, the research team from the University of Copenhagen explained. To bridge the gap between theoretical rights and practical access, social workers must frequently intervene to defend marginalised patients, while physicians in countries like the Czech Republic utilise personal discretion to classify treatments as “acute care” to legally compel hospitals to provide treatment. Ultimately, receiving medical attention often depends on the willingness of individual healthcare providers to bypass restrictive frameworks. As a result, securing essential treatment is often reduced to a matter of luck, depending heavily on the informal networks of the doctors and the specific resources of the patients themselves. Heidelberg University researchers Manuela Orjuela-Grimm and Veronika Wiemker discuss their research on healthcare barriers. “It’s really contingent on personal relationships and healthcare providers… instead of being a right,” Veronika Wiemker, a researcher at the Heidelberg University on the situation in Germany, reflecting the shared reality across the continent. Faced with such systemic exclusion, undocumented migrants utilise alternative routes to care. To treat their conditions, individuals proactively stockpile medicine, consult online forums or artificial intelligence, and rely on transnational healthcare – such as travelling across borders for treatment or using telemedicine to maintain remote consultations with doctors in their countries of origin, as the researchers from Prague’s Charles University found. Young migrants navigate fragmented care Driven under the administrative radar, undocumented children face severe healthcare fragmentation, missing crucial developmental screenings and continuous medical support. The situation for undocumented children is particularly dire, despite being specially protected under international provisions. As undocumented parents often lack official birth certificates, their newborns remain largely under the administrative radar. The living conditions for these youngest migrants are frequently severe; in France alone, researchers from Paris Sorbonne University report that an estimated 3,000 homeless newborns and their mothers are discharged from hospitals directly onto the streets each year. Sorbonne University researchers Fanny Teissandier and Andrea Tortelli outline their methodology. Without stable housing or formal documentation, young migrants across the continent frequently miss out on crucial immunisations and preventive measures, mental health support, and basic dental care. While school-aged children occasionally receive basic entry assessments or see school nurses – as is the practice in countries like Germany and Denmark – the ongoing absence of holistic, continuous care exposes them to severe developmental risks and untreated chronic conditions. Unaccompanied minors endure even deeper vulnerability, often surviving on the streets while facing malnutrition and severe trauma. Despite being theoretically protected by local authorities, these youths remain highly vulnerable to exploitation, sex work, and chronic stress. Ultimately, the transition to adulthood introduces a severe, continent-wide cliff edge for these adolescents. Upon turning 18, temporary legal protections abruptly dissolve – either plunging the young adults into mandatory insurance systems they cannot afford or stripping them of their rights entirely. Ageing populations undergo unique crises Elderly undocumented migrants often endure accelerated ageing and complete exclusion from formal European long-term healthcare networks. The plight of the elderly introduces an entirely distinct set of challenges for local administrators, revealing severe gaps in long-term care. While some older migrants are newly arrived parents joining their children, many others are former labourers who planned to briefly work abroad but ultimately remained for decades. After years of surviving precarious, physically demanding jobs in the informal economy, these individuals frequently experience “accelerated ageing”, untreated chronic pain, and rapid cognitive decline. Furthermore, returning to their countries of origin is rarely a viable solution, as many have lived in Europe for well over a decade and no longer possess any social ties or family networks back home. Their vulnerability is compounded by European health systems that intrinsically tie medical entitlements to formal employment. Once these individuals age out of the workforce or lose their physical capacity to continue their demanding labour, they lose their economic value – frequently stripping them of their eligibility for public health subsidies and plunging them into poverty. This loss of economic value and legal status leaves elderly undocumented migrants completely excluded from formal long-term care solutions. Fearing that elderly, homeless migrants will become permanent “bed blockers” with no follow-up care options, hospitals in countries like France sometimes even deny them access to inpatient admission. Fear fuels harmful data gaps The bureaucratic ‘Chicken and Egg’ cycle: Financial burden and fear drive clinical avoidance, creating a data deficit that fuels policy paralysis. Beyond the immediate health consequences, the overarching fear of deportation forces individuals to “pretend not to be there.” Because undocumented migrants often actively avoid clinics, they remain completely hidden from formal health frameworks, creating a massive data blind spot for policymakers. Closing this gap is a global mandate, forming the core of the third and fifth priorities of the WHO Global Action Plan regarding migration health research and data. WHO’s Daniel Míč emphasises data to bridge divides. Daniel Míč, representing the World Health Organization (WHO) Special Initiative on Health and Migration, stressed that this dynamic creates a bureaucratic “chicken and egg” scenario. “If you are in a vulnerable situation, and you are afraid of being deported, or you are afraid of being punished by the system that you seek health or care from, there’s a problem,” he warned, noting that capturing necessary public health data becomes difficult when fear drives individuals away from the frontline clinics that would otherwise document their conditions. This data deficit is further compounded by the fact that defining who exactly qualifies as an “undocumented migrant” remains a major challenge. Because each national system applies its own administrative labels, the practical barriers these individuals face are dictated entirely by the bureaucracy of the country they reside in. Ultimately, “we will understand the challenges only if we have the data,” Míč said, stressing that concrete evidence is the only way to bridge political divides and present actionable solutions to policymakers. To close this harmful data gap, the GRACE consortium plans to synthesise its preliminary findings into targeted case studies and scientific reports by the end of the year. Recognising the immense value of this frontline research guiding European member states in building inclusive healthcare systems, Míč expressed a readiness to resume dialogue with the 4EU+ Alliance, hoping to translate previous discussions into a concrete collaboration. More Countries Refer to Refugees in Health Policies, but Access and Data Gaps Persist Image Credits: Adhitya Ginanjar/Unsplash, Tim Mossholder/Unsplash/HPW, University of Geneve/HUG, WHO/HPW, Felix Sassmannshausen/HPW, Beth Macdonald/Unsplash. Member States Support Extending Talks on Pandemic Agreement Annex, Propose New ‘Method’ 19/05/2026 Kerry Cullinan Pakistan’s Adeel Khokhar All World Health Organization (WHO) member states supported the extension of talks on the last outstanding piece of the Pandemic Agreement, the Pathogen Access and Benefit-Sharing (PABS) annex, at the World Health Assembly’s (WHA) Committee A on Monday. A draft PABS annex was due to have been presented to the WHA for approval, but instead, a report from the World Health Organization (WHO) Director General notes that member states need more time to reach an agreement. The PABS annex will govern how dangerous pathogens are shared during public health emergencies and how to share any medical products (benefits) produced as a result of manufacturers getting access to this information. A draft annex will either be presented at next year’s WHA or at a special WHA if agreement is reached beforehand, according to the report. Several of the many member states speaking on PABS in Committee A expressed confidence that the annex would be completed by the end of the year. However, divisions between developed and developing countries remained stark. Pakistan warned that the PABS negotiations should not be concluded in a way that “preserves the commercial privileges of a handful of manufacturers”. Pakistan’s representative told the committee: “We are witnessing a sustained effort by some member states to hollow out Article 12 [of the Pandemic Agreement], which clearly establishes the principle of equal footing” between sharing dangerous pathogens and sharing any benefits that manufacturers accrue from such knowledge. “We will not sign off on a multilateral system success story that serves the interests of industry over the health security of billions,” he added. ‘Conducive to R&D’ Malaysia’s representative in Committee A. On the other end of the spectrum, the European Union warned that a PABS agreement should not stifle research and development. “The Pandemic Agreement, as well as the revised IHR [International Health Regulations], contain important provisions that will significantly increase our capacity to confront pandemic emergencies and do so in a more equitable manner,” said the European Union. “The PABS system has an important role to play in this context, but we need to ensure that the system is also conducive to innovation, and research and development for medical countermeasures, then it can lead to a robust uptake by the private sector.” African countries, represented by South Africa, explained once again their demands for an equitable PABS system, including that the annex should include legally binding contracts between the WHO and manufacturers. Impetus for a global PABS system comes from the need to correct the inequities of the COVID-19 pandemic, when developing countries were initially unable to get vaccines – even for healthworkers – as these had all been bought by wealthy countries. As Namibia reminded the committee: “We negotiated the Pandemic Agreement because the world watched developing countries bury their loved ones due to COVID-19 while vaccines sat unused in warehouses elsewhere. That memory must anchor every line that we now draft.” “The credibility of this agreement now rests on the PABS annex. If access obligations read ‘shall’ while benefit-sharing obligations read ‘options’, and ‘where available’, we will have written inequity into international laws with our own hands.” “Benefit-sharing obligations must be legally binding and enforceable,” said Nigeria. “Technology transfer and non-exclusive licensing and local production partnerships must be obligations manufacturers sign onto, not options they select from a menu.” Malaysia emphasises that annex must clearly spell out the rights and obligations of parties, and be “operationally implementable”. Referring to the current hantavirus and Ebola outbreaks, Spain urged the completion of the annex so that the Pandemic Agreement could come into force and provide a solid regulatory framework “to prevent, prepare, and respond to health emergencies”. New methods for future talks? After six formal meetings and several informal sessions, the Intergovernmental Working Group (IGWG) will reconvene in July. However, Colombia stated that the extension of the negotiations on the PABS annex “will only make sense if it allows for a more balanced result, which is technically solid and useful for global public health. ” Colombia’s representative said that the main barrier is that the “rules of intellectual property applied to public health become a barrier to access and the production of vaccines, treatments, and diagnostics, just as happened during the COVID 19 pandemic.” Colombia proposed new “working methods” for the talks, including that they are open rather than behind closed doors, and “a progressive step-by-step approach” to the text, using “the concept of progressive consensus.” Colombia has previously suggested voting on contentious issues. Meanwhile, civil society observer Knowledge Ecology International (KEI) also proposed that negotiators “should consider new approaches, including some features of the benefit-sharing agreement in the new Law of the Sea Treaty, for areas beyond national jurisdiction. “In that agreement, governments take responsibility for the enforcement of benefit-sharing, and the triggers for benefit-sharing are downstream, on the filing or patents or the registration or sale of products.” Posts navigation Older postsNewer posts
Russia Tries to Block Debate on Attacks on Health Facilities in Ukraine 20/05/2026 Disha Shetty Interior of a hospital room in Kherson heavily damaged during conflict, showing extensive structural destruction and debris. Neither Russia’s delegate banging her desk to interrupt Ukraine’s representative speaking at the World Health Assembly (WHA), nor her request to dismiss debate, stopped member states from condemning Russia’s attacks on Ukraine’s health system. A report by the World Health Organization’s (WHO) Director-General before delegates estimated that Russia’s aggression on Ukraine has caused 55,600 civilian casualties, including 14,999 deaths. Violence intensified in 2025 with civilian casualties going up by 31% compared to the previous year, and by 70% when compared to 2023. The WHO also documented 579 attacks on healthcare facilities that caused 19 deaths and 204 injuries among healthcare workers and patients in 2025. This was an 18% increase compared to 2024. “Since this report was published, WHO has recorded 190 new attacks on health care, with 86 injuries and 15 deaths between 1 January and 6 May, 2026,” said Dr Altaf Mossani, Director of Humanitarian Disaster Management, WHO Emergency Preparedness and Response program. “On May 14, a clearly marked United Nations vehicle was severely damaged by drone strikes in Kherson City. This is the second incident that week,” he added. Russia targeting healthcare infrastructure The 79th World Health Assembly in session. Countries raised alarm at the WHA that 202 of Ukraine’s 11,887 health facilities have been severely damaged, and 1,013 units are partially damaged. “We strongly condemn Russia’s ongoing war of aggression against Ukraine and the deliberate escalation of attacks targeting civilians and civilian infrastructure, including health care facilities, and we are deeply alarmed by the sharp increase in attacks on the health infrastructure since the last World Health Assembly,” Moldova’s representative told the WHA. Civilian attacks also drew sharp criticism, leaving Russia isolated during the discussion. “Russia’s attacks on energy infrastructure and other civilian targets, such as hospitals, elderly homes, or kindergartens, became increasingly vicious and brutal,” said Germany’s delegate. “On average, it has been said already, there have been more than 3,000 Russian attacks directly affecting health care institutions, two each day.” Ghana empathised with countries that are receiving a large number of refugees from Ukraine as a result of the conflict, resulting in an additional burden on their health systems. High drama by the Russian representative Russia’s representative to the WHA banged the desk to interrupt Ukraine’s speaker and called the WHO’s report on the health situation in Ukraine “disinformation.” Russia’s representative first moved to dismiss the debate on the report on Ukraine entirely. That request was put to a vote and defeated. Following extensive discussion on the report, Russia again moved to stop the WHA from noting the report. Russia was reminded that noting the report was merely procedural, but it requested a vote again. Once again, countries voted in favour of noting the report. At one point, the Russian representative banged the desk several times to interrupt the Ukrainian speaker, and was reminded to raise the country’s flag if she wanted to make a statement. Russia then accused the WHO of spreading misinformation. “WHO is talking only about attacks on Ukraine, ignoring the information that has been submitted to WHO on attacks on Russian facilities. So, we would ask WHO to stop misleading the world and to stop disseminating misinformation when it comes to voting on this report,” the representative accused. WHO’s report noted that there were 21 attacks on healthcare facilities in Russia, causing 17 injuries. Russia did not agree with this number. However, the Russian representative said, “more than 250 Russian facilities were attacked by Ukraine, and only 35 of them have been officially reported by WHO. And indeed, in the report, even that figure has deliberately been lowered”. Russia opposed the noting of the report by the WHA. The report was noted nevertheless, following a vote. Polio needs attention Polio remains endemic in the WHO’s Eastern Mediterranean Region (EMRO) region. WHA also discussed polio that remains an issue in several countries like Pakistan and Afghanistan. Conflicts and funding cuts have in recent years interrupted polio vaccination campaigns. In Gaza, polio made a resurgence as conflict raged. Most of these areas fall under the WHO’s Eastern Mediterranean Region (EMRO) region. “We are actually the last part of the world where that virus remains endemic, but we are doing our utmost to tackle this issue. We have seen, however, that in Afghanistan and Pakistan there have been declines in transmission trends, and we think that is a cause for optimism about wild polio virus transmission,” Libya said, making a statement on behalf of the EMRO region. Other countries reminded the WHA that polio is still a relevant issue that needs attention. “We wish to recall that polio is still a global health challenge because new cases of wild polio have been recorded in certain countries, and there are new coast cases in conflict areas. Then, hence, the need for further international effort to ensure that we have national and regional preparedness,” Oman’s representative told the WHA. Also read: Polio Eradication Imperiled by $2.3 Billion Funding Gap Image Credits: WHO Ukraine, X/WHO, WHO. WHO: Ebola Outbreak Is a Deadly Regional Threat But Not a Global Pandemic Risk 20/05/2026 Stefan Anderson The WHO has determined that the Ebola outbreak raising alarm worldwide does not pose a pandemic threat. GENEVA — The Ebola outbreak unfolding in the Democratic Republic of Congo (DRC) and Uganda poses a “low” risk globally, according to an expert committee of the World Health Organization (WHO). However, the national and regional risk is “high”, according to the International Health Regulations (IHR) Emergency Committee. Last Sunday, WHO Director-General Dr Tedros Adhanom Ghebreyesus had already declared the outbreak a public health emergency of international concern (PHEIC), the WHO’s second-highest level of alert, before convening the emergency committee. This is the first time in WHO’s history that this has occurred. Tedros was motivated by the scale and speed of the spread of the Bundibugyo virus, a rare and particularly deadly strain of Ebola, which has killed at least 131 people and infected over 500 others. The emergency meeting, convened on Tuesday to assess the threat of the current outbreak, concurred that the situation is a PHEIC but “not a pandemic emergency,” Tedros told a media briefing on Wednesday. The committee, chaired by Professor Lucille Blumberg, agreed with the Director-General’s assessment and is finalising its recommendations in the coming days. “Our prime aim was to support the decision and decide whether this is a public health emergency of international concern, and to consider whether there’s a pandemic emergency. The former was agreed to,” Blumberg said. Investigations into the outbreak’s origin Anaïs Legand speaking at the emergency press conference on the Ebola crisis. “Investigations are ongoing to ascertain when and where exactly this outbreak started,” said Anaïs Legand, a technical officer for high-threat pathogens at WHO’s health emergencies programme. “Given the scale, we are thinking that it has started probably a couple of months ago, but investigations are ongoing, and our priority is really to cut the transmission chain by implementing contact tracing, isolating and caring for all suspect and confirmed cases.” The Bundibugyo species was last seen in 2007, and there is currently no vaccine or treatment licensed for it. Investigators say the true scale of the epidemic in DRC is much larger than current case counts suggest. War, and a very long drive Dr Mohamed Yakub Janabi, WHO’s regional director for Africa. WHO officials laid out several reasons the outbreak escaped detection. The province of Ituri, where it emerged, is engulfed in war. Fighting between the DRC army and the M23 armed group has intensified in recent months, displacing more than 100,000 people. Beyond the conflict, eastern DRC is among the most challenging places in the world to mount a public health response. Health facilities are sparse, roads are limited, and much of the terrain is forested and mountainous. A previous Ebola outbreak in the same region in 2018-19 took close to two years to bring under control, even with a licensed vaccine available. Dr Mohamed Yakub Janabi, WHO’s regional director for Africa, said the combination of factors made early detection enormously difficult. “Detecting outbreaks such as Ebola in a complex setting like Ituri province in the DRC is inherently challenging,” he said. “Surveillance systems rely on a combination of community reporting, local health facilities, lab confirmation, and partner coordination.” Samples from the outbreak zone must travel 1,700 kilometres to reach the Institut National de Recherche Biomédicale in Kinshasa, the only facility in the country with the capacity to test for Bundibugyo. The distance to the capital is comparable to London to Warsaw – a roughly a 24-hour drive on smooth European roads, a far cry from the remote jungle tracks and dirt roads of Ituri. “In remote or insecure areas, it can take time for cases to be recognised and samples transported,” Janabi said. Symptoms mistaken for endemic diseases Nearly 7 tonnes of emergency medical supplies and equipment along with a team of 35 experts from WHO and the DRC’s health ministry, arrived today in Bunia from Kinshasa to support frontline #Ebola response in Ituri Province. The Bundibugyo strain’s early symptoms also overlap with diseases endemic to eastern DRC, leading health workers to mistake initial cases for more common illnesses. “Nonspecific early symptoms, for instance, if you take malaria and typhoid, the early symptoms are the same,” Tedros said. “The region is very endemic to those diseases, so the health workers will associate the early signs with malaria or typhoid, and they can’t diagnose based on the symptoms. They may start treating that.” Dr Abdi Mahamud, WHO’s director for health emergency alert and response operations, said the diagnostic challenge would have tripped up better-resourced systems. “This outbreak is happening in a highly endemic [setting for] other diseases that present similar symptoms – malaria, dysentery, and others,” he said. “If you don’t have that high index of suspicion, if you don’t have the right facility to test, even in high-income countries, you will have that delay in the start of an outbreak.” Diagnostic tests routinely used across the region added another layer of delay. The Bundibugyo strain belongs to a different genus, Orthoebolavirus, than the more common Zaire strain that most existing tests are optimised to detect. “There was a problem linked to the traditional test we use,” Tedros said. “The traditional test is optimised with Zaire, and the same sample was taken and tested, but since the test kit is optimised with Zaire, [Bundibugyo] could not be detected.” No vaccine, but a pipeline Vasee Moorthy, WHO’s research and development lead on the current outbreak, laid out the state of the vaccine pipeline for the Bundibugyo strain. The Bundibugyo strain has no licensed vaccine or therapeutic. WHO’s research and development lead, Vasee Moorthy, said a pipeline of candidates is being accelerated but remains months away. Moorthy said the most promising candidate is an rVSV Bundibugyo vaccine, the equivalent for this strain of Ervebo, the licensed Merck vaccine used against the more common Zaire Ebola strain since 2019. “There are no doses of this which are currently available for clinical trial, so this needs to be prioritised,” Moorthy said. “The information that we have is that this is likely to take six to nine months.” A second candidate, built on the ChAdOx1 platform used in the AstraZeneca COVID-19 vaccine, is being developed by Oxford and the Serum Institute of India. “They are manufacturing that as we speak, but there is no animal data to support [its efficacy],” Moorthy said. “It is possible that doses of that could be available for clinical trial in two to three months, but there is a lot of uncertainty about that.” Even in the most optimistic scenario, neither candidate is likely to be available to materially shape the trajectory of the current outbreak. In the meantime, the response is being built around the basics: safe treatment centres, patient referral pathways, contact tracing, and the protection of health workers, among whom the first confirmed case in the outbreak was identified. “The protection of healthcare workers and families is absolutely paramount,” Blumberg said. “The people in the area and those who respond need to be kept safe and allowed to be able to do what they need to do in a critical time such as this.” Tedros: Rubio suffers ‘lack of understanding’ US Secretary of State Marco Rubio. The WHO chief used the press conference to push back at US Secretary of State Marco Rubio, who said this week the agency had been “a little late to identify this thing.” The US has banned citizens of the DRC, Uganda and Sudan from entry, closed its only dedicated Ebola lab, withdrawn from the WHO, and defunded the agency. “On what the Secretary said, it could be from a lack of understanding of how IHR works, and the responsibilities of WHO and other entities,” Tedros said. “We don’t replace the country’s work, we only support them, so that’s why there could be some lack of understanding.” Tedros suggested conflict in the affected region was a more fundamental factor in the delay than anything WHO could have done differently. “Health facilities cannot work optimally when there is conflict and when the health workers are also fleeing as part of the community which is displaced,” he said. “It affects the whole surveillance system, and not only that, but it also affects access.” “I think that’s what we should understand, the secretary or others.” Asked repeatedly whether US funding cuts to DRC surveillance programmes had contributed to the outbreak going undetected, Tedros declined to draw a direct line. “We don’t need to jump to conclusions before we understand the whole complexity. It would be very difficult to associate it with funding alone,” he said, noting that the diagnostic gap was a question of the wrong tests being administered rather than supply. Legand echoed the point, noting the issue stems from test type, not supply: “For the time being, it’s not a supply issue. We need to ensure that the right platform with the right data arrives at the right place. This is the work that is being done as we speak.” The outbreak, meanwhile, continues to spread through a war zone with no vaccine, no cure, and a diagnostic system still catching up to the strain it now faces. Image Credits: @WHO African Region, Gage Skidmore. Grim Warning of Dwindling Funds for Emergencies as States Vote on Attacks in Lebanon and Iran 20/05/2026 Kerry Cullinan Dr Annette Heinzelmann, emergency director for the WHO Eastern Mediterranean Region (EMRO) The grim impossibility of addressing rising health emergencies with dwindling budgets was raised at the World Health Assembly (WHA) on Tuesday – amid votes on attacks on healthcare in Lebanon and Israel. “Outbreaks are accelerating, while the systems designed to stop them are being weakened,” warned Dr Annette Heinzelmann, emergency director for the WHO Eastern Mediterranean Region (EMRO), during a discussion of health emergencies in Committee A. “The gap between needs and resources is now unsustainable. The WHO Health Emergency Programme faced a $553 million funding gap in 2024 and 2025. The contingency fund for emergencies entered 2026 with just $19.5 million, while our regional emergency workforce has been cut by half. We cannot continue confronting expanding emergencies with shrinking capacity.” In EMRO, 117 million people need humanitarian assistance; there are 14 graded emergencies, 44 active outbreaks, and more than 50 public health events across 17 member states. “Conflict, displacement, climate shock, economic collapse, and diseases are colliding into a single expanding poly crisis,” Heinzelmann warned, speaking on behalf of the regional director. “Across Gaza, Sudan, Yemen, Somalia, and Afghanistan, and amid escalation affecting Iran, Syria, and Lebanon, WHO is sustaining trauma care, delivering medicines, reinforcing surveillance, and supporting governments to manage growing public health risks.” Votes on Lebanon and Iran Regional conflict is compounding the EMRO health crises. Lebanon received overwhelming support from the majority of member states in the wake of Israeli attacks on its health infrastructure – but there was little support for Iran’s appeal for support against similar attacks. Ninety-five member states voted in favour of a resolution that noted “a health emergency in Lebanon resulting from ongoing and recently intensified hostilities” and called for “the full protection of healthcare in Lebanon, including patients, health personnel, facilities and transport”. Only Israel and Honduras opposed the resolution, which did not name Israel as the aggressor. Voting on the resolution in support of Lebanon, following attacks on its health care by Israel. However, Iran’s resolution, condemning recent attacks on patients and health infrastructure, including on the Pasteur Institute – was defeated. The resolution did not mention Israel and the United States as the aggressors. Only 19 countries supported Iran, 30 voted against, and a whopping 58 countries abstained. Several countries cited Iran’s attacks against its own citizens and Gulf states, and the blockade of the Strait of Hormuz, preventing the flow of medical supplies, as reasons for not supporting the resolution. Voting on the resolution in support of Iran, in the wake of US and Israeli attacks on its health infrastructure. Haemorrhagic fever, extreme weather Voting came at the end of a discussion on the WHO’s involvement in health emergencies in the WHA’s Committee A. In 2025, WHO responded to 50 emergencies in 82 countries and territories, of which 20 were Grade 3 emergencies requiring the highest level of organisation-wide support, the organisation reported. Disease outbreaks included viral haemorrhagic fever: Sudan virus disease in Uganda; Marburg in Tanzania and Ethiopia; Ebola in the Democratic Republic of the Congo (DRC) and Rift Valley fever in Mauritania and Senegal. Mpox was declared a public health emergency of international concern (PHEIC), affecting 98 countries, with 52 974 confirmed cases – 84% in Africa – and 215 deaths. Thirty-three countries reported cholera outbreaks involving over 614 828 cases and 7,598 deaths. Angola, the DRC and Sudan had the highest cases. The WHO provided over 58 million doses of “emergency vaccines” for cholera, meningitis, yellow fever and Ebola. Challenges included “limited surveillance capacities and insufficient production of critical vaccines”. Three out of four emergencies were either caused or exacerbated by extreme weather events such as flooding, droughts and cyclones. Earthquakes in Afghanistan and Myanmar, severe Pacific typhoons and three category-5 hurricanes, including Hurricane Melissa, caused death and damage. The global cost of natural disasters is estimated at over $ 200 billion annually. So great was the demand for WHO’s assistance that its Contingency Fund for Emergencies was left with $19.5 million by the end of the year. Attacks on healthcare The severely destroyed Al-Shifa hospital in Gaza City, Palestine, in February 2025. Last year, the WHO verified 1,351 attacks on healthcare, resulting in 925 health facilities damaged or destroyed. The Independent Oversight and Advisory Committee (IOAC) for the WHO Health Emergencies Programme reports a “significant and alarming escalation” in these attacks that are likely to “underestimate the true scale of the crisis as reporting is uneven”. EMRO’s Heinzelmann said that almost 40% of these attacks occurred in her region, accounting for almost 90% of related deaths. “Attacks on healthcare must stop, humanitarian access must be guaranteed, and financing for preparedness and emergency response must increase now, not after the next global crisis is already underway,” she urged. Several member states, including Jordan, Switzerland, Australia, urged an end to attacks on health facilities and personnel and respect for international humanitarian law. Lack of financing The IOAC noted its deep concern at the “dramatic reductions in official development assistance from major donors”. During the 2008 global economic recession, the WHO “deprioritised” its emergency-related teams and reduced the workforce – but paid a high price during the Ebola outbreak in West Africa, “which resulted in over 11,000 lives lost and posed an existential threat to WHO”, noted the IOAC. “It is the IOAC’s responsibility to ensure that past weaknesses are not reprised and that WHO’s emergency capacities remain safeguarded.” In the WHO’s 2026‒2027 budget, the base budget of the emergencies programme has been set at $918.5 million, with 51% for country offices, 22% for regional offices and 27% for headquarters. Image Credits: Nour Alsaqqa/ MSF. WHO is Alarmed at ‘Scale and Speed’ of Ebola Outbreak as Hantavirus Threat Recedes 19/05/2026 Disha Shetty & Stefan Anderson Dr Tedros Adhanom Ghebreyesus is currently serving his second five-year term as WHO Director-General. His mandate expires on August 15, 2027. GENEVA — The outbreak of a deadly strain of Ebola for which there is no vaccine is accelerating through the Democratic Republic of Congo (DRC) and Uganda at a “scale and speed” alarming the World Health Organization (WHO), as cases climb and authorities scramble to contain the spread. “I’m deeply concerned about the scale and speed of the epidemic,” WHO chief Dr Tedros Adhanom Ghebreyesus told the 79th World Health Assembly on Tuesday, addressing delegates from 192 nations gathered in Geneva. More than 500 suspected cases and 130 suspected deaths beyond the confirmed caseload have been reported. Tedros said the figures would change as field operations scale up, including strengthening surveillance, contact tracing, and laboratory testing. “So far, 30 cases have been confirmed in the DRC from the northern province of Ituri,” he added. “Uganda has also informed WHO of two confirmed cases in the capital of Kampala, including one death among two individuals who travelled from DRC, and there is one US citizen confirmed positive and transferred to Germany.” “This epidemic is caused by Bundibugyo, a species of Ebola virus for which there are no vaccines or therapeutics,” Tedros said. Diagnostic tests in the region were designed for a different strain of Ebola and missed early infections, resulting in a four-week gap before the outbreak was detected. Ongoing shortages of diagnostic equipment on the frontlines mean the true size of the outbreak remains unknown. “In the absence of a vaccine, there are many other measures countries, of course, can take to stop the spread of this virus and save lives, even without medical countermeasures, including risk communication and community engagement,” Tedros said, commending Uganda for postponing its annual Martyrs’ Day celebrations, which can draw up to two million people. The Ebola virus kills up to half of those it infects, making any outbreak particularly dangerous. In response to the outbreak, the United States banned citizens from the DRC, Uganda and Sudan from entering the US on Monday. Also read: Tedros: ‘We Live in Difficult, Dangerous and Divisive Times’ ‘Did not do this lightly’ Ongoing 79th session of the WHA in Geneva, Switzerland. The rapid spiral led Tedros to declare the outbreak a public health emergency of international concern (PHEIC) on Sunday, the first time a Director-General has done so before convening an emergency committee. “I did not do this lightly,” he told the assembly. “I did it in accordance with Article 12 of the International Health Regulations, after consulting the ministers of health of both countries.” The emergency committee will meet later on Tuesday to advise on what response measures countries should adopt, as there is no vaccine and no cure for the strain of Ebola now spreading. The first confirmed case was a health worker, meaning the virus was already moving through medical settings before anyone knew it was there. After heavy criticism of the WHO’s slow handling of the 2014 West African Ebola epidemic, the agency’s chief appears unwilling to allow a repeat of history. Tedros said an additional $3.4 million was released from the WHO’s Contingency Fund for Emergencies, bringing the total committed to the response to $3.9 million. “WHO has a team on the ground supporting national authorities to respond,” he said. “We have deployed people, supplies, equipment, and funds.” LIVE: @DrTedros‘ address to the #WHA79 delegates https://t.co/IUGcXQ3cLe — World Health Organization (WHO) (@WHO) May 19, 2026 Deadly delays leave authorities flying blind Ebola health worker in protective gear. File image. Cases have surfaced in densely populated urban areas, including the Ugandan capital Kampala and the eastern DRC city of Goma, home to millions of people and serving as major hubs for cross-border trade and movement. The outbreak is likely to have originated in DRC’s Ituri province, a high-traffic mining area on the borders of South Sudan and Uganda, which “increases the risk of regional exportation and cross-border transmission”, according to the WHO. Fighting in the area between the DRC army and M23, an Islamist armed group, has intensified since late 2025 and escalated significantly over the past two months. More than 100,000 people have been newly displaced by the conflict, Tedros told the assembly – potentially carrying the virus with them as they go, far from the reach of surveillance teams and into communities with little capacity to identify or isolate new cases. “In Ebola outbreaks, you know what displacement means,” Tedros said. “The area is also a mining zone with high levels of population movement that increase the risk of further spread.” Local funeral practices, which involve close contact and touching the deceased, also accelerated transmission before authorities knew the outbreak was happening. The current outbreak is the third recorded outbreak of Bundibugyo, first identified in 2007. Hantavirus contained There are no known vaccines or therapeutics for this strain of Ebola making containment a challenge. The picture is markedly different for hantavirus, which Tedros also addressed. Two weeks ago, the hantavirus outbreak aboard the MV Hondius cruise ship, sparked international panic and wall-to-wall news coverage, but it has now been brought under control, Tedros told the assembly. “WHO’s assessment continues to be that the risk of hantavirus globally is low,” Tedros said. The ship docked in Rotterdam on Sunday, with the crew now in quarantine until 29 June. Passengers, who have been repatriated, will be monitored until 21 June. “So far, there are 11 reported cases, including three deaths, and no deaths have been reported since the second of May, when WHO was first informed of the outbreak on the ship. Those numbers have changed little since the outbreak was first reported to WHO two weeks ago,” Tedros said. The two outbreaks, emerging within two weeks of each other, served as a reminder of WHO’s core function, Tedros told the assembly. “The outbreaks of Ebola and Hantavirus in the past two weeks show why international threats need an international response,” he said. “They show why the world needs the international health regulations and why it needs WHO.” WHO successes: tobacco and taxes Tedros also highlighted WHO’s wins in his address, including the decline in tobacco use. “Tobacco use has dropped by one-third globally and continues to decline in 140 countries. With support from WHO, Maldives became the first country to adopt a generational tobacco ban for people born from 2007. This year, the United Kingdom followed suit, banning the sale of tobacco to anyone born from 2009 onwards,” he said. Since 2025, the WHO has been encouraging countries to tax tobacco, alcohol, and sugary drinks by at least 50% by 2035. “In the past 12 months, India, Jamaica, Malaysia, Mauritius, Mexico, Montenegro, Viet Nam, Saudi Arabia, Sierra Leone and Zambia were among countries that either announced, introduced or increased taxes on one or more of these products,” Tedros said. WHO’s advocacy to increase the rate of breastfeeding globally has also yielded positive results, with almost half of children worldwide being breastfed for at least for six months, Tedros said. A billion more people now have access to safe drinking water compared to just a decade ago, but the levels of violence against women have remained stagnant for two decades. However, the shortage of healthcare workers is hampering progress: “The world is facing a shortage of 11 million health workers by 2030, with the biggest gaps in the African and Eastern Mediterranean regions. More than half the gap is a shortage of nurses,” Tedros said. The world is also set to miss every one of the 52 health-related Sustainable Development Goal targets by 2030, the WHO revealed on the eve of the WHA. Malaria cases are rising, maternal deaths are still occurring at nearly three times the targeted rate and childhood vaccination coverage is plateauing or falling in some regions, and progress on global health goals has slowed, stalled or reversed across virtually every measure since 2015, according to the 2026 World Health Statistics report. Image Credits: WHO/Christopher Black , WHO/X, Africa CDC , WHO/X. Undocumented Migrants Fall Through Europe’s Healthcare Cracks, Joint Research Shows 19/05/2026 Felix Sassmannshausen Undocumented migrants navigate precarious conditions, often lacking health safety nets, despite contributing to informal economies. As Europe grapples with shifting demographics and an influx of migration, researchers are mapping how undocumented migrants navigate the administrative cracks of the continent’s healthcare systems – helping to fill a critical data gap identified by the World Health Organization. Inside the neoclassical venue of La Pastorale in Geneva, around 30 participants from six European universities convened on Monday on the sidelines of the World Health Assembly to dissect an expanding public health crisis related to the healthcare of immigrants, whose status and lack of resources means they often seek care in the shadows of the formal system – or fall through the cracks altogether until an emergency. The Geneva Health Forum event highlighted how complex administrative barriers keep undocumented migrant children and the elderly across the continent from accessing essential healthcare, leaving untreated chronic conditions, severe mental health crises, and emergencies to strain local resources. Professors Claudine Burton-Jeangros and Yves Jackson of the University of Geneva. The “Growing and ageing in the shadows” (GRACE) project, co-directed by Professor of Medicine Yves Jackson and health sociologist Professor Claudine Burton-Jeangros of the University of Geneva, explores these disparities as part of the European University Alliance (4EU+). The consortium unites scholars from the universities of Geneva, Heidelberg, Prague, Milan, Paris Sorbonne, and Copenhagen. Mapping the barriers and needs in Europe’s cities remains exceptionally difficult, as a lack of information and personnel, coupled with a profound fear of discrimination or deportation, drives undocumented migrants away from clinical settings and creates severe data deficits. The scale of this blind spot is particularly evident among minors; in Germany, for example, population estimates for undocumented children range wildly from a few thousand to over 100,000, the researchers noted. To enable evidence-based policymaking, the GRACE consortium navigates these blind spots by conducting in-depth interviews with frontline healthcare providers, social workers, and non-governmental actors to uncover the practical realities these vulnerable groups experience. While the results presented on Monday were preliminary, the consortium projects final results by the end of the year. They aim to use the findings to inform and advocate to policymakers on how to improve healthcare access. Fragmented bureaucracies erode rights of undocumented migrants WHO data on inclusion of refugee and migrant health aspects in national policies, legislation strategies or plans across thematic areas in the European Region. Access to equitable healthcare is a fundamental human right, reinforced by international frameworks such as the WHO Global Action Plan and the 2026 Progress Declaration of the International Migration Review Forum (IMRF) – the primary UN platform for tracking global migration commitments. Although the WHO notes significant recent progress – such as the WHO European Region’s action plan to improve legal access to care – these theoretical rights continue to routinely erode within the continent’s complex bureaucracies. In universal healthcare systems like Denmark’s – where the uninsured population also includes European Union citizens who have simply fallen out of the formal labour market – the mandate for a central registration number excludes those without formal residency documents. Lacking this registration number, undocumented individuals are forced to rely on a parallel, privately funded network of volunteer-run clinics for even the most basic medical care. Even in jurisdictions with progressive entitlements specifically designed for undocumented populations, such as France – where, notably, children cannot legally be classified as undocumented – administrative labyrinths and illegal discrimination by providers severely limit practical access. Although the French State Medical Aid guarantees free access to essential care after three months of residency, eligible patients are still frequently turned away by providers who illegally refuse to treat those relying on state support. University of Geneva researchers Srilak Weerawardane and Emma Perneger present preliminary findings. Germany also sees a growing number of uninsured migrants falling through the cracks. And this is not surprising since it enforces a severe legal Catch-22, the researchers found: while doctors maintain confidentiality, social welfare offices must report undocumented patients to immigration authorities if public funds cover their care. Additionally, hospitals frequently deny expensive treatments to avoid unpaid hospital bills. Ultimately, this systemic threat breeds a profound fear of deportation, driving undocumented migrants away from clinics entirely. Switzerland’s mandatory healthcare system grants all residents the right and legal obligation to purchase expensive insurance. Undocumented migrants – strictly excluding asylum seekers with pending applications – cannot opt out but face severe barriers to state subsidies. Forced to pay out of pocket, they accumulate massive debt, which accounts for an estimated 90% of their total arrears in Geneva. University of Geneva researchers concluded this financial burden traps individuals in poverty and paralyses future regularisation attempts, since being debt-free is a primary requirement for legal residency. Healthcare hinges on relationships instead of rights Locked out of formal systems, undocumented migrants rely on informal networks and alternative routes for essential healthcare. Because official avenues remain blocked, fragmented NGO clinics and volunteer doctors often serve as the primary safety net for basic care, the research team from the University of Copenhagen explained. To bridge the gap between theoretical rights and practical access, social workers must frequently intervene to defend marginalised patients, while physicians in countries like the Czech Republic utilise personal discretion to classify treatments as “acute care” to legally compel hospitals to provide treatment. Ultimately, receiving medical attention often depends on the willingness of individual healthcare providers to bypass restrictive frameworks. As a result, securing essential treatment is often reduced to a matter of luck, depending heavily on the informal networks of the doctors and the specific resources of the patients themselves. Heidelberg University researchers Manuela Orjuela-Grimm and Veronika Wiemker discuss their research on healthcare barriers. “It’s really contingent on personal relationships and healthcare providers… instead of being a right,” Veronika Wiemker, a researcher at the Heidelberg University on the situation in Germany, reflecting the shared reality across the continent. Faced with such systemic exclusion, undocumented migrants utilise alternative routes to care. To treat their conditions, individuals proactively stockpile medicine, consult online forums or artificial intelligence, and rely on transnational healthcare – such as travelling across borders for treatment or using telemedicine to maintain remote consultations with doctors in their countries of origin, as the researchers from Prague’s Charles University found. Young migrants navigate fragmented care Driven under the administrative radar, undocumented children face severe healthcare fragmentation, missing crucial developmental screenings and continuous medical support. The situation for undocumented children is particularly dire, despite being specially protected under international provisions. As undocumented parents often lack official birth certificates, their newborns remain largely under the administrative radar. The living conditions for these youngest migrants are frequently severe; in France alone, researchers from Paris Sorbonne University report that an estimated 3,000 homeless newborns and their mothers are discharged from hospitals directly onto the streets each year. Sorbonne University researchers Fanny Teissandier and Andrea Tortelli outline their methodology. Without stable housing or formal documentation, young migrants across the continent frequently miss out on crucial immunisations and preventive measures, mental health support, and basic dental care. While school-aged children occasionally receive basic entry assessments or see school nurses – as is the practice in countries like Germany and Denmark – the ongoing absence of holistic, continuous care exposes them to severe developmental risks and untreated chronic conditions. Unaccompanied minors endure even deeper vulnerability, often surviving on the streets while facing malnutrition and severe trauma. Despite being theoretically protected by local authorities, these youths remain highly vulnerable to exploitation, sex work, and chronic stress. Ultimately, the transition to adulthood introduces a severe, continent-wide cliff edge for these adolescents. Upon turning 18, temporary legal protections abruptly dissolve – either plunging the young adults into mandatory insurance systems they cannot afford or stripping them of their rights entirely. Ageing populations undergo unique crises Elderly undocumented migrants often endure accelerated ageing and complete exclusion from formal European long-term healthcare networks. The plight of the elderly introduces an entirely distinct set of challenges for local administrators, revealing severe gaps in long-term care. While some older migrants are newly arrived parents joining their children, many others are former labourers who planned to briefly work abroad but ultimately remained for decades. After years of surviving precarious, physically demanding jobs in the informal economy, these individuals frequently experience “accelerated ageing”, untreated chronic pain, and rapid cognitive decline. Furthermore, returning to their countries of origin is rarely a viable solution, as many have lived in Europe for well over a decade and no longer possess any social ties or family networks back home. Their vulnerability is compounded by European health systems that intrinsically tie medical entitlements to formal employment. Once these individuals age out of the workforce or lose their physical capacity to continue their demanding labour, they lose their economic value – frequently stripping them of their eligibility for public health subsidies and plunging them into poverty. This loss of economic value and legal status leaves elderly undocumented migrants completely excluded from formal long-term care solutions. Fearing that elderly, homeless migrants will become permanent “bed blockers” with no follow-up care options, hospitals in countries like France sometimes even deny them access to inpatient admission. Fear fuels harmful data gaps The bureaucratic ‘Chicken and Egg’ cycle: Financial burden and fear drive clinical avoidance, creating a data deficit that fuels policy paralysis. Beyond the immediate health consequences, the overarching fear of deportation forces individuals to “pretend not to be there.” Because undocumented migrants often actively avoid clinics, they remain completely hidden from formal health frameworks, creating a massive data blind spot for policymakers. Closing this gap is a global mandate, forming the core of the third and fifth priorities of the WHO Global Action Plan regarding migration health research and data. WHO’s Daniel Míč emphasises data to bridge divides. Daniel Míč, representing the World Health Organization (WHO) Special Initiative on Health and Migration, stressed that this dynamic creates a bureaucratic “chicken and egg” scenario. “If you are in a vulnerable situation, and you are afraid of being deported, or you are afraid of being punished by the system that you seek health or care from, there’s a problem,” he warned, noting that capturing necessary public health data becomes difficult when fear drives individuals away from the frontline clinics that would otherwise document their conditions. This data deficit is further compounded by the fact that defining who exactly qualifies as an “undocumented migrant” remains a major challenge. Because each national system applies its own administrative labels, the practical barriers these individuals face are dictated entirely by the bureaucracy of the country they reside in. Ultimately, “we will understand the challenges only if we have the data,” Míč said, stressing that concrete evidence is the only way to bridge political divides and present actionable solutions to policymakers. To close this harmful data gap, the GRACE consortium plans to synthesise its preliminary findings into targeted case studies and scientific reports by the end of the year. Recognising the immense value of this frontline research guiding European member states in building inclusive healthcare systems, Míč expressed a readiness to resume dialogue with the 4EU+ Alliance, hoping to translate previous discussions into a concrete collaboration. More Countries Refer to Refugees in Health Policies, but Access and Data Gaps Persist Image Credits: Adhitya Ginanjar/Unsplash, Tim Mossholder/Unsplash/HPW, University of Geneve/HUG, WHO/HPW, Felix Sassmannshausen/HPW, Beth Macdonald/Unsplash. Member States Support Extending Talks on Pandemic Agreement Annex, Propose New ‘Method’ 19/05/2026 Kerry Cullinan Pakistan’s Adeel Khokhar All World Health Organization (WHO) member states supported the extension of talks on the last outstanding piece of the Pandemic Agreement, the Pathogen Access and Benefit-Sharing (PABS) annex, at the World Health Assembly’s (WHA) Committee A on Monday. A draft PABS annex was due to have been presented to the WHA for approval, but instead, a report from the World Health Organization (WHO) Director General notes that member states need more time to reach an agreement. The PABS annex will govern how dangerous pathogens are shared during public health emergencies and how to share any medical products (benefits) produced as a result of manufacturers getting access to this information. A draft annex will either be presented at next year’s WHA or at a special WHA if agreement is reached beforehand, according to the report. Several of the many member states speaking on PABS in Committee A expressed confidence that the annex would be completed by the end of the year. However, divisions between developed and developing countries remained stark. Pakistan warned that the PABS negotiations should not be concluded in a way that “preserves the commercial privileges of a handful of manufacturers”. Pakistan’s representative told the committee: “We are witnessing a sustained effort by some member states to hollow out Article 12 [of the Pandemic Agreement], which clearly establishes the principle of equal footing” between sharing dangerous pathogens and sharing any benefits that manufacturers accrue from such knowledge. “We will not sign off on a multilateral system success story that serves the interests of industry over the health security of billions,” he added. ‘Conducive to R&D’ Malaysia’s representative in Committee A. On the other end of the spectrum, the European Union warned that a PABS agreement should not stifle research and development. “The Pandemic Agreement, as well as the revised IHR [International Health Regulations], contain important provisions that will significantly increase our capacity to confront pandemic emergencies and do so in a more equitable manner,” said the European Union. “The PABS system has an important role to play in this context, but we need to ensure that the system is also conducive to innovation, and research and development for medical countermeasures, then it can lead to a robust uptake by the private sector.” African countries, represented by South Africa, explained once again their demands for an equitable PABS system, including that the annex should include legally binding contracts between the WHO and manufacturers. Impetus for a global PABS system comes from the need to correct the inequities of the COVID-19 pandemic, when developing countries were initially unable to get vaccines – even for healthworkers – as these had all been bought by wealthy countries. As Namibia reminded the committee: “We negotiated the Pandemic Agreement because the world watched developing countries bury their loved ones due to COVID-19 while vaccines sat unused in warehouses elsewhere. That memory must anchor every line that we now draft.” “The credibility of this agreement now rests on the PABS annex. If access obligations read ‘shall’ while benefit-sharing obligations read ‘options’, and ‘where available’, we will have written inequity into international laws with our own hands.” “Benefit-sharing obligations must be legally binding and enforceable,” said Nigeria. “Technology transfer and non-exclusive licensing and local production partnerships must be obligations manufacturers sign onto, not options they select from a menu.” Malaysia emphasises that annex must clearly spell out the rights and obligations of parties, and be “operationally implementable”. Referring to the current hantavirus and Ebola outbreaks, Spain urged the completion of the annex so that the Pandemic Agreement could come into force and provide a solid regulatory framework “to prevent, prepare, and respond to health emergencies”. New methods for future talks? After six formal meetings and several informal sessions, the Intergovernmental Working Group (IGWG) will reconvene in July. However, Colombia stated that the extension of the negotiations on the PABS annex “will only make sense if it allows for a more balanced result, which is technically solid and useful for global public health. ” Colombia’s representative said that the main barrier is that the “rules of intellectual property applied to public health become a barrier to access and the production of vaccines, treatments, and diagnostics, just as happened during the COVID 19 pandemic.” Colombia proposed new “working methods” for the talks, including that they are open rather than behind closed doors, and “a progressive step-by-step approach” to the text, using “the concept of progressive consensus.” Colombia has previously suggested voting on contentious issues. Meanwhile, civil society observer Knowledge Ecology International (KEI) also proposed that negotiators “should consider new approaches, including some features of the benefit-sharing agreement in the new Law of the Sea Treaty, for areas beyond national jurisdiction. “In that agreement, governments take responsibility for the enforcement of benefit-sharing, and the triggers for benefit-sharing are downstream, on the filing or patents or the registration or sale of products.” Posts navigation Older postsNewer posts
WHO: Ebola Outbreak Is a Deadly Regional Threat But Not a Global Pandemic Risk 20/05/2026 Stefan Anderson The WHO has determined that the Ebola outbreak raising alarm worldwide does not pose a pandemic threat. GENEVA — The Ebola outbreak unfolding in the Democratic Republic of Congo (DRC) and Uganda poses a “low” risk globally, according to an expert committee of the World Health Organization (WHO). However, the national and regional risk is “high”, according to the International Health Regulations (IHR) Emergency Committee. Last Sunday, WHO Director-General Dr Tedros Adhanom Ghebreyesus had already declared the outbreak a public health emergency of international concern (PHEIC), the WHO’s second-highest level of alert, before convening the emergency committee. This is the first time in WHO’s history that this has occurred. Tedros was motivated by the scale and speed of the spread of the Bundibugyo virus, a rare and particularly deadly strain of Ebola, which has killed at least 131 people and infected over 500 others. The emergency meeting, convened on Tuesday to assess the threat of the current outbreak, concurred that the situation is a PHEIC but “not a pandemic emergency,” Tedros told a media briefing on Wednesday. The committee, chaired by Professor Lucille Blumberg, agreed with the Director-General’s assessment and is finalising its recommendations in the coming days. “Our prime aim was to support the decision and decide whether this is a public health emergency of international concern, and to consider whether there’s a pandemic emergency. The former was agreed to,” Blumberg said. Investigations into the outbreak’s origin Anaïs Legand speaking at the emergency press conference on the Ebola crisis. “Investigations are ongoing to ascertain when and where exactly this outbreak started,” said Anaïs Legand, a technical officer for high-threat pathogens at WHO’s health emergencies programme. “Given the scale, we are thinking that it has started probably a couple of months ago, but investigations are ongoing, and our priority is really to cut the transmission chain by implementing contact tracing, isolating and caring for all suspect and confirmed cases.” The Bundibugyo species was last seen in 2007, and there is currently no vaccine or treatment licensed for it. Investigators say the true scale of the epidemic in DRC is much larger than current case counts suggest. War, and a very long drive Dr Mohamed Yakub Janabi, WHO’s regional director for Africa. WHO officials laid out several reasons the outbreak escaped detection. The province of Ituri, where it emerged, is engulfed in war. Fighting between the DRC army and the M23 armed group has intensified in recent months, displacing more than 100,000 people. Beyond the conflict, eastern DRC is among the most challenging places in the world to mount a public health response. Health facilities are sparse, roads are limited, and much of the terrain is forested and mountainous. A previous Ebola outbreak in the same region in 2018-19 took close to two years to bring under control, even with a licensed vaccine available. Dr Mohamed Yakub Janabi, WHO’s regional director for Africa, said the combination of factors made early detection enormously difficult. “Detecting outbreaks such as Ebola in a complex setting like Ituri province in the DRC is inherently challenging,” he said. “Surveillance systems rely on a combination of community reporting, local health facilities, lab confirmation, and partner coordination.” Samples from the outbreak zone must travel 1,700 kilometres to reach the Institut National de Recherche Biomédicale in Kinshasa, the only facility in the country with the capacity to test for Bundibugyo. The distance to the capital is comparable to London to Warsaw – a roughly a 24-hour drive on smooth European roads, a far cry from the remote jungle tracks and dirt roads of Ituri. “In remote or insecure areas, it can take time for cases to be recognised and samples transported,” Janabi said. Symptoms mistaken for endemic diseases Nearly 7 tonnes of emergency medical supplies and equipment along with a team of 35 experts from WHO and the DRC’s health ministry, arrived today in Bunia from Kinshasa to support frontline #Ebola response in Ituri Province. The Bundibugyo strain’s early symptoms also overlap with diseases endemic to eastern DRC, leading health workers to mistake initial cases for more common illnesses. “Nonspecific early symptoms, for instance, if you take malaria and typhoid, the early symptoms are the same,” Tedros said. “The region is very endemic to those diseases, so the health workers will associate the early signs with malaria or typhoid, and they can’t diagnose based on the symptoms. They may start treating that.” Dr Abdi Mahamud, WHO’s director for health emergency alert and response operations, said the diagnostic challenge would have tripped up better-resourced systems. “This outbreak is happening in a highly endemic [setting for] other diseases that present similar symptoms – malaria, dysentery, and others,” he said. “If you don’t have that high index of suspicion, if you don’t have the right facility to test, even in high-income countries, you will have that delay in the start of an outbreak.” Diagnostic tests routinely used across the region added another layer of delay. The Bundibugyo strain belongs to a different genus, Orthoebolavirus, than the more common Zaire strain that most existing tests are optimised to detect. “There was a problem linked to the traditional test we use,” Tedros said. “The traditional test is optimised with Zaire, and the same sample was taken and tested, but since the test kit is optimised with Zaire, [Bundibugyo] could not be detected.” No vaccine, but a pipeline Vasee Moorthy, WHO’s research and development lead on the current outbreak, laid out the state of the vaccine pipeline for the Bundibugyo strain. The Bundibugyo strain has no licensed vaccine or therapeutic. WHO’s research and development lead, Vasee Moorthy, said a pipeline of candidates is being accelerated but remains months away. Moorthy said the most promising candidate is an rVSV Bundibugyo vaccine, the equivalent for this strain of Ervebo, the licensed Merck vaccine used against the more common Zaire Ebola strain since 2019. “There are no doses of this which are currently available for clinical trial, so this needs to be prioritised,” Moorthy said. “The information that we have is that this is likely to take six to nine months.” A second candidate, built on the ChAdOx1 platform used in the AstraZeneca COVID-19 vaccine, is being developed by Oxford and the Serum Institute of India. “They are manufacturing that as we speak, but there is no animal data to support [its efficacy],” Moorthy said. “It is possible that doses of that could be available for clinical trial in two to three months, but there is a lot of uncertainty about that.” Even in the most optimistic scenario, neither candidate is likely to be available to materially shape the trajectory of the current outbreak. In the meantime, the response is being built around the basics: safe treatment centres, patient referral pathways, contact tracing, and the protection of health workers, among whom the first confirmed case in the outbreak was identified. “The protection of healthcare workers and families is absolutely paramount,” Blumberg said. “The people in the area and those who respond need to be kept safe and allowed to be able to do what they need to do in a critical time such as this.” Tedros: Rubio suffers ‘lack of understanding’ US Secretary of State Marco Rubio. The WHO chief used the press conference to push back at US Secretary of State Marco Rubio, who said this week the agency had been “a little late to identify this thing.” The US has banned citizens of the DRC, Uganda and Sudan from entry, closed its only dedicated Ebola lab, withdrawn from the WHO, and defunded the agency. “On what the Secretary said, it could be from a lack of understanding of how IHR works, and the responsibilities of WHO and other entities,” Tedros said. “We don’t replace the country’s work, we only support them, so that’s why there could be some lack of understanding.” Tedros suggested conflict in the affected region was a more fundamental factor in the delay than anything WHO could have done differently. “Health facilities cannot work optimally when there is conflict and when the health workers are also fleeing as part of the community which is displaced,” he said. “It affects the whole surveillance system, and not only that, but it also affects access.” “I think that’s what we should understand, the secretary or others.” Asked repeatedly whether US funding cuts to DRC surveillance programmes had contributed to the outbreak going undetected, Tedros declined to draw a direct line. “We don’t need to jump to conclusions before we understand the whole complexity. It would be very difficult to associate it with funding alone,” he said, noting that the diagnostic gap was a question of the wrong tests being administered rather than supply. Legand echoed the point, noting the issue stems from test type, not supply: “For the time being, it’s not a supply issue. We need to ensure that the right platform with the right data arrives at the right place. This is the work that is being done as we speak.” The outbreak, meanwhile, continues to spread through a war zone with no vaccine, no cure, and a diagnostic system still catching up to the strain it now faces. Image Credits: @WHO African Region, Gage Skidmore. Grim Warning of Dwindling Funds for Emergencies as States Vote on Attacks in Lebanon and Iran 20/05/2026 Kerry Cullinan Dr Annette Heinzelmann, emergency director for the WHO Eastern Mediterranean Region (EMRO) The grim impossibility of addressing rising health emergencies with dwindling budgets was raised at the World Health Assembly (WHA) on Tuesday – amid votes on attacks on healthcare in Lebanon and Israel. “Outbreaks are accelerating, while the systems designed to stop them are being weakened,” warned Dr Annette Heinzelmann, emergency director for the WHO Eastern Mediterranean Region (EMRO), during a discussion of health emergencies in Committee A. “The gap between needs and resources is now unsustainable. The WHO Health Emergency Programme faced a $553 million funding gap in 2024 and 2025. The contingency fund for emergencies entered 2026 with just $19.5 million, while our regional emergency workforce has been cut by half. We cannot continue confronting expanding emergencies with shrinking capacity.” In EMRO, 117 million people need humanitarian assistance; there are 14 graded emergencies, 44 active outbreaks, and more than 50 public health events across 17 member states. “Conflict, displacement, climate shock, economic collapse, and diseases are colliding into a single expanding poly crisis,” Heinzelmann warned, speaking on behalf of the regional director. “Across Gaza, Sudan, Yemen, Somalia, and Afghanistan, and amid escalation affecting Iran, Syria, and Lebanon, WHO is sustaining trauma care, delivering medicines, reinforcing surveillance, and supporting governments to manage growing public health risks.” Votes on Lebanon and Iran Regional conflict is compounding the EMRO health crises. Lebanon received overwhelming support from the majority of member states in the wake of Israeli attacks on its health infrastructure – but there was little support for Iran’s appeal for support against similar attacks. Ninety-five member states voted in favour of a resolution that noted “a health emergency in Lebanon resulting from ongoing and recently intensified hostilities” and called for “the full protection of healthcare in Lebanon, including patients, health personnel, facilities and transport”. Only Israel and Honduras opposed the resolution, which did not name Israel as the aggressor. Voting on the resolution in support of Lebanon, following attacks on its health care by Israel. However, Iran’s resolution, condemning recent attacks on patients and health infrastructure, including on the Pasteur Institute – was defeated. The resolution did not mention Israel and the United States as the aggressors. Only 19 countries supported Iran, 30 voted against, and a whopping 58 countries abstained. Several countries cited Iran’s attacks against its own citizens and Gulf states, and the blockade of the Strait of Hormuz, preventing the flow of medical supplies, as reasons for not supporting the resolution. Voting on the resolution in support of Iran, in the wake of US and Israeli attacks on its health infrastructure. Haemorrhagic fever, extreme weather Voting came at the end of a discussion on the WHO’s involvement in health emergencies in the WHA’s Committee A. In 2025, WHO responded to 50 emergencies in 82 countries and territories, of which 20 were Grade 3 emergencies requiring the highest level of organisation-wide support, the organisation reported. Disease outbreaks included viral haemorrhagic fever: Sudan virus disease in Uganda; Marburg in Tanzania and Ethiopia; Ebola in the Democratic Republic of the Congo (DRC) and Rift Valley fever in Mauritania and Senegal. Mpox was declared a public health emergency of international concern (PHEIC), affecting 98 countries, with 52 974 confirmed cases – 84% in Africa – and 215 deaths. Thirty-three countries reported cholera outbreaks involving over 614 828 cases and 7,598 deaths. Angola, the DRC and Sudan had the highest cases. The WHO provided over 58 million doses of “emergency vaccines” for cholera, meningitis, yellow fever and Ebola. Challenges included “limited surveillance capacities and insufficient production of critical vaccines”. Three out of four emergencies were either caused or exacerbated by extreme weather events such as flooding, droughts and cyclones. Earthquakes in Afghanistan and Myanmar, severe Pacific typhoons and three category-5 hurricanes, including Hurricane Melissa, caused death and damage. The global cost of natural disasters is estimated at over $ 200 billion annually. So great was the demand for WHO’s assistance that its Contingency Fund for Emergencies was left with $19.5 million by the end of the year. Attacks on healthcare The severely destroyed Al-Shifa hospital in Gaza City, Palestine, in February 2025. Last year, the WHO verified 1,351 attacks on healthcare, resulting in 925 health facilities damaged or destroyed. The Independent Oversight and Advisory Committee (IOAC) for the WHO Health Emergencies Programme reports a “significant and alarming escalation” in these attacks that are likely to “underestimate the true scale of the crisis as reporting is uneven”. EMRO’s Heinzelmann said that almost 40% of these attacks occurred in her region, accounting for almost 90% of related deaths. “Attacks on healthcare must stop, humanitarian access must be guaranteed, and financing for preparedness and emergency response must increase now, not after the next global crisis is already underway,” she urged. Several member states, including Jordan, Switzerland, Australia, urged an end to attacks on health facilities and personnel and respect for international humanitarian law. Lack of financing The IOAC noted its deep concern at the “dramatic reductions in official development assistance from major donors”. During the 2008 global economic recession, the WHO “deprioritised” its emergency-related teams and reduced the workforce – but paid a high price during the Ebola outbreak in West Africa, “which resulted in over 11,000 lives lost and posed an existential threat to WHO”, noted the IOAC. “It is the IOAC’s responsibility to ensure that past weaknesses are not reprised and that WHO’s emergency capacities remain safeguarded.” In the WHO’s 2026‒2027 budget, the base budget of the emergencies programme has been set at $918.5 million, with 51% for country offices, 22% for regional offices and 27% for headquarters. Image Credits: Nour Alsaqqa/ MSF. WHO is Alarmed at ‘Scale and Speed’ of Ebola Outbreak as Hantavirus Threat Recedes 19/05/2026 Disha Shetty & Stefan Anderson Dr Tedros Adhanom Ghebreyesus is currently serving his second five-year term as WHO Director-General. His mandate expires on August 15, 2027. GENEVA — The outbreak of a deadly strain of Ebola for which there is no vaccine is accelerating through the Democratic Republic of Congo (DRC) and Uganda at a “scale and speed” alarming the World Health Organization (WHO), as cases climb and authorities scramble to contain the spread. “I’m deeply concerned about the scale and speed of the epidemic,” WHO chief Dr Tedros Adhanom Ghebreyesus told the 79th World Health Assembly on Tuesday, addressing delegates from 192 nations gathered in Geneva. More than 500 suspected cases and 130 suspected deaths beyond the confirmed caseload have been reported. Tedros said the figures would change as field operations scale up, including strengthening surveillance, contact tracing, and laboratory testing. “So far, 30 cases have been confirmed in the DRC from the northern province of Ituri,” he added. “Uganda has also informed WHO of two confirmed cases in the capital of Kampala, including one death among two individuals who travelled from DRC, and there is one US citizen confirmed positive and transferred to Germany.” “This epidemic is caused by Bundibugyo, a species of Ebola virus for which there are no vaccines or therapeutics,” Tedros said. Diagnostic tests in the region were designed for a different strain of Ebola and missed early infections, resulting in a four-week gap before the outbreak was detected. Ongoing shortages of diagnostic equipment on the frontlines mean the true size of the outbreak remains unknown. “In the absence of a vaccine, there are many other measures countries, of course, can take to stop the spread of this virus and save lives, even without medical countermeasures, including risk communication and community engagement,” Tedros said, commending Uganda for postponing its annual Martyrs’ Day celebrations, which can draw up to two million people. The Ebola virus kills up to half of those it infects, making any outbreak particularly dangerous. In response to the outbreak, the United States banned citizens from the DRC, Uganda and Sudan from entering the US on Monday. Also read: Tedros: ‘We Live in Difficult, Dangerous and Divisive Times’ ‘Did not do this lightly’ Ongoing 79th session of the WHA in Geneva, Switzerland. The rapid spiral led Tedros to declare the outbreak a public health emergency of international concern (PHEIC) on Sunday, the first time a Director-General has done so before convening an emergency committee. “I did not do this lightly,” he told the assembly. “I did it in accordance with Article 12 of the International Health Regulations, after consulting the ministers of health of both countries.” The emergency committee will meet later on Tuesday to advise on what response measures countries should adopt, as there is no vaccine and no cure for the strain of Ebola now spreading. The first confirmed case was a health worker, meaning the virus was already moving through medical settings before anyone knew it was there. After heavy criticism of the WHO’s slow handling of the 2014 West African Ebola epidemic, the agency’s chief appears unwilling to allow a repeat of history. Tedros said an additional $3.4 million was released from the WHO’s Contingency Fund for Emergencies, bringing the total committed to the response to $3.9 million. “WHO has a team on the ground supporting national authorities to respond,” he said. “We have deployed people, supplies, equipment, and funds.” LIVE: @DrTedros‘ address to the #WHA79 delegates https://t.co/IUGcXQ3cLe — World Health Organization (WHO) (@WHO) May 19, 2026 Deadly delays leave authorities flying blind Ebola health worker in protective gear. File image. Cases have surfaced in densely populated urban areas, including the Ugandan capital Kampala and the eastern DRC city of Goma, home to millions of people and serving as major hubs for cross-border trade and movement. The outbreak is likely to have originated in DRC’s Ituri province, a high-traffic mining area on the borders of South Sudan and Uganda, which “increases the risk of regional exportation and cross-border transmission”, according to the WHO. Fighting in the area between the DRC army and M23, an Islamist armed group, has intensified since late 2025 and escalated significantly over the past two months. More than 100,000 people have been newly displaced by the conflict, Tedros told the assembly – potentially carrying the virus with them as they go, far from the reach of surveillance teams and into communities with little capacity to identify or isolate new cases. “In Ebola outbreaks, you know what displacement means,” Tedros said. “The area is also a mining zone with high levels of population movement that increase the risk of further spread.” Local funeral practices, which involve close contact and touching the deceased, also accelerated transmission before authorities knew the outbreak was happening. The current outbreak is the third recorded outbreak of Bundibugyo, first identified in 2007. Hantavirus contained There are no known vaccines or therapeutics for this strain of Ebola making containment a challenge. The picture is markedly different for hantavirus, which Tedros also addressed. Two weeks ago, the hantavirus outbreak aboard the MV Hondius cruise ship, sparked international panic and wall-to-wall news coverage, but it has now been brought under control, Tedros told the assembly. “WHO’s assessment continues to be that the risk of hantavirus globally is low,” Tedros said. The ship docked in Rotterdam on Sunday, with the crew now in quarantine until 29 June. Passengers, who have been repatriated, will be monitored until 21 June. “So far, there are 11 reported cases, including three deaths, and no deaths have been reported since the second of May, when WHO was first informed of the outbreak on the ship. Those numbers have changed little since the outbreak was first reported to WHO two weeks ago,” Tedros said. The two outbreaks, emerging within two weeks of each other, served as a reminder of WHO’s core function, Tedros told the assembly. “The outbreaks of Ebola and Hantavirus in the past two weeks show why international threats need an international response,” he said. “They show why the world needs the international health regulations and why it needs WHO.” WHO successes: tobacco and taxes Tedros also highlighted WHO’s wins in his address, including the decline in tobacco use. “Tobacco use has dropped by one-third globally and continues to decline in 140 countries. With support from WHO, Maldives became the first country to adopt a generational tobacco ban for people born from 2007. This year, the United Kingdom followed suit, banning the sale of tobacco to anyone born from 2009 onwards,” he said. Since 2025, the WHO has been encouraging countries to tax tobacco, alcohol, and sugary drinks by at least 50% by 2035. “In the past 12 months, India, Jamaica, Malaysia, Mauritius, Mexico, Montenegro, Viet Nam, Saudi Arabia, Sierra Leone and Zambia were among countries that either announced, introduced or increased taxes on one or more of these products,” Tedros said. WHO’s advocacy to increase the rate of breastfeeding globally has also yielded positive results, with almost half of children worldwide being breastfed for at least for six months, Tedros said. A billion more people now have access to safe drinking water compared to just a decade ago, but the levels of violence against women have remained stagnant for two decades. However, the shortage of healthcare workers is hampering progress: “The world is facing a shortage of 11 million health workers by 2030, with the biggest gaps in the African and Eastern Mediterranean regions. More than half the gap is a shortage of nurses,” Tedros said. The world is also set to miss every one of the 52 health-related Sustainable Development Goal targets by 2030, the WHO revealed on the eve of the WHA. Malaria cases are rising, maternal deaths are still occurring at nearly three times the targeted rate and childhood vaccination coverage is plateauing or falling in some regions, and progress on global health goals has slowed, stalled or reversed across virtually every measure since 2015, according to the 2026 World Health Statistics report. Image Credits: WHO/Christopher Black , WHO/X, Africa CDC , WHO/X. Undocumented Migrants Fall Through Europe’s Healthcare Cracks, Joint Research Shows 19/05/2026 Felix Sassmannshausen Undocumented migrants navigate precarious conditions, often lacking health safety nets, despite contributing to informal economies. As Europe grapples with shifting demographics and an influx of migration, researchers are mapping how undocumented migrants navigate the administrative cracks of the continent’s healthcare systems – helping to fill a critical data gap identified by the World Health Organization. Inside the neoclassical venue of La Pastorale in Geneva, around 30 participants from six European universities convened on Monday on the sidelines of the World Health Assembly to dissect an expanding public health crisis related to the healthcare of immigrants, whose status and lack of resources means they often seek care in the shadows of the formal system – or fall through the cracks altogether until an emergency. The Geneva Health Forum event highlighted how complex administrative barriers keep undocumented migrant children and the elderly across the continent from accessing essential healthcare, leaving untreated chronic conditions, severe mental health crises, and emergencies to strain local resources. Professors Claudine Burton-Jeangros and Yves Jackson of the University of Geneva. The “Growing and ageing in the shadows” (GRACE) project, co-directed by Professor of Medicine Yves Jackson and health sociologist Professor Claudine Burton-Jeangros of the University of Geneva, explores these disparities as part of the European University Alliance (4EU+). The consortium unites scholars from the universities of Geneva, Heidelberg, Prague, Milan, Paris Sorbonne, and Copenhagen. Mapping the barriers and needs in Europe’s cities remains exceptionally difficult, as a lack of information and personnel, coupled with a profound fear of discrimination or deportation, drives undocumented migrants away from clinical settings and creates severe data deficits. The scale of this blind spot is particularly evident among minors; in Germany, for example, population estimates for undocumented children range wildly from a few thousand to over 100,000, the researchers noted. To enable evidence-based policymaking, the GRACE consortium navigates these blind spots by conducting in-depth interviews with frontline healthcare providers, social workers, and non-governmental actors to uncover the practical realities these vulnerable groups experience. While the results presented on Monday were preliminary, the consortium projects final results by the end of the year. They aim to use the findings to inform and advocate to policymakers on how to improve healthcare access. Fragmented bureaucracies erode rights of undocumented migrants WHO data on inclusion of refugee and migrant health aspects in national policies, legislation strategies or plans across thematic areas in the European Region. Access to equitable healthcare is a fundamental human right, reinforced by international frameworks such as the WHO Global Action Plan and the 2026 Progress Declaration of the International Migration Review Forum (IMRF) – the primary UN platform for tracking global migration commitments. Although the WHO notes significant recent progress – such as the WHO European Region’s action plan to improve legal access to care – these theoretical rights continue to routinely erode within the continent’s complex bureaucracies. In universal healthcare systems like Denmark’s – where the uninsured population also includes European Union citizens who have simply fallen out of the formal labour market – the mandate for a central registration number excludes those without formal residency documents. Lacking this registration number, undocumented individuals are forced to rely on a parallel, privately funded network of volunteer-run clinics for even the most basic medical care. Even in jurisdictions with progressive entitlements specifically designed for undocumented populations, such as France – where, notably, children cannot legally be classified as undocumented – administrative labyrinths and illegal discrimination by providers severely limit practical access. Although the French State Medical Aid guarantees free access to essential care after three months of residency, eligible patients are still frequently turned away by providers who illegally refuse to treat those relying on state support. University of Geneva researchers Srilak Weerawardane and Emma Perneger present preliminary findings. Germany also sees a growing number of uninsured migrants falling through the cracks. And this is not surprising since it enforces a severe legal Catch-22, the researchers found: while doctors maintain confidentiality, social welfare offices must report undocumented patients to immigration authorities if public funds cover their care. Additionally, hospitals frequently deny expensive treatments to avoid unpaid hospital bills. Ultimately, this systemic threat breeds a profound fear of deportation, driving undocumented migrants away from clinics entirely. Switzerland’s mandatory healthcare system grants all residents the right and legal obligation to purchase expensive insurance. Undocumented migrants – strictly excluding asylum seekers with pending applications – cannot opt out but face severe barriers to state subsidies. Forced to pay out of pocket, they accumulate massive debt, which accounts for an estimated 90% of their total arrears in Geneva. University of Geneva researchers concluded this financial burden traps individuals in poverty and paralyses future regularisation attempts, since being debt-free is a primary requirement for legal residency. Healthcare hinges on relationships instead of rights Locked out of formal systems, undocumented migrants rely on informal networks and alternative routes for essential healthcare. Because official avenues remain blocked, fragmented NGO clinics and volunteer doctors often serve as the primary safety net for basic care, the research team from the University of Copenhagen explained. To bridge the gap between theoretical rights and practical access, social workers must frequently intervene to defend marginalised patients, while physicians in countries like the Czech Republic utilise personal discretion to classify treatments as “acute care” to legally compel hospitals to provide treatment. Ultimately, receiving medical attention often depends on the willingness of individual healthcare providers to bypass restrictive frameworks. As a result, securing essential treatment is often reduced to a matter of luck, depending heavily on the informal networks of the doctors and the specific resources of the patients themselves. Heidelberg University researchers Manuela Orjuela-Grimm and Veronika Wiemker discuss their research on healthcare barriers. “It’s really contingent on personal relationships and healthcare providers… instead of being a right,” Veronika Wiemker, a researcher at the Heidelberg University on the situation in Germany, reflecting the shared reality across the continent. Faced with such systemic exclusion, undocumented migrants utilise alternative routes to care. To treat their conditions, individuals proactively stockpile medicine, consult online forums or artificial intelligence, and rely on transnational healthcare – such as travelling across borders for treatment or using telemedicine to maintain remote consultations with doctors in their countries of origin, as the researchers from Prague’s Charles University found. Young migrants navigate fragmented care Driven under the administrative radar, undocumented children face severe healthcare fragmentation, missing crucial developmental screenings and continuous medical support. The situation for undocumented children is particularly dire, despite being specially protected under international provisions. As undocumented parents often lack official birth certificates, their newborns remain largely under the administrative radar. The living conditions for these youngest migrants are frequently severe; in France alone, researchers from Paris Sorbonne University report that an estimated 3,000 homeless newborns and their mothers are discharged from hospitals directly onto the streets each year. Sorbonne University researchers Fanny Teissandier and Andrea Tortelli outline their methodology. Without stable housing or formal documentation, young migrants across the continent frequently miss out on crucial immunisations and preventive measures, mental health support, and basic dental care. While school-aged children occasionally receive basic entry assessments or see school nurses – as is the practice in countries like Germany and Denmark – the ongoing absence of holistic, continuous care exposes them to severe developmental risks and untreated chronic conditions. Unaccompanied minors endure even deeper vulnerability, often surviving on the streets while facing malnutrition and severe trauma. Despite being theoretically protected by local authorities, these youths remain highly vulnerable to exploitation, sex work, and chronic stress. Ultimately, the transition to adulthood introduces a severe, continent-wide cliff edge for these adolescents. Upon turning 18, temporary legal protections abruptly dissolve – either plunging the young adults into mandatory insurance systems they cannot afford or stripping them of their rights entirely. Ageing populations undergo unique crises Elderly undocumented migrants often endure accelerated ageing and complete exclusion from formal European long-term healthcare networks. The plight of the elderly introduces an entirely distinct set of challenges for local administrators, revealing severe gaps in long-term care. While some older migrants are newly arrived parents joining their children, many others are former labourers who planned to briefly work abroad but ultimately remained for decades. After years of surviving precarious, physically demanding jobs in the informal economy, these individuals frequently experience “accelerated ageing”, untreated chronic pain, and rapid cognitive decline. Furthermore, returning to their countries of origin is rarely a viable solution, as many have lived in Europe for well over a decade and no longer possess any social ties or family networks back home. Their vulnerability is compounded by European health systems that intrinsically tie medical entitlements to formal employment. Once these individuals age out of the workforce or lose their physical capacity to continue their demanding labour, they lose their economic value – frequently stripping them of their eligibility for public health subsidies and plunging them into poverty. This loss of economic value and legal status leaves elderly undocumented migrants completely excluded from formal long-term care solutions. Fearing that elderly, homeless migrants will become permanent “bed blockers” with no follow-up care options, hospitals in countries like France sometimes even deny them access to inpatient admission. Fear fuels harmful data gaps The bureaucratic ‘Chicken and Egg’ cycle: Financial burden and fear drive clinical avoidance, creating a data deficit that fuels policy paralysis. Beyond the immediate health consequences, the overarching fear of deportation forces individuals to “pretend not to be there.” Because undocumented migrants often actively avoid clinics, they remain completely hidden from formal health frameworks, creating a massive data blind spot for policymakers. Closing this gap is a global mandate, forming the core of the third and fifth priorities of the WHO Global Action Plan regarding migration health research and data. WHO’s Daniel Míč emphasises data to bridge divides. Daniel Míč, representing the World Health Organization (WHO) Special Initiative on Health and Migration, stressed that this dynamic creates a bureaucratic “chicken and egg” scenario. “If you are in a vulnerable situation, and you are afraid of being deported, or you are afraid of being punished by the system that you seek health or care from, there’s a problem,” he warned, noting that capturing necessary public health data becomes difficult when fear drives individuals away from the frontline clinics that would otherwise document their conditions. This data deficit is further compounded by the fact that defining who exactly qualifies as an “undocumented migrant” remains a major challenge. Because each national system applies its own administrative labels, the practical barriers these individuals face are dictated entirely by the bureaucracy of the country they reside in. Ultimately, “we will understand the challenges only if we have the data,” Míč said, stressing that concrete evidence is the only way to bridge political divides and present actionable solutions to policymakers. To close this harmful data gap, the GRACE consortium plans to synthesise its preliminary findings into targeted case studies and scientific reports by the end of the year. Recognising the immense value of this frontline research guiding European member states in building inclusive healthcare systems, Míč expressed a readiness to resume dialogue with the 4EU+ Alliance, hoping to translate previous discussions into a concrete collaboration. More Countries Refer to Refugees in Health Policies, but Access and Data Gaps Persist Image Credits: Adhitya Ginanjar/Unsplash, Tim Mossholder/Unsplash/HPW, University of Geneve/HUG, WHO/HPW, Felix Sassmannshausen/HPW, Beth Macdonald/Unsplash. Member States Support Extending Talks on Pandemic Agreement Annex, Propose New ‘Method’ 19/05/2026 Kerry Cullinan Pakistan’s Adeel Khokhar All World Health Organization (WHO) member states supported the extension of talks on the last outstanding piece of the Pandemic Agreement, the Pathogen Access and Benefit-Sharing (PABS) annex, at the World Health Assembly’s (WHA) Committee A on Monday. A draft PABS annex was due to have been presented to the WHA for approval, but instead, a report from the World Health Organization (WHO) Director General notes that member states need more time to reach an agreement. The PABS annex will govern how dangerous pathogens are shared during public health emergencies and how to share any medical products (benefits) produced as a result of manufacturers getting access to this information. A draft annex will either be presented at next year’s WHA or at a special WHA if agreement is reached beforehand, according to the report. Several of the many member states speaking on PABS in Committee A expressed confidence that the annex would be completed by the end of the year. However, divisions between developed and developing countries remained stark. Pakistan warned that the PABS negotiations should not be concluded in a way that “preserves the commercial privileges of a handful of manufacturers”. Pakistan’s representative told the committee: “We are witnessing a sustained effort by some member states to hollow out Article 12 [of the Pandemic Agreement], which clearly establishes the principle of equal footing” between sharing dangerous pathogens and sharing any benefits that manufacturers accrue from such knowledge. “We will not sign off on a multilateral system success story that serves the interests of industry over the health security of billions,” he added. ‘Conducive to R&D’ Malaysia’s representative in Committee A. On the other end of the spectrum, the European Union warned that a PABS agreement should not stifle research and development. “The Pandemic Agreement, as well as the revised IHR [International Health Regulations], contain important provisions that will significantly increase our capacity to confront pandemic emergencies and do so in a more equitable manner,” said the European Union. “The PABS system has an important role to play in this context, but we need to ensure that the system is also conducive to innovation, and research and development for medical countermeasures, then it can lead to a robust uptake by the private sector.” African countries, represented by South Africa, explained once again their demands for an equitable PABS system, including that the annex should include legally binding contracts between the WHO and manufacturers. Impetus for a global PABS system comes from the need to correct the inequities of the COVID-19 pandemic, when developing countries were initially unable to get vaccines – even for healthworkers – as these had all been bought by wealthy countries. As Namibia reminded the committee: “We negotiated the Pandemic Agreement because the world watched developing countries bury their loved ones due to COVID-19 while vaccines sat unused in warehouses elsewhere. That memory must anchor every line that we now draft.” “The credibility of this agreement now rests on the PABS annex. If access obligations read ‘shall’ while benefit-sharing obligations read ‘options’, and ‘where available’, we will have written inequity into international laws with our own hands.” “Benefit-sharing obligations must be legally binding and enforceable,” said Nigeria. “Technology transfer and non-exclusive licensing and local production partnerships must be obligations manufacturers sign onto, not options they select from a menu.” Malaysia emphasises that annex must clearly spell out the rights and obligations of parties, and be “operationally implementable”. Referring to the current hantavirus and Ebola outbreaks, Spain urged the completion of the annex so that the Pandemic Agreement could come into force and provide a solid regulatory framework “to prevent, prepare, and respond to health emergencies”. New methods for future talks? After six formal meetings and several informal sessions, the Intergovernmental Working Group (IGWG) will reconvene in July. However, Colombia stated that the extension of the negotiations on the PABS annex “will only make sense if it allows for a more balanced result, which is technically solid and useful for global public health. ” Colombia’s representative said that the main barrier is that the “rules of intellectual property applied to public health become a barrier to access and the production of vaccines, treatments, and diagnostics, just as happened during the COVID 19 pandemic.” Colombia proposed new “working methods” for the talks, including that they are open rather than behind closed doors, and “a progressive step-by-step approach” to the text, using “the concept of progressive consensus.” Colombia has previously suggested voting on contentious issues. Meanwhile, civil society observer Knowledge Ecology International (KEI) also proposed that negotiators “should consider new approaches, including some features of the benefit-sharing agreement in the new Law of the Sea Treaty, for areas beyond national jurisdiction. “In that agreement, governments take responsibility for the enforcement of benefit-sharing, and the triggers for benefit-sharing are downstream, on the filing or patents or the registration or sale of products.” Posts navigation Older postsNewer posts
Grim Warning of Dwindling Funds for Emergencies as States Vote on Attacks in Lebanon and Iran 20/05/2026 Kerry Cullinan Dr Annette Heinzelmann, emergency director for the WHO Eastern Mediterranean Region (EMRO) The grim impossibility of addressing rising health emergencies with dwindling budgets was raised at the World Health Assembly (WHA) on Tuesday – amid votes on attacks on healthcare in Lebanon and Israel. “Outbreaks are accelerating, while the systems designed to stop them are being weakened,” warned Dr Annette Heinzelmann, emergency director for the WHO Eastern Mediterranean Region (EMRO), during a discussion of health emergencies in Committee A. “The gap between needs and resources is now unsustainable. The WHO Health Emergency Programme faced a $553 million funding gap in 2024 and 2025. The contingency fund for emergencies entered 2026 with just $19.5 million, while our regional emergency workforce has been cut by half. We cannot continue confronting expanding emergencies with shrinking capacity.” In EMRO, 117 million people need humanitarian assistance; there are 14 graded emergencies, 44 active outbreaks, and more than 50 public health events across 17 member states. “Conflict, displacement, climate shock, economic collapse, and diseases are colliding into a single expanding poly crisis,” Heinzelmann warned, speaking on behalf of the regional director. “Across Gaza, Sudan, Yemen, Somalia, and Afghanistan, and amid escalation affecting Iran, Syria, and Lebanon, WHO is sustaining trauma care, delivering medicines, reinforcing surveillance, and supporting governments to manage growing public health risks.” Votes on Lebanon and Iran Regional conflict is compounding the EMRO health crises. Lebanon received overwhelming support from the majority of member states in the wake of Israeli attacks on its health infrastructure – but there was little support for Iran’s appeal for support against similar attacks. Ninety-five member states voted in favour of a resolution that noted “a health emergency in Lebanon resulting from ongoing and recently intensified hostilities” and called for “the full protection of healthcare in Lebanon, including patients, health personnel, facilities and transport”. Only Israel and Honduras opposed the resolution, which did not name Israel as the aggressor. Voting on the resolution in support of Lebanon, following attacks on its health care by Israel. However, Iran’s resolution, condemning recent attacks on patients and health infrastructure, including on the Pasteur Institute – was defeated. The resolution did not mention Israel and the United States as the aggressors. Only 19 countries supported Iran, 30 voted against, and a whopping 58 countries abstained. Several countries cited Iran’s attacks against its own citizens and Gulf states, and the blockade of the Strait of Hormuz, preventing the flow of medical supplies, as reasons for not supporting the resolution. Voting on the resolution in support of Iran, in the wake of US and Israeli attacks on its health infrastructure. Haemorrhagic fever, extreme weather Voting came at the end of a discussion on the WHO’s involvement in health emergencies in the WHA’s Committee A. In 2025, WHO responded to 50 emergencies in 82 countries and territories, of which 20 were Grade 3 emergencies requiring the highest level of organisation-wide support, the organisation reported. Disease outbreaks included viral haemorrhagic fever: Sudan virus disease in Uganda; Marburg in Tanzania and Ethiopia; Ebola in the Democratic Republic of the Congo (DRC) and Rift Valley fever in Mauritania and Senegal. Mpox was declared a public health emergency of international concern (PHEIC), affecting 98 countries, with 52 974 confirmed cases – 84% in Africa – and 215 deaths. Thirty-three countries reported cholera outbreaks involving over 614 828 cases and 7,598 deaths. Angola, the DRC and Sudan had the highest cases. The WHO provided over 58 million doses of “emergency vaccines” for cholera, meningitis, yellow fever and Ebola. Challenges included “limited surveillance capacities and insufficient production of critical vaccines”. Three out of four emergencies were either caused or exacerbated by extreme weather events such as flooding, droughts and cyclones. Earthquakes in Afghanistan and Myanmar, severe Pacific typhoons and three category-5 hurricanes, including Hurricane Melissa, caused death and damage. The global cost of natural disasters is estimated at over $ 200 billion annually. So great was the demand for WHO’s assistance that its Contingency Fund for Emergencies was left with $19.5 million by the end of the year. Attacks on healthcare The severely destroyed Al-Shifa hospital in Gaza City, Palestine, in February 2025. Last year, the WHO verified 1,351 attacks on healthcare, resulting in 925 health facilities damaged or destroyed. The Independent Oversight and Advisory Committee (IOAC) for the WHO Health Emergencies Programme reports a “significant and alarming escalation” in these attacks that are likely to “underestimate the true scale of the crisis as reporting is uneven”. EMRO’s Heinzelmann said that almost 40% of these attacks occurred in her region, accounting for almost 90% of related deaths. “Attacks on healthcare must stop, humanitarian access must be guaranteed, and financing for preparedness and emergency response must increase now, not after the next global crisis is already underway,” she urged. Several member states, including Jordan, Switzerland, Australia, urged an end to attacks on health facilities and personnel and respect for international humanitarian law. Lack of financing The IOAC noted its deep concern at the “dramatic reductions in official development assistance from major donors”. During the 2008 global economic recession, the WHO “deprioritised” its emergency-related teams and reduced the workforce – but paid a high price during the Ebola outbreak in West Africa, “which resulted in over 11,000 lives lost and posed an existential threat to WHO”, noted the IOAC. “It is the IOAC’s responsibility to ensure that past weaknesses are not reprised and that WHO’s emergency capacities remain safeguarded.” In the WHO’s 2026‒2027 budget, the base budget of the emergencies programme has been set at $918.5 million, with 51% for country offices, 22% for regional offices and 27% for headquarters. Image Credits: Nour Alsaqqa/ MSF. WHO is Alarmed at ‘Scale and Speed’ of Ebola Outbreak as Hantavirus Threat Recedes 19/05/2026 Disha Shetty & Stefan Anderson Dr Tedros Adhanom Ghebreyesus is currently serving his second five-year term as WHO Director-General. His mandate expires on August 15, 2027. GENEVA — The outbreak of a deadly strain of Ebola for which there is no vaccine is accelerating through the Democratic Republic of Congo (DRC) and Uganda at a “scale and speed” alarming the World Health Organization (WHO), as cases climb and authorities scramble to contain the spread. “I’m deeply concerned about the scale and speed of the epidemic,” WHO chief Dr Tedros Adhanom Ghebreyesus told the 79th World Health Assembly on Tuesday, addressing delegates from 192 nations gathered in Geneva. More than 500 suspected cases and 130 suspected deaths beyond the confirmed caseload have been reported. Tedros said the figures would change as field operations scale up, including strengthening surveillance, contact tracing, and laboratory testing. “So far, 30 cases have been confirmed in the DRC from the northern province of Ituri,” he added. “Uganda has also informed WHO of two confirmed cases in the capital of Kampala, including one death among two individuals who travelled from DRC, and there is one US citizen confirmed positive and transferred to Germany.” “This epidemic is caused by Bundibugyo, a species of Ebola virus for which there are no vaccines or therapeutics,” Tedros said. Diagnostic tests in the region were designed for a different strain of Ebola and missed early infections, resulting in a four-week gap before the outbreak was detected. Ongoing shortages of diagnostic equipment on the frontlines mean the true size of the outbreak remains unknown. “In the absence of a vaccine, there are many other measures countries, of course, can take to stop the spread of this virus and save lives, even without medical countermeasures, including risk communication and community engagement,” Tedros said, commending Uganda for postponing its annual Martyrs’ Day celebrations, which can draw up to two million people. The Ebola virus kills up to half of those it infects, making any outbreak particularly dangerous. In response to the outbreak, the United States banned citizens from the DRC, Uganda and Sudan from entering the US on Monday. Also read: Tedros: ‘We Live in Difficult, Dangerous and Divisive Times’ ‘Did not do this lightly’ Ongoing 79th session of the WHA in Geneva, Switzerland. The rapid spiral led Tedros to declare the outbreak a public health emergency of international concern (PHEIC) on Sunday, the first time a Director-General has done so before convening an emergency committee. “I did not do this lightly,” he told the assembly. “I did it in accordance with Article 12 of the International Health Regulations, after consulting the ministers of health of both countries.” The emergency committee will meet later on Tuesday to advise on what response measures countries should adopt, as there is no vaccine and no cure for the strain of Ebola now spreading. The first confirmed case was a health worker, meaning the virus was already moving through medical settings before anyone knew it was there. After heavy criticism of the WHO’s slow handling of the 2014 West African Ebola epidemic, the agency’s chief appears unwilling to allow a repeat of history. Tedros said an additional $3.4 million was released from the WHO’s Contingency Fund for Emergencies, bringing the total committed to the response to $3.9 million. “WHO has a team on the ground supporting national authorities to respond,” he said. “We have deployed people, supplies, equipment, and funds.” LIVE: @DrTedros‘ address to the #WHA79 delegates https://t.co/IUGcXQ3cLe — World Health Organization (WHO) (@WHO) May 19, 2026 Deadly delays leave authorities flying blind Ebola health worker in protective gear. File image. Cases have surfaced in densely populated urban areas, including the Ugandan capital Kampala and the eastern DRC city of Goma, home to millions of people and serving as major hubs for cross-border trade and movement. The outbreak is likely to have originated in DRC’s Ituri province, a high-traffic mining area on the borders of South Sudan and Uganda, which “increases the risk of regional exportation and cross-border transmission”, according to the WHO. Fighting in the area between the DRC army and M23, an Islamist armed group, has intensified since late 2025 and escalated significantly over the past two months. More than 100,000 people have been newly displaced by the conflict, Tedros told the assembly – potentially carrying the virus with them as they go, far from the reach of surveillance teams and into communities with little capacity to identify or isolate new cases. “In Ebola outbreaks, you know what displacement means,” Tedros said. “The area is also a mining zone with high levels of population movement that increase the risk of further spread.” Local funeral practices, which involve close contact and touching the deceased, also accelerated transmission before authorities knew the outbreak was happening. The current outbreak is the third recorded outbreak of Bundibugyo, first identified in 2007. Hantavirus contained There are no known vaccines or therapeutics for this strain of Ebola making containment a challenge. The picture is markedly different for hantavirus, which Tedros also addressed. Two weeks ago, the hantavirus outbreak aboard the MV Hondius cruise ship, sparked international panic and wall-to-wall news coverage, but it has now been brought under control, Tedros told the assembly. “WHO’s assessment continues to be that the risk of hantavirus globally is low,” Tedros said. The ship docked in Rotterdam on Sunday, with the crew now in quarantine until 29 June. Passengers, who have been repatriated, will be monitored until 21 June. “So far, there are 11 reported cases, including three deaths, and no deaths have been reported since the second of May, when WHO was first informed of the outbreak on the ship. Those numbers have changed little since the outbreak was first reported to WHO two weeks ago,” Tedros said. The two outbreaks, emerging within two weeks of each other, served as a reminder of WHO’s core function, Tedros told the assembly. “The outbreaks of Ebola and Hantavirus in the past two weeks show why international threats need an international response,” he said. “They show why the world needs the international health regulations and why it needs WHO.” WHO successes: tobacco and taxes Tedros also highlighted WHO’s wins in his address, including the decline in tobacco use. “Tobacco use has dropped by one-third globally and continues to decline in 140 countries. With support from WHO, Maldives became the first country to adopt a generational tobacco ban for people born from 2007. This year, the United Kingdom followed suit, banning the sale of tobacco to anyone born from 2009 onwards,” he said. Since 2025, the WHO has been encouraging countries to tax tobacco, alcohol, and sugary drinks by at least 50% by 2035. “In the past 12 months, India, Jamaica, Malaysia, Mauritius, Mexico, Montenegro, Viet Nam, Saudi Arabia, Sierra Leone and Zambia were among countries that either announced, introduced or increased taxes on one or more of these products,” Tedros said. WHO’s advocacy to increase the rate of breastfeeding globally has also yielded positive results, with almost half of children worldwide being breastfed for at least for six months, Tedros said. A billion more people now have access to safe drinking water compared to just a decade ago, but the levels of violence against women have remained stagnant for two decades. However, the shortage of healthcare workers is hampering progress: “The world is facing a shortage of 11 million health workers by 2030, with the biggest gaps in the African and Eastern Mediterranean regions. More than half the gap is a shortage of nurses,” Tedros said. The world is also set to miss every one of the 52 health-related Sustainable Development Goal targets by 2030, the WHO revealed on the eve of the WHA. Malaria cases are rising, maternal deaths are still occurring at nearly three times the targeted rate and childhood vaccination coverage is plateauing or falling in some regions, and progress on global health goals has slowed, stalled or reversed across virtually every measure since 2015, according to the 2026 World Health Statistics report. Image Credits: WHO/Christopher Black , WHO/X, Africa CDC , WHO/X. Undocumented Migrants Fall Through Europe’s Healthcare Cracks, Joint Research Shows 19/05/2026 Felix Sassmannshausen Undocumented migrants navigate precarious conditions, often lacking health safety nets, despite contributing to informal economies. As Europe grapples with shifting demographics and an influx of migration, researchers are mapping how undocumented migrants navigate the administrative cracks of the continent’s healthcare systems – helping to fill a critical data gap identified by the World Health Organization. Inside the neoclassical venue of La Pastorale in Geneva, around 30 participants from six European universities convened on Monday on the sidelines of the World Health Assembly to dissect an expanding public health crisis related to the healthcare of immigrants, whose status and lack of resources means they often seek care in the shadows of the formal system – or fall through the cracks altogether until an emergency. The Geneva Health Forum event highlighted how complex administrative barriers keep undocumented migrant children and the elderly across the continent from accessing essential healthcare, leaving untreated chronic conditions, severe mental health crises, and emergencies to strain local resources. Professors Claudine Burton-Jeangros and Yves Jackson of the University of Geneva. The “Growing and ageing in the shadows” (GRACE) project, co-directed by Professor of Medicine Yves Jackson and health sociologist Professor Claudine Burton-Jeangros of the University of Geneva, explores these disparities as part of the European University Alliance (4EU+). The consortium unites scholars from the universities of Geneva, Heidelberg, Prague, Milan, Paris Sorbonne, and Copenhagen. Mapping the barriers and needs in Europe’s cities remains exceptionally difficult, as a lack of information and personnel, coupled with a profound fear of discrimination or deportation, drives undocumented migrants away from clinical settings and creates severe data deficits. The scale of this blind spot is particularly evident among minors; in Germany, for example, population estimates for undocumented children range wildly from a few thousand to over 100,000, the researchers noted. To enable evidence-based policymaking, the GRACE consortium navigates these blind spots by conducting in-depth interviews with frontline healthcare providers, social workers, and non-governmental actors to uncover the practical realities these vulnerable groups experience. While the results presented on Monday were preliminary, the consortium projects final results by the end of the year. They aim to use the findings to inform and advocate to policymakers on how to improve healthcare access. Fragmented bureaucracies erode rights of undocumented migrants WHO data on inclusion of refugee and migrant health aspects in national policies, legislation strategies or plans across thematic areas in the European Region. Access to equitable healthcare is a fundamental human right, reinforced by international frameworks such as the WHO Global Action Plan and the 2026 Progress Declaration of the International Migration Review Forum (IMRF) – the primary UN platform for tracking global migration commitments. Although the WHO notes significant recent progress – such as the WHO European Region’s action plan to improve legal access to care – these theoretical rights continue to routinely erode within the continent’s complex bureaucracies. In universal healthcare systems like Denmark’s – where the uninsured population also includes European Union citizens who have simply fallen out of the formal labour market – the mandate for a central registration number excludes those without formal residency documents. Lacking this registration number, undocumented individuals are forced to rely on a parallel, privately funded network of volunteer-run clinics for even the most basic medical care. Even in jurisdictions with progressive entitlements specifically designed for undocumented populations, such as France – where, notably, children cannot legally be classified as undocumented – administrative labyrinths and illegal discrimination by providers severely limit practical access. Although the French State Medical Aid guarantees free access to essential care after three months of residency, eligible patients are still frequently turned away by providers who illegally refuse to treat those relying on state support. University of Geneva researchers Srilak Weerawardane and Emma Perneger present preliminary findings. Germany also sees a growing number of uninsured migrants falling through the cracks. And this is not surprising since it enforces a severe legal Catch-22, the researchers found: while doctors maintain confidentiality, social welfare offices must report undocumented patients to immigration authorities if public funds cover their care. Additionally, hospitals frequently deny expensive treatments to avoid unpaid hospital bills. Ultimately, this systemic threat breeds a profound fear of deportation, driving undocumented migrants away from clinics entirely. Switzerland’s mandatory healthcare system grants all residents the right and legal obligation to purchase expensive insurance. Undocumented migrants – strictly excluding asylum seekers with pending applications – cannot opt out but face severe barriers to state subsidies. Forced to pay out of pocket, they accumulate massive debt, which accounts for an estimated 90% of their total arrears in Geneva. University of Geneva researchers concluded this financial burden traps individuals in poverty and paralyses future regularisation attempts, since being debt-free is a primary requirement for legal residency. Healthcare hinges on relationships instead of rights Locked out of formal systems, undocumented migrants rely on informal networks and alternative routes for essential healthcare. Because official avenues remain blocked, fragmented NGO clinics and volunteer doctors often serve as the primary safety net for basic care, the research team from the University of Copenhagen explained. To bridge the gap between theoretical rights and practical access, social workers must frequently intervene to defend marginalised patients, while physicians in countries like the Czech Republic utilise personal discretion to classify treatments as “acute care” to legally compel hospitals to provide treatment. Ultimately, receiving medical attention often depends on the willingness of individual healthcare providers to bypass restrictive frameworks. As a result, securing essential treatment is often reduced to a matter of luck, depending heavily on the informal networks of the doctors and the specific resources of the patients themselves. Heidelberg University researchers Manuela Orjuela-Grimm and Veronika Wiemker discuss their research on healthcare barriers. “It’s really contingent on personal relationships and healthcare providers… instead of being a right,” Veronika Wiemker, a researcher at the Heidelberg University on the situation in Germany, reflecting the shared reality across the continent. Faced with such systemic exclusion, undocumented migrants utilise alternative routes to care. To treat their conditions, individuals proactively stockpile medicine, consult online forums or artificial intelligence, and rely on transnational healthcare – such as travelling across borders for treatment or using telemedicine to maintain remote consultations with doctors in their countries of origin, as the researchers from Prague’s Charles University found. Young migrants navigate fragmented care Driven under the administrative radar, undocumented children face severe healthcare fragmentation, missing crucial developmental screenings and continuous medical support. The situation for undocumented children is particularly dire, despite being specially protected under international provisions. As undocumented parents often lack official birth certificates, their newborns remain largely under the administrative radar. The living conditions for these youngest migrants are frequently severe; in France alone, researchers from Paris Sorbonne University report that an estimated 3,000 homeless newborns and their mothers are discharged from hospitals directly onto the streets each year. Sorbonne University researchers Fanny Teissandier and Andrea Tortelli outline their methodology. Without stable housing or formal documentation, young migrants across the continent frequently miss out on crucial immunisations and preventive measures, mental health support, and basic dental care. While school-aged children occasionally receive basic entry assessments or see school nurses – as is the practice in countries like Germany and Denmark – the ongoing absence of holistic, continuous care exposes them to severe developmental risks and untreated chronic conditions. Unaccompanied minors endure even deeper vulnerability, often surviving on the streets while facing malnutrition and severe trauma. Despite being theoretically protected by local authorities, these youths remain highly vulnerable to exploitation, sex work, and chronic stress. Ultimately, the transition to adulthood introduces a severe, continent-wide cliff edge for these adolescents. Upon turning 18, temporary legal protections abruptly dissolve – either plunging the young adults into mandatory insurance systems they cannot afford or stripping them of their rights entirely. Ageing populations undergo unique crises Elderly undocumented migrants often endure accelerated ageing and complete exclusion from formal European long-term healthcare networks. The plight of the elderly introduces an entirely distinct set of challenges for local administrators, revealing severe gaps in long-term care. While some older migrants are newly arrived parents joining their children, many others are former labourers who planned to briefly work abroad but ultimately remained for decades. After years of surviving precarious, physically demanding jobs in the informal economy, these individuals frequently experience “accelerated ageing”, untreated chronic pain, and rapid cognitive decline. Furthermore, returning to their countries of origin is rarely a viable solution, as many have lived in Europe for well over a decade and no longer possess any social ties or family networks back home. Their vulnerability is compounded by European health systems that intrinsically tie medical entitlements to formal employment. Once these individuals age out of the workforce or lose their physical capacity to continue their demanding labour, they lose their economic value – frequently stripping them of their eligibility for public health subsidies and plunging them into poverty. This loss of economic value and legal status leaves elderly undocumented migrants completely excluded from formal long-term care solutions. Fearing that elderly, homeless migrants will become permanent “bed blockers” with no follow-up care options, hospitals in countries like France sometimes even deny them access to inpatient admission. Fear fuels harmful data gaps The bureaucratic ‘Chicken and Egg’ cycle: Financial burden and fear drive clinical avoidance, creating a data deficit that fuels policy paralysis. Beyond the immediate health consequences, the overarching fear of deportation forces individuals to “pretend not to be there.” Because undocumented migrants often actively avoid clinics, they remain completely hidden from formal health frameworks, creating a massive data blind spot for policymakers. Closing this gap is a global mandate, forming the core of the third and fifth priorities of the WHO Global Action Plan regarding migration health research and data. WHO’s Daniel Míč emphasises data to bridge divides. Daniel Míč, representing the World Health Organization (WHO) Special Initiative on Health and Migration, stressed that this dynamic creates a bureaucratic “chicken and egg” scenario. “If you are in a vulnerable situation, and you are afraid of being deported, or you are afraid of being punished by the system that you seek health or care from, there’s a problem,” he warned, noting that capturing necessary public health data becomes difficult when fear drives individuals away from the frontline clinics that would otherwise document their conditions. This data deficit is further compounded by the fact that defining who exactly qualifies as an “undocumented migrant” remains a major challenge. Because each national system applies its own administrative labels, the practical barriers these individuals face are dictated entirely by the bureaucracy of the country they reside in. Ultimately, “we will understand the challenges only if we have the data,” Míč said, stressing that concrete evidence is the only way to bridge political divides and present actionable solutions to policymakers. To close this harmful data gap, the GRACE consortium plans to synthesise its preliminary findings into targeted case studies and scientific reports by the end of the year. Recognising the immense value of this frontline research guiding European member states in building inclusive healthcare systems, Míč expressed a readiness to resume dialogue with the 4EU+ Alliance, hoping to translate previous discussions into a concrete collaboration. More Countries Refer to Refugees in Health Policies, but Access and Data Gaps Persist Image Credits: Adhitya Ginanjar/Unsplash, Tim Mossholder/Unsplash/HPW, University of Geneve/HUG, WHO/HPW, Felix Sassmannshausen/HPW, Beth Macdonald/Unsplash. Member States Support Extending Talks on Pandemic Agreement Annex, Propose New ‘Method’ 19/05/2026 Kerry Cullinan Pakistan’s Adeel Khokhar All World Health Organization (WHO) member states supported the extension of talks on the last outstanding piece of the Pandemic Agreement, the Pathogen Access and Benefit-Sharing (PABS) annex, at the World Health Assembly’s (WHA) Committee A on Monday. A draft PABS annex was due to have been presented to the WHA for approval, but instead, a report from the World Health Organization (WHO) Director General notes that member states need more time to reach an agreement. The PABS annex will govern how dangerous pathogens are shared during public health emergencies and how to share any medical products (benefits) produced as a result of manufacturers getting access to this information. A draft annex will either be presented at next year’s WHA or at a special WHA if agreement is reached beforehand, according to the report. Several of the many member states speaking on PABS in Committee A expressed confidence that the annex would be completed by the end of the year. However, divisions between developed and developing countries remained stark. Pakistan warned that the PABS negotiations should not be concluded in a way that “preserves the commercial privileges of a handful of manufacturers”. Pakistan’s representative told the committee: “We are witnessing a sustained effort by some member states to hollow out Article 12 [of the Pandemic Agreement], which clearly establishes the principle of equal footing” between sharing dangerous pathogens and sharing any benefits that manufacturers accrue from such knowledge. “We will not sign off on a multilateral system success story that serves the interests of industry over the health security of billions,” he added. ‘Conducive to R&D’ Malaysia’s representative in Committee A. On the other end of the spectrum, the European Union warned that a PABS agreement should not stifle research and development. “The Pandemic Agreement, as well as the revised IHR [International Health Regulations], contain important provisions that will significantly increase our capacity to confront pandemic emergencies and do so in a more equitable manner,” said the European Union. “The PABS system has an important role to play in this context, but we need to ensure that the system is also conducive to innovation, and research and development for medical countermeasures, then it can lead to a robust uptake by the private sector.” African countries, represented by South Africa, explained once again their demands for an equitable PABS system, including that the annex should include legally binding contracts between the WHO and manufacturers. Impetus for a global PABS system comes from the need to correct the inequities of the COVID-19 pandemic, when developing countries were initially unable to get vaccines – even for healthworkers – as these had all been bought by wealthy countries. As Namibia reminded the committee: “We negotiated the Pandemic Agreement because the world watched developing countries bury their loved ones due to COVID-19 while vaccines sat unused in warehouses elsewhere. That memory must anchor every line that we now draft.” “The credibility of this agreement now rests on the PABS annex. If access obligations read ‘shall’ while benefit-sharing obligations read ‘options’, and ‘where available’, we will have written inequity into international laws with our own hands.” “Benefit-sharing obligations must be legally binding and enforceable,” said Nigeria. “Technology transfer and non-exclusive licensing and local production partnerships must be obligations manufacturers sign onto, not options they select from a menu.” Malaysia emphasises that annex must clearly spell out the rights and obligations of parties, and be “operationally implementable”. Referring to the current hantavirus and Ebola outbreaks, Spain urged the completion of the annex so that the Pandemic Agreement could come into force and provide a solid regulatory framework “to prevent, prepare, and respond to health emergencies”. New methods for future talks? After six formal meetings and several informal sessions, the Intergovernmental Working Group (IGWG) will reconvene in July. However, Colombia stated that the extension of the negotiations on the PABS annex “will only make sense if it allows for a more balanced result, which is technically solid and useful for global public health. ” Colombia’s representative said that the main barrier is that the “rules of intellectual property applied to public health become a barrier to access and the production of vaccines, treatments, and diagnostics, just as happened during the COVID 19 pandemic.” Colombia proposed new “working methods” for the talks, including that they are open rather than behind closed doors, and “a progressive step-by-step approach” to the text, using “the concept of progressive consensus.” Colombia has previously suggested voting on contentious issues. Meanwhile, civil society observer Knowledge Ecology International (KEI) also proposed that negotiators “should consider new approaches, including some features of the benefit-sharing agreement in the new Law of the Sea Treaty, for areas beyond national jurisdiction. “In that agreement, governments take responsibility for the enforcement of benefit-sharing, and the triggers for benefit-sharing are downstream, on the filing or patents or the registration or sale of products.” Posts navigation Older postsNewer posts
WHO is Alarmed at ‘Scale and Speed’ of Ebola Outbreak as Hantavirus Threat Recedes 19/05/2026 Disha Shetty & Stefan Anderson Dr Tedros Adhanom Ghebreyesus is currently serving his second five-year term as WHO Director-General. His mandate expires on August 15, 2027. GENEVA — The outbreak of a deadly strain of Ebola for which there is no vaccine is accelerating through the Democratic Republic of Congo (DRC) and Uganda at a “scale and speed” alarming the World Health Organization (WHO), as cases climb and authorities scramble to contain the spread. “I’m deeply concerned about the scale and speed of the epidemic,” WHO chief Dr Tedros Adhanom Ghebreyesus told the 79th World Health Assembly on Tuesday, addressing delegates from 192 nations gathered in Geneva. More than 500 suspected cases and 130 suspected deaths beyond the confirmed caseload have been reported. Tedros said the figures would change as field operations scale up, including strengthening surveillance, contact tracing, and laboratory testing. “So far, 30 cases have been confirmed in the DRC from the northern province of Ituri,” he added. “Uganda has also informed WHO of two confirmed cases in the capital of Kampala, including one death among two individuals who travelled from DRC, and there is one US citizen confirmed positive and transferred to Germany.” “This epidemic is caused by Bundibugyo, a species of Ebola virus for which there are no vaccines or therapeutics,” Tedros said. Diagnostic tests in the region were designed for a different strain of Ebola and missed early infections, resulting in a four-week gap before the outbreak was detected. Ongoing shortages of diagnostic equipment on the frontlines mean the true size of the outbreak remains unknown. “In the absence of a vaccine, there are many other measures countries, of course, can take to stop the spread of this virus and save lives, even without medical countermeasures, including risk communication and community engagement,” Tedros said, commending Uganda for postponing its annual Martyrs’ Day celebrations, which can draw up to two million people. The Ebola virus kills up to half of those it infects, making any outbreak particularly dangerous. In response to the outbreak, the United States banned citizens from the DRC, Uganda and Sudan from entering the US on Monday. Also read: Tedros: ‘We Live in Difficult, Dangerous and Divisive Times’ ‘Did not do this lightly’ Ongoing 79th session of the WHA in Geneva, Switzerland. The rapid spiral led Tedros to declare the outbreak a public health emergency of international concern (PHEIC) on Sunday, the first time a Director-General has done so before convening an emergency committee. “I did not do this lightly,” he told the assembly. “I did it in accordance with Article 12 of the International Health Regulations, after consulting the ministers of health of both countries.” The emergency committee will meet later on Tuesday to advise on what response measures countries should adopt, as there is no vaccine and no cure for the strain of Ebola now spreading. The first confirmed case was a health worker, meaning the virus was already moving through medical settings before anyone knew it was there. After heavy criticism of the WHO’s slow handling of the 2014 West African Ebola epidemic, the agency’s chief appears unwilling to allow a repeat of history. Tedros said an additional $3.4 million was released from the WHO’s Contingency Fund for Emergencies, bringing the total committed to the response to $3.9 million. “WHO has a team on the ground supporting national authorities to respond,” he said. “We have deployed people, supplies, equipment, and funds.” LIVE: @DrTedros‘ address to the #WHA79 delegates https://t.co/IUGcXQ3cLe — World Health Organization (WHO) (@WHO) May 19, 2026 Deadly delays leave authorities flying blind Ebola health worker in protective gear. File image. Cases have surfaced in densely populated urban areas, including the Ugandan capital Kampala and the eastern DRC city of Goma, home to millions of people and serving as major hubs for cross-border trade and movement. The outbreak is likely to have originated in DRC’s Ituri province, a high-traffic mining area on the borders of South Sudan and Uganda, which “increases the risk of regional exportation and cross-border transmission”, according to the WHO. Fighting in the area between the DRC army and M23, an Islamist armed group, has intensified since late 2025 and escalated significantly over the past two months. More than 100,000 people have been newly displaced by the conflict, Tedros told the assembly – potentially carrying the virus with them as they go, far from the reach of surveillance teams and into communities with little capacity to identify or isolate new cases. “In Ebola outbreaks, you know what displacement means,” Tedros said. “The area is also a mining zone with high levels of population movement that increase the risk of further spread.” Local funeral practices, which involve close contact and touching the deceased, also accelerated transmission before authorities knew the outbreak was happening. The current outbreak is the third recorded outbreak of Bundibugyo, first identified in 2007. Hantavirus contained There are no known vaccines or therapeutics for this strain of Ebola making containment a challenge. The picture is markedly different for hantavirus, which Tedros also addressed. Two weeks ago, the hantavirus outbreak aboard the MV Hondius cruise ship, sparked international panic and wall-to-wall news coverage, but it has now been brought under control, Tedros told the assembly. “WHO’s assessment continues to be that the risk of hantavirus globally is low,” Tedros said. The ship docked in Rotterdam on Sunday, with the crew now in quarantine until 29 June. Passengers, who have been repatriated, will be monitored until 21 June. “So far, there are 11 reported cases, including three deaths, and no deaths have been reported since the second of May, when WHO was first informed of the outbreak on the ship. Those numbers have changed little since the outbreak was first reported to WHO two weeks ago,” Tedros said. The two outbreaks, emerging within two weeks of each other, served as a reminder of WHO’s core function, Tedros told the assembly. “The outbreaks of Ebola and Hantavirus in the past two weeks show why international threats need an international response,” he said. “They show why the world needs the international health regulations and why it needs WHO.” WHO successes: tobacco and taxes Tedros also highlighted WHO’s wins in his address, including the decline in tobacco use. “Tobacco use has dropped by one-third globally and continues to decline in 140 countries. With support from WHO, Maldives became the first country to adopt a generational tobacco ban for people born from 2007. This year, the United Kingdom followed suit, banning the sale of tobacco to anyone born from 2009 onwards,” he said. Since 2025, the WHO has been encouraging countries to tax tobacco, alcohol, and sugary drinks by at least 50% by 2035. “In the past 12 months, India, Jamaica, Malaysia, Mauritius, Mexico, Montenegro, Viet Nam, Saudi Arabia, Sierra Leone and Zambia were among countries that either announced, introduced or increased taxes on one or more of these products,” Tedros said. WHO’s advocacy to increase the rate of breastfeeding globally has also yielded positive results, with almost half of children worldwide being breastfed for at least for six months, Tedros said. A billion more people now have access to safe drinking water compared to just a decade ago, but the levels of violence against women have remained stagnant for two decades. However, the shortage of healthcare workers is hampering progress: “The world is facing a shortage of 11 million health workers by 2030, with the biggest gaps in the African and Eastern Mediterranean regions. More than half the gap is a shortage of nurses,” Tedros said. The world is also set to miss every one of the 52 health-related Sustainable Development Goal targets by 2030, the WHO revealed on the eve of the WHA. Malaria cases are rising, maternal deaths are still occurring at nearly three times the targeted rate and childhood vaccination coverage is plateauing or falling in some regions, and progress on global health goals has slowed, stalled or reversed across virtually every measure since 2015, according to the 2026 World Health Statistics report. Image Credits: WHO/Christopher Black , WHO/X, Africa CDC , WHO/X. Undocumented Migrants Fall Through Europe’s Healthcare Cracks, Joint Research Shows 19/05/2026 Felix Sassmannshausen Undocumented migrants navigate precarious conditions, often lacking health safety nets, despite contributing to informal economies. As Europe grapples with shifting demographics and an influx of migration, researchers are mapping how undocumented migrants navigate the administrative cracks of the continent’s healthcare systems – helping to fill a critical data gap identified by the World Health Organization. Inside the neoclassical venue of La Pastorale in Geneva, around 30 participants from six European universities convened on Monday on the sidelines of the World Health Assembly to dissect an expanding public health crisis related to the healthcare of immigrants, whose status and lack of resources means they often seek care in the shadows of the formal system – or fall through the cracks altogether until an emergency. The Geneva Health Forum event highlighted how complex administrative barriers keep undocumented migrant children and the elderly across the continent from accessing essential healthcare, leaving untreated chronic conditions, severe mental health crises, and emergencies to strain local resources. Professors Claudine Burton-Jeangros and Yves Jackson of the University of Geneva. The “Growing and ageing in the shadows” (GRACE) project, co-directed by Professor of Medicine Yves Jackson and health sociologist Professor Claudine Burton-Jeangros of the University of Geneva, explores these disparities as part of the European University Alliance (4EU+). The consortium unites scholars from the universities of Geneva, Heidelberg, Prague, Milan, Paris Sorbonne, and Copenhagen. Mapping the barriers and needs in Europe’s cities remains exceptionally difficult, as a lack of information and personnel, coupled with a profound fear of discrimination or deportation, drives undocumented migrants away from clinical settings and creates severe data deficits. The scale of this blind spot is particularly evident among minors; in Germany, for example, population estimates for undocumented children range wildly from a few thousand to over 100,000, the researchers noted. To enable evidence-based policymaking, the GRACE consortium navigates these blind spots by conducting in-depth interviews with frontline healthcare providers, social workers, and non-governmental actors to uncover the practical realities these vulnerable groups experience. While the results presented on Monday were preliminary, the consortium projects final results by the end of the year. They aim to use the findings to inform and advocate to policymakers on how to improve healthcare access. Fragmented bureaucracies erode rights of undocumented migrants WHO data on inclusion of refugee and migrant health aspects in national policies, legislation strategies or plans across thematic areas in the European Region. Access to equitable healthcare is a fundamental human right, reinforced by international frameworks such as the WHO Global Action Plan and the 2026 Progress Declaration of the International Migration Review Forum (IMRF) – the primary UN platform for tracking global migration commitments. Although the WHO notes significant recent progress – such as the WHO European Region’s action plan to improve legal access to care – these theoretical rights continue to routinely erode within the continent’s complex bureaucracies. In universal healthcare systems like Denmark’s – where the uninsured population also includes European Union citizens who have simply fallen out of the formal labour market – the mandate for a central registration number excludes those without formal residency documents. Lacking this registration number, undocumented individuals are forced to rely on a parallel, privately funded network of volunteer-run clinics for even the most basic medical care. Even in jurisdictions with progressive entitlements specifically designed for undocumented populations, such as France – where, notably, children cannot legally be classified as undocumented – administrative labyrinths and illegal discrimination by providers severely limit practical access. Although the French State Medical Aid guarantees free access to essential care after three months of residency, eligible patients are still frequently turned away by providers who illegally refuse to treat those relying on state support. University of Geneva researchers Srilak Weerawardane and Emma Perneger present preliminary findings. Germany also sees a growing number of uninsured migrants falling through the cracks. And this is not surprising since it enforces a severe legal Catch-22, the researchers found: while doctors maintain confidentiality, social welfare offices must report undocumented patients to immigration authorities if public funds cover their care. Additionally, hospitals frequently deny expensive treatments to avoid unpaid hospital bills. Ultimately, this systemic threat breeds a profound fear of deportation, driving undocumented migrants away from clinics entirely. Switzerland’s mandatory healthcare system grants all residents the right and legal obligation to purchase expensive insurance. Undocumented migrants – strictly excluding asylum seekers with pending applications – cannot opt out but face severe barriers to state subsidies. Forced to pay out of pocket, they accumulate massive debt, which accounts for an estimated 90% of their total arrears in Geneva. University of Geneva researchers concluded this financial burden traps individuals in poverty and paralyses future regularisation attempts, since being debt-free is a primary requirement for legal residency. Healthcare hinges on relationships instead of rights Locked out of formal systems, undocumented migrants rely on informal networks and alternative routes for essential healthcare. Because official avenues remain blocked, fragmented NGO clinics and volunteer doctors often serve as the primary safety net for basic care, the research team from the University of Copenhagen explained. To bridge the gap between theoretical rights and practical access, social workers must frequently intervene to defend marginalised patients, while physicians in countries like the Czech Republic utilise personal discretion to classify treatments as “acute care” to legally compel hospitals to provide treatment. Ultimately, receiving medical attention often depends on the willingness of individual healthcare providers to bypass restrictive frameworks. As a result, securing essential treatment is often reduced to a matter of luck, depending heavily on the informal networks of the doctors and the specific resources of the patients themselves. Heidelberg University researchers Manuela Orjuela-Grimm and Veronika Wiemker discuss their research on healthcare barriers. “It’s really contingent on personal relationships and healthcare providers… instead of being a right,” Veronika Wiemker, a researcher at the Heidelberg University on the situation in Germany, reflecting the shared reality across the continent. Faced with such systemic exclusion, undocumented migrants utilise alternative routes to care. To treat their conditions, individuals proactively stockpile medicine, consult online forums or artificial intelligence, and rely on transnational healthcare – such as travelling across borders for treatment or using telemedicine to maintain remote consultations with doctors in their countries of origin, as the researchers from Prague’s Charles University found. Young migrants navigate fragmented care Driven under the administrative radar, undocumented children face severe healthcare fragmentation, missing crucial developmental screenings and continuous medical support. The situation for undocumented children is particularly dire, despite being specially protected under international provisions. As undocumented parents often lack official birth certificates, their newborns remain largely under the administrative radar. The living conditions for these youngest migrants are frequently severe; in France alone, researchers from Paris Sorbonne University report that an estimated 3,000 homeless newborns and their mothers are discharged from hospitals directly onto the streets each year. Sorbonne University researchers Fanny Teissandier and Andrea Tortelli outline their methodology. Without stable housing or formal documentation, young migrants across the continent frequently miss out on crucial immunisations and preventive measures, mental health support, and basic dental care. While school-aged children occasionally receive basic entry assessments or see school nurses – as is the practice in countries like Germany and Denmark – the ongoing absence of holistic, continuous care exposes them to severe developmental risks and untreated chronic conditions. Unaccompanied minors endure even deeper vulnerability, often surviving on the streets while facing malnutrition and severe trauma. Despite being theoretically protected by local authorities, these youths remain highly vulnerable to exploitation, sex work, and chronic stress. Ultimately, the transition to adulthood introduces a severe, continent-wide cliff edge for these adolescents. Upon turning 18, temporary legal protections abruptly dissolve – either plunging the young adults into mandatory insurance systems they cannot afford or stripping them of their rights entirely. Ageing populations undergo unique crises Elderly undocumented migrants often endure accelerated ageing and complete exclusion from formal European long-term healthcare networks. The plight of the elderly introduces an entirely distinct set of challenges for local administrators, revealing severe gaps in long-term care. While some older migrants are newly arrived parents joining their children, many others are former labourers who planned to briefly work abroad but ultimately remained for decades. After years of surviving precarious, physically demanding jobs in the informal economy, these individuals frequently experience “accelerated ageing”, untreated chronic pain, and rapid cognitive decline. Furthermore, returning to their countries of origin is rarely a viable solution, as many have lived in Europe for well over a decade and no longer possess any social ties or family networks back home. Their vulnerability is compounded by European health systems that intrinsically tie medical entitlements to formal employment. Once these individuals age out of the workforce or lose their physical capacity to continue their demanding labour, they lose their economic value – frequently stripping them of their eligibility for public health subsidies and plunging them into poverty. This loss of economic value and legal status leaves elderly undocumented migrants completely excluded from formal long-term care solutions. Fearing that elderly, homeless migrants will become permanent “bed blockers” with no follow-up care options, hospitals in countries like France sometimes even deny them access to inpatient admission. Fear fuels harmful data gaps The bureaucratic ‘Chicken and Egg’ cycle: Financial burden and fear drive clinical avoidance, creating a data deficit that fuels policy paralysis. Beyond the immediate health consequences, the overarching fear of deportation forces individuals to “pretend not to be there.” Because undocumented migrants often actively avoid clinics, they remain completely hidden from formal health frameworks, creating a massive data blind spot for policymakers. Closing this gap is a global mandate, forming the core of the third and fifth priorities of the WHO Global Action Plan regarding migration health research and data. WHO’s Daniel Míč emphasises data to bridge divides. Daniel Míč, representing the World Health Organization (WHO) Special Initiative on Health and Migration, stressed that this dynamic creates a bureaucratic “chicken and egg” scenario. “If you are in a vulnerable situation, and you are afraid of being deported, or you are afraid of being punished by the system that you seek health or care from, there’s a problem,” he warned, noting that capturing necessary public health data becomes difficult when fear drives individuals away from the frontline clinics that would otherwise document their conditions. This data deficit is further compounded by the fact that defining who exactly qualifies as an “undocumented migrant” remains a major challenge. Because each national system applies its own administrative labels, the practical barriers these individuals face are dictated entirely by the bureaucracy of the country they reside in. Ultimately, “we will understand the challenges only if we have the data,” Míč said, stressing that concrete evidence is the only way to bridge political divides and present actionable solutions to policymakers. To close this harmful data gap, the GRACE consortium plans to synthesise its preliminary findings into targeted case studies and scientific reports by the end of the year. Recognising the immense value of this frontline research guiding European member states in building inclusive healthcare systems, Míč expressed a readiness to resume dialogue with the 4EU+ Alliance, hoping to translate previous discussions into a concrete collaboration. More Countries Refer to Refugees in Health Policies, but Access and Data Gaps Persist Image Credits: Adhitya Ginanjar/Unsplash, Tim Mossholder/Unsplash/HPW, University of Geneve/HUG, WHO/HPW, Felix Sassmannshausen/HPW, Beth Macdonald/Unsplash. Member States Support Extending Talks on Pandemic Agreement Annex, Propose New ‘Method’ 19/05/2026 Kerry Cullinan Pakistan’s Adeel Khokhar All World Health Organization (WHO) member states supported the extension of talks on the last outstanding piece of the Pandemic Agreement, the Pathogen Access and Benefit-Sharing (PABS) annex, at the World Health Assembly’s (WHA) Committee A on Monday. A draft PABS annex was due to have been presented to the WHA for approval, but instead, a report from the World Health Organization (WHO) Director General notes that member states need more time to reach an agreement. The PABS annex will govern how dangerous pathogens are shared during public health emergencies and how to share any medical products (benefits) produced as a result of manufacturers getting access to this information. A draft annex will either be presented at next year’s WHA or at a special WHA if agreement is reached beforehand, according to the report. Several of the many member states speaking on PABS in Committee A expressed confidence that the annex would be completed by the end of the year. However, divisions between developed and developing countries remained stark. Pakistan warned that the PABS negotiations should not be concluded in a way that “preserves the commercial privileges of a handful of manufacturers”. Pakistan’s representative told the committee: “We are witnessing a sustained effort by some member states to hollow out Article 12 [of the Pandemic Agreement], which clearly establishes the principle of equal footing” between sharing dangerous pathogens and sharing any benefits that manufacturers accrue from such knowledge. “We will not sign off on a multilateral system success story that serves the interests of industry over the health security of billions,” he added. ‘Conducive to R&D’ Malaysia’s representative in Committee A. On the other end of the spectrum, the European Union warned that a PABS agreement should not stifle research and development. “The Pandemic Agreement, as well as the revised IHR [International Health Regulations], contain important provisions that will significantly increase our capacity to confront pandemic emergencies and do so in a more equitable manner,” said the European Union. “The PABS system has an important role to play in this context, but we need to ensure that the system is also conducive to innovation, and research and development for medical countermeasures, then it can lead to a robust uptake by the private sector.” African countries, represented by South Africa, explained once again their demands for an equitable PABS system, including that the annex should include legally binding contracts between the WHO and manufacturers. Impetus for a global PABS system comes from the need to correct the inequities of the COVID-19 pandemic, when developing countries were initially unable to get vaccines – even for healthworkers – as these had all been bought by wealthy countries. As Namibia reminded the committee: “We negotiated the Pandemic Agreement because the world watched developing countries bury their loved ones due to COVID-19 while vaccines sat unused in warehouses elsewhere. That memory must anchor every line that we now draft.” “The credibility of this agreement now rests on the PABS annex. If access obligations read ‘shall’ while benefit-sharing obligations read ‘options’, and ‘where available’, we will have written inequity into international laws with our own hands.” “Benefit-sharing obligations must be legally binding and enforceable,” said Nigeria. “Technology transfer and non-exclusive licensing and local production partnerships must be obligations manufacturers sign onto, not options they select from a menu.” Malaysia emphasises that annex must clearly spell out the rights and obligations of parties, and be “operationally implementable”. Referring to the current hantavirus and Ebola outbreaks, Spain urged the completion of the annex so that the Pandemic Agreement could come into force and provide a solid regulatory framework “to prevent, prepare, and respond to health emergencies”. New methods for future talks? After six formal meetings and several informal sessions, the Intergovernmental Working Group (IGWG) will reconvene in July. However, Colombia stated that the extension of the negotiations on the PABS annex “will only make sense if it allows for a more balanced result, which is technically solid and useful for global public health. ” Colombia’s representative said that the main barrier is that the “rules of intellectual property applied to public health become a barrier to access and the production of vaccines, treatments, and diagnostics, just as happened during the COVID 19 pandemic.” Colombia proposed new “working methods” for the talks, including that they are open rather than behind closed doors, and “a progressive step-by-step approach” to the text, using “the concept of progressive consensus.” Colombia has previously suggested voting on contentious issues. Meanwhile, civil society observer Knowledge Ecology International (KEI) also proposed that negotiators “should consider new approaches, including some features of the benefit-sharing agreement in the new Law of the Sea Treaty, for areas beyond national jurisdiction. “In that agreement, governments take responsibility for the enforcement of benefit-sharing, and the triggers for benefit-sharing are downstream, on the filing or patents or the registration or sale of products.” Posts navigation Older postsNewer posts
Undocumented Migrants Fall Through Europe’s Healthcare Cracks, Joint Research Shows 19/05/2026 Felix Sassmannshausen Undocumented migrants navigate precarious conditions, often lacking health safety nets, despite contributing to informal economies. As Europe grapples with shifting demographics and an influx of migration, researchers are mapping how undocumented migrants navigate the administrative cracks of the continent’s healthcare systems – helping to fill a critical data gap identified by the World Health Organization. Inside the neoclassical venue of La Pastorale in Geneva, around 30 participants from six European universities convened on Monday on the sidelines of the World Health Assembly to dissect an expanding public health crisis related to the healthcare of immigrants, whose status and lack of resources means they often seek care in the shadows of the formal system – or fall through the cracks altogether until an emergency. The Geneva Health Forum event highlighted how complex administrative barriers keep undocumented migrant children and the elderly across the continent from accessing essential healthcare, leaving untreated chronic conditions, severe mental health crises, and emergencies to strain local resources. Professors Claudine Burton-Jeangros and Yves Jackson of the University of Geneva. The “Growing and ageing in the shadows” (GRACE) project, co-directed by Professor of Medicine Yves Jackson and health sociologist Professor Claudine Burton-Jeangros of the University of Geneva, explores these disparities as part of the European University Alliance (4EU+). The consortium unites scholars from the universities of Geneva, Heidelberg, Prague, Milan, Paris Sorbonne, and Copenhagen. Mapping the barriers and needs in Europe’s cities remains exceptionally difficult, as a lack of information and personnel, coupled with a profound fear of discrimination or deportation, drives undocumented migrants away from clinical settings and creates severe data deficits. The scale of this blind spot is particularly evident among minors; in Germany, for example, population estimates for undocumented children range wildly from a few thousand to over 100,000, the researchers noted. To enable evidence-based policymaking, the GRACE consortium navigates these blind spots by conducting in-depth interviews with frontline healthcare providers, social workers, and non-governmental actors to uncover the practical realities these vulnerable groups experience. While the results presented on Monday were preliminary, the consortium projects final results by the end of the year. They aim to use the findings to inform and advocate to policymakers on how to improve healthcare access. Fragmented bureaucracies erode rights of undocumented migrants WHO data on inclusion of refugee and migrant health aspects in national policies, legislation strategies or plans across thematic areas in the European Region. Access to equitable healthcare is a fundamental human right, reinforced by international frameworks such as the WHO Global Action Plan and the 2026 Progress Declaration of the International Migration Review Forum (IMRF) – the primary UN platform for tracking global migration commitments. Although the WHO notes significant recent progress – such as the WHO European Region’s action plan to improve legal access to care – these theoretical rights continue to routinely erode within the continent’s complex bureaucracies. In universal healthcare systems like Denmark’s – where the uninsured population also includes European Union citizens who have simply fallen out of the formal labour market – the mandate for a central registration number excludes those without formal residency documents. Lacking this registration number, undocumented individuals are forced to rely on a parallel, privately funded network of volunteer-run clinics for even the most basic medical care. Even in jurisdictions with progressive entitlements specifically designed for undocumented populations, such as France – where, notably, children cannot legally be classified as undocumented – administrative labyrinths and illegal discrimination by providers severely limit practical access. Although the French State Medical Aid guarantees free access to essential care after three months of residency, eligible patients are still frequently turned away by providers who illegally refuse to treat those relying on state support. University of Geneva researchers Srilak Weerawardane and Emma Perneger present preliminary findings. Germany also sees a growing number of uninsured migrants falling through the cracks. And this is not surprising since it enforces a severe legal Catch-22, the researchers found: while doctors maintain confidentiality, social welfare offices must report undocumented patients to immigration authorities if public funds cover their care. Additionally, hospitals frequently deny expensive treatments to avoid unpaid hospital bills. Ultimately, this systemic threat breeds a profound fear of deportation, driving undocumented migrants away from clinics entirely. Switzerland’s mandatory healthcare system grants all residents the right and legal obligation to purchase expensive insurance. Undocumented migrants – strictly excluding asylum seekers with pending applications – cannot opt out but face severe barriers to state subsidies. Forced to pay out of pocket, they accumulate massive debt, which accounts for an estimated 90% of their total arrears in Geneva. University of Geneva researchers concluded this financial burden traps individuals in poverty and paralyses future regularisation attempts, since being debt-free is a primary requirement for legal residency. Healthcare hinges on relationships instead of rights Locked out of formal systems, undocumented migrants rely on informal networks and alternative routes for essential healthcare. Because official avenues remain blocked, fragmented NGO clinics and volunteer doctors often serve as the primary safety net for basic care, the research team from the University of Copenhagen explained. To bridge the gap between theoretical rights and practical access, social workers must frequently intervene to defend marginalised patients, while physicians in countries like the Czech Republic utilise personal discretion to classify treatments as “acute care” to legally compel hospitals to provide treatment. Ultimately, receiving medical attention often depends on the willingness of individual healthcare providers to bypass restrictive frameworks. As a result, securing essential treatment is often reduced to a matter of luck, depending heavily on the informal networks of the doctors and the specific resources of the patients themselves. Heidelberg University researchers Manuela Orjuela-Grimm and Veronika Wiemker discuss their research on healthcare barriers. “It’s really contingent on personal relationships and healthcare providers… instead of being a right,” Veronika Wiemker, a researcher at the Heidelberg University on the situation in Germany, reflecting the shared reality across the continent. Faced with such systemic exclusion, undocumented migrants utilise alternative routes to care. To treat their conditions, individuals proactively stockpile medicine, consult online forums or artificial intelligence, and rely on transnational healthcare – such as travelling across borders for treatment or using telemedicine to maintain remote consultations with doctors in their countries of origin, as the researchers from Prague’s Charles University found. Young migrants navigate fragmented care Driven under the administrative radar, undocumented children face severe healthcare fragmentation, missing crucial developmental screenings and continuous medical support. The situation for undocumented children is particularly dire, despite being specially protected under international provisions. As undocumented parents often lack official birth certificates, their newborns remain largely under the administrative radar. The living conditions for these youngest migrants are frequently severe; in France alone, researchers from Paris Sorbonne University report that an estimated 3,000 homeless newborns and their mothers are discharged from hospitals directly onto the streets each year. Sorbonne University researchers Fanny Teissandier and Andrea Tortelli outline their methodology. Without stable housing or formal documentation, young migrants across the continent frequently miss out on crucial immunisations and preventive measures, mental health support, and basic dental care. While school-aged children occasionally receive basic entry assessments or see school nurses – as is the practice in countries like Germany and Denmark – the ongoing absence of holistic, continuous care exposes them to severe developmental risks and untreated chronic conditions. Unaccompanied minors endure even deeper vulnerability, often surviving on the streets while facing malnutrition and severe trauma. Despite being theoretically protected by local authorities, these youths remain highly vulnerable to exploitation, sex work, and chronic stress. Ultimately, the transition to adulthood introduces a severe, continent-wide cliff edge for these adolescents. Upon turning 18, temporary legal protections abruptly dissolve – either plunging the young adults into mandatory insurance systems they cannot afford or stripping them of their rights entirely. Ageing populations undergo unique crises Elderly undocumented migrants often endure accelerated ageing and complete exclusion from formal European long-term healthcare networks. The plight of the elderly introduces an entirely distinct set of challenges for local administrators, revealing severe gaps in long-term care. While some older migrants are newly arrived parents joining their children, many others are former labourers who planned to briefly work abroad but ultimately remained for decades. After years of surviving precarious, physically demanding jobs in the informal economy, these individuals frequently experience “accelerated ageing”, untreated chronic pain, and rapid cognitive decline. Furthermore, returning to their countries of origin is rarely a viable solution, as many have lived in Europe for well over a decade and no longer possess any social ties or family networks back home. Their vulnerability is compounded by European health systems that intrinsically tie medical entitlements to formal employment. Once these individuals age out of the workforce or lose their physical capacity to continue their demanding labour, they lose their economic value – frequently stripping them of their eligibility for public health subsidies and plunging them into poverty. This loss of economic value and legal status leaves elderly undocumented migrants completely excluded from formal long-term care solutions. Fearing that elderly, homeless migrants will become permanent “bed blockers” with no follow-up care options, hospitals in countries like France sometimes even deny them access to inpatient admission. Fear fuels harmful data gaps The bureaucratic ‘Chicken and Egg’ cycle: Financial burden and fear drive clinical avoidance, creating a data deficit that fuels policy paralysis. Beyond the immediate health consequences, the overarching fear of deportation forces individuals to “pretend not to be there.” Because undocumented migrants often actively avoid clinics, they remain completely hidden from formal health frameworks, creating a massive data blind spot for policymakers. Closing this gap is a global mandate, forming the core of the third and fifth priorities of the WHO Global Action Plan regarding migration health research and data. WHO’s Daniel Míč emphasises data to bridge divides. Daniel Míč, representing the World Health Organization (WHO) Special Initiative on Health and Migration, stressed that this dynamic creates a bureaucratic “chicken and egg” scenario. “If you are in a vulnerable situation, and you are afraid of being deported, or you are afraid of being punished by the system that you seek health or care from, there’s a problem,” he warned, noting that capturing necessary public health data becomes difficult when fear drives individuals away from the frontline clinics that would otherwise document their conditions. This data deficit is further compounded by the fact that defining who exactly qualifies as an “undocumented migrant” remains a major challenge. Because each national system applies its own administrative labels, the practical barriers these individuals face are dictated entirely by the bureaucracy of the country they reside in. Ultimately, “we will understand the challenges only if we have the data,” Míč said, stressing that concrete evidence is the only way to bridge political divides and present actionable solutions to policymakers. To close this harmful data gap, the GRACE consortium plans to synthesise its preliminary findings into targeted case studies and scientific reports by the end of the year. Recognising the immense value of this frontline research guiding European member states in building inclusive healthcare systems, Míč expressed a readiness to resume dialogue with the 4EU+ Alliance, hoping to translate previous discussions into a concrete collaboration. More Countries Refer to Refugees in Health Policies, but Access and Data Gaps Persist Image Credits: Adhitya Ginanjar/Unsplash, Tim Mossholder/Unsplash/HPW, University of Geneve/HUG, WHO/HPW, Felix Sassmannshausen/HPW, Beth Macdonald/Unsplash. Member States Support Extending Talks on Pandemic Agreement Annex, Propose New ‘Method’ 19/05/2026 Kerry Cullinan Pakistan’s Adeel Khokhar All World Health Organization (WHO) member states supported the extension of talks on the last outstanding piece of the Pandemic Agreement, the Pathogen Access and Benefit-Sharing (PABS) annex, at the World Health Assembly’s (WHA) Committee A on Monday. A draft PABS annex was due to have been presented to the WHA for approval, but instead, a report from the World Health Organization (WHO) Director General notes that member states need more time to reach an agreement. The PABS annex will govern how dangerous pathogens are shared during public health emergencies and how to share any medical products (benefits) produced as a result of manufacturers getting access to this information. A draft annex will either be presented at next year’s WHA or at a special WHA if agreement is reached beforehand, according to the report. Several of the many member states speaking on PABS in Committee A expressed confidence that the annex would be completed by the end of the year. However, divisions between developed and developing countries remained stark. Pakistan warned that the PABS negotiations should not be concluded in a way that “preserves the commercial privileges of a handful of manufacturers”. Pakistan’s representative told the committee: “We are witnessing a sustained effort by some member states to hollow out Article 12 [of the Pandemic Agreement], which clearly establishes the principle of equal footing” between sharing dangerous pathogens and sharing any benefits that manufacturers accrue from such knowledge. “We will not sign off on a multilateral system success story that serves the interests of industry over the health security of billions,” he added. ‘Conducive to R&D’ Malaysia’s representative in Committee A. On the other end of the spectrum, the European Union warned that a PABS agreement should not stifle research and development. “The Pandemic Agreement, as well as the revised IHR [International Health Regulations], contain important provisions that will significantly increase our capacity to confront pandemic emergencies and do so in a more equitable manner,” said the European Union. “The PABS system has an important role to play in this context, but we need to ensure that the system is also conducive to innovation, and research and development for medical countermeasures, then it can lead to a robust uptake by the private sector.” African countries, represented by South Africa, explained once again their demands for an equitable PABS system, including that the annex should include legally binding contracts between the WHO and manufacturers. Impetus for a global PABS system comes from the need to correct the inequities of the COVID-19 pandemic, when developing countries were initially unable to get vaccines – even for healthworkers – as these had all been bought by wealthy countries. As Namibia reminded the committee: “We negotiated the Pandemic Agreement because the world watched developing countries bury their loved ones due to COVID-19 while vaccines sat unused in warehouses elsewhere. That memory must anchor every line that we now draft.” “The credibility of this agreement now rests on the PABS annex. If access obligations read ‘shall’ while benefit-sharing obligations read ‘options’, and ‘where available’, we will have written inequity into international laws with our own hands.” “Benefit-sharing obligations must be legally binding and enforceable,” said Nigeria. “Technology transfer and non-exclusive licensing and local production partnerships must be obligations manufacturers sign onto, not options they select from a menu.” Malaysia emphasises that annex must clearly spell out the rights and obligations of parties, and be “operationally implementable”. Referring to the current hantavirus and Ebola outbreaks, Spain urged the completion of the annex so that the Pandemic Agreement could come into force and provide a solid regulatory framework “to prevent, prepare, and respond to health emergencies”. New methods for future talks? After six formal meetings and several informal sessions, the Intergovernmental Working Group (IGWG) will reconvene in July. However, Colombia stated that the extension of the negotiations on the PABS annex “will only make sense if it allows for a more balanced result, which is technically solid and useful for global public health. ” Colombia’s representative said that the main barrier is that the “rules of intellectual property applied to public health become a barrier to access and the production of vaccines, treatments, and diagnostics, just as happened during the COVID 19 pandemic.” Colombia proposed new “working methods” for the talks, including that they are open rather than behind closed doors, and “a progressive step-by-step approach” to the text, using “the concept of progressive consensus.” Colombia has previously suggested voting on contentious issues. Meanwhile, civil society observer Knowledge Ecology International (KEI) also proposed that negotiators “should consider new approaches, including some features of the benefit-sharing agreement in the new Law of the Sea Treaty, for areas beyond national jurisdiction. “In that agreement, governments take responsibility for the enforcement of benefit-sharing, and the triggers for benefit-sharing are downstream, on the filing or patents or the registration or sale of products.” Posts navigation Older postsNewer posts
Member States Support Extending Talks on Pandemic Agreement Annex, Propose New ‘Method’ 19/05/2026 Kerry Cullinan Pakistan’s Adeel Khokhar All World Health Organization (WHO) member states supported the extension of talks on the last outstanding piece of the Pandemic Agreement, the Pathogen Access and Benefit-Sharing (PABS) annex, at the World Health Assembly’s (WHA) Committee A on Monday. A draft PABS annex was due to have been presented to the WHA for approval, but instead, a report from the World Health Organization (WHO) Director General notes that member states need more time to reach an agreement. The PABS annex will govern how dangerous pathogens are shared during public health emergencies and how to share any medical products (benefits) produced as a result of manufacturers getting access to this information. A draft annex will either be presented at next year’s WHA or at a special WHA if agreement is reached beforehand, according to the report. Several of the many member states speaking on PABS in Committee A expressed confidence that the annex would be completed by the end of the year. However, divisions between developed and developing countries remained stark. Pakistan warned that the PABS negotiations should not be concluded in a way that “preserves the commercial privileges of a handful of manufacturers”. Pakistan’s representative told the committee: “We are witnessing a sustained effort by some member states to hollow out Article 12 [of the Pandemic Agreement], which clearly establishes the principle of equal footing” between sharing dangerous pathogens and sharing any benefits that manufacturers accrue from such knowledge. “We will not sign off on a multilateral system success story that serves the interests of industry over the health security of billions,” he added. ‘Conducive to R&D’ Malaysia’s representative in Committee A. On the other end of the spectrum, the European Union warned that a PABS agreement should not stifle research and development. “The Pandemic Agreement, as well as the revised IHR [International Health Regulations], contain important provisions that will significantly increase our capacity to confront pandemic emergencies and do so in a more equitable manner,” said the European Union. “The PABS system has an important role to play in this context, but we need to ensure that the system is also conducive to innovation, and research and development for medical countermeasures, then it can lead to a robust uptake by the private sector.” African countries, represented by South Africa, explained once again their demands for an equitable PABS system, including that the annex should include legally binding contracts between the WHO and manufacturers. Impetus for a global PABS system comes from the need to correct the inequities of the COVID-19 pandemic, when developing countries were initially unable to get vaccines – even for healthworkers – as these had all been bought by wealthy countries. As Namibia reminded the committee: “We negotiated the Pandemic Agreement because the world watched developing countries bury their loved ones due to COVID-19 while vaccines sat unused in warehouses elsewhere. That memory must anchor every line that we now draft.” “The credibility of this agreement now rests on the PABS annex. If access obligations read ‘shall’ while benefit-sharing obligations read ‘options’, and ‘where available’, we will have written inequity into international laws with our own hands.” “Benefit-sharing obligations must be legally binding and enforceable,” said Nigeria. “Technology transfer and non-exclusive licensing and local production partnerships must be obligations manufacturers sign onto, not options they select from a menu.” Malaysia emphasises that annex must clearly spell out the rights and obligations of parties, and be “operationally implementable”. Referring to the current hantavirus and Ebola outbreaks, Spain urged the completion of the annex so that the Pandemic Agreement could come into force and provide a solid regulatory framework “to prevent, prepare, and respond to health emergencies”. New methods for future talks? After six formal meetings and several informal sessions, the Intergovernmental Working Group (IGWG) will reconvene in July. However, Colombia stated that the extension of the negotiations on the PABS annex “will only make sense if it allows for a more balanced result, which is technically solid and useful for global public health. ” Colombia’s representative said that the main barrier is that the “rules of intellectual property applied to public health become a barrier to access and the production of vaccines, treatments, and diagnostics, just as happened during the COVID 19 pandemic.” Colombia proposed new “working methods” for the talks, including that they are open rather than behind closed doors, and “a progressive step-by-step approach” to the text, using “the concept of progressive consensus.” Colombia has previously suggested voting on contentious issues. Meanwhile, civil society observer Knowledge Ecology International (KEI) also proposed that negotiators “should consider new approaches, including some features of the benefit-sharing agreement in the new Law of the Sea Treaty, for areas beyond national jurisdiction. “In that agreement, governments take responsibility for the enforcement of benefit-sharing, and the triggers for benefit-sharing are downstream, on the filing or patents or the registration or sale of products.” Posts navigation Older postsNewer posts